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Abstract
The serendipitous discovery of penicillin by Alexander Fleming in 1928 marked the glorious 
beginning of the modem antibiotic era with an innumerable number of lives being saved every 
single day by the use of antibiotics. Unfortunately, emergences of antibiotic resistance are taking 
us back to the pre-antibiotic era. Indiscriminate uses of antibiotics for therapeutic purposes and 
growth promotion in cattle are the major factors for the spread of antimicrobial drug resistance. 
Exposure of sub lethal levels of antibiotics to pathogenic microorganisms leads to the 
development of resistance, which then in due course spreads to other bacterial communities via 
horizontal and vertical gene transfer. Natural environment acts as a centre stage for such events 
and act as reservoir for antibiotic resistant bacteria. Anthropogenically polluted rivers can act as 
one such reservoir.
This thesis explores this possibility and describes the isolation characterization of multidrug 
resistant bacteria from the water samples of Dighty Bum. Five different strains of multidrug 
resistant bacteria viz. Enterobacter spp., Burkholderia cepacia, Aeromonas hydrophila, 
Enterobacter agglomerans, and Pseudomonas stutzeri that were resistant towards ampicillin, co- 
trimoxazole, novobiocin and tetracycline were successfully identified. Furthermore, the incidence 
of plasmid mediated and efflux pump mediated drug resistance has been proved in this work. 
Further studies involving proteomic and genomic analysis/comparison of environmental bacteria 
and their laboratory counterparts revealed the influence of the environment in conferring 
increased resistance and virulence in environmental strains as evidenced by marked variation in 
outer membrane proteins and virulence gene expression.
Thus the findings of the present study point out the role of our natural ecosystems, especially 
rivers, in spreading multidrug resistant pathogenic bacteria and warrants further study and 
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Chapter 1. Introduction and Literature Review
Bacterial infections are associated with significant human suffering and mortality (NIH, 2011). 
They play a major role in human activity because of their ability to transfer quickly and 
effectively to susceptible individuals, causing morbid and fatal diseases. The human body is a 
reservoir for large numbers of microbes, especially bacteria. Most of these are non-pathogenic, 
but a few are opportunistic pathogens (Dethlefsen et al., 2007). One well-known group of 
commensal bacteria in the gastrointestinal tract of mammals are the Enterobacteriaceae family. 
The organisms of this group help in the fermentation of undigested carbohydrates and production 
of vitamins in the gut (Wallace et a l, 2011). However, a few members of this family may cause 
significant disease in the form of food poisoning when conditions become suitable for them, e.g. 
lowered immunity etc. Alexander Fleming’s discovery of penicillin in 1928 and the subsequent 
isolation and development of the first mass-produced antibiotic led to perhaps the greatest 
medical revolution of the 20th century. Many health problems and casualties during World War II 
were successfully treated with penicillin. The advent of antibiotics dramatically increased the 
average human life expectancy by eight years over the period between 1940 to 1972 (Smith et al., 
2013; Hollis & Ahmed 2013). However, antibiotics have been unknowingly used for thousands 
of years in certain traditional medicines as naturally occurring chemical substances with potent 
bactericidal properties (Oldfield & Feng, 2014). Fleming’s discovery led to a golden age of 
antibiotic discoveries and widespread clinical usage of antibiotics became commonplace 
(Verbeken et al., 2014).
Four years after Fleming’s discovery of penicillin, the discovery of Prontosil further led to 
the development of sulphonamide drugs, another class of bactericidal drugs (Barr et al., 1986). 
Sulphonamides and penicillin were first used in the 1930s and 1940s to treat bacterial infections,
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yet evidence of antibiotic resistance was also shown by Fleming himself shortly after his 
discovery of penicillin (Yoneyama & Katsumata, 2006). Because of their ability to adapt quickly 
in response to external environment, bacteria soon developed resistance to the existing antibiotics 
as an evolutionary response to the challenges towards their growth and survival. For example, the 
Shigella spp. outbreak that occurred in Japan in 1953 led to the isolation of Shigella dysenteriae, 
a bacterial strain with multiple-drug resistance, which exhibits significant resistance against many 
drugs or antibiotics, such as sulphonamides, streptomycin, tetracycline and chloramphenicol 
(Watanabe, 1963) Resistance in bacteria can occur naturally, with recent research showing that 
bacteria exhibited antibiotic resistance long before Fleming’s discovery (D’Costa et al., 2011; 
Wardwell et a l, 2009) . In a study by D’Costa et al. (2011), bacteria isolated within permafrost 
dating back over 3,000 years ago were found to have markers of antibiotic resistance. Another 
study by Wardwell et al. (2009) found antibiotic resistant indigenous bacteria in a 2,000 year old 
peat bog habitat.
Even though some strains of bacteria naturally develop antibiotic resistance phenotypes, it 
is without question that bacteria over-exposed to antibiotics will eventually develop resistance 
towards the antibiotic as a natural survival mechanism (Davies & Davies, 2010). An example of 
this can be found in closely related families of bacteria, such as Pseudomonas spp. (Hibbing et 
al., 2010). Substantial evidence suggests that irresponsible antibiotic administration in clinical 
institutions has been a major reason for the exponential growth of antibiotic resistant bacteria 
(Knobler et al., 2003). In 2007, there were 400,000 reported infections and 25,000 reported 
deaths in Europe due to antibiotic resistant bacteria (Gillings, 2013). This has resulted in an 
estimated cumulative 2.5 million extra days in hospital and a societal cost of €1.5 billion annually
2
(Gilbert, n.d.). Therefore, drug resistant bacteria have become a significant medical and economic 
concern throughout the world.
1.1 Mechanisms of antibiotic resistance
Antibiotic resistance is often described as a simple evolutionary response to environmental 
pressures, when a bacterial colony is exposed to drugs, the cells that develop defences to these 
antibiotics will survive and multiply (Davies & Davies 2010). Antibiotic resistance in bacteria is 
a survival mechanism against adverse environmental conditions and can be either inherent as a 
natural feature of the species or can be acquired through a favourable mutation in the DNA or 
through exchange of genetic material coding for resistance to an antibiotic (Barr et al., 1986). 
The success of any therapeutic agent, such as antibiotics, is compromised by the potential 
development of tolerance or resistance to the antibiotic in use. Resistance to antibiotics is a 
natural trait that occurs in some microbes, as in the case of Gram-negative bacteria in which the 
extra outer membrane acts as an additional barrier that reduces permeability for the entry of 
antibiotics (Ahmed et al., 2010).
Antibiotics that have been developed to slow down and inhibit-bacterial growth-act in a 
number of ways, including the inhibition of cell wall synthesis (P-lactam antibiotics) (Cho et a l , 
2014), inhibition of protein synthesis (streptomycin) (Luzzatto et al., 1969) and the prevention of 
the replication of genetic material (ciprofloxacin) (Fournier et al., 2000). In turn, et al., several 
strains of bacteria have developed defence mechanisms tailored to counteract the functional 
mechanisms of these antibiotics, making these drugs inactive or ineffective in carrying out their 
functions (Davies & Davies, 2010). For example, changes in the number and character of porin 
channels that carry vital nutrients in and out of bacteria can lead to resistance to kanamycin 
(Hibbing et al., 2010).
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Inactivation of antibiotics by enzymatic action is another common way by which bacteria 
develop resistance to antibiotics (Davies, 1994). Some bacteria have enzymes that can modify the 
structures of antibiotics in ways that prevent its action against the microbe (Wright, 2005). 
Aminoglycosides, such as kanamycin and tobramycin, are inactivated by modifications that 
reduce the net positive charges on polycationic antibiotics (Davies & Wright, 1997), These 
processes involve phosphorylation catalysed by aminoglycoside phosphoryltransferase (APH), 
acetylation by aminoglycoside acetyltransferase (AAC), or adenylation by aminoglycoside 
adenyltransferase (Davies & Wright, 1997; Wright et a l , 1998; Magnet & Blanchard, 2005; 
Morar & Wright, 2010). On the other hand, penicillins, cephalosporins, and carbapenems, such as 
imipenem, are inactivated by enzymatic hydrolysis by P-lactamases which usually occurs in the 
bacterial periplasm (Li & Nikaido, 2009). The P-lactamase enzymes such as penicillinases 
degrade the penicillin drug by cleaving its P-lactam ring (D’Costa et al., 2011). Genes coding for 
these inactivating enzymes can easily produce resistance as additional components on plasmids.
Some bacterial enzymes induce a physiological or structural change that alters the target 
site of the drug so that it is no longer bound by the antibiotic. These changes can come about 
through the selection for random point mutations during normal bacterial reproduction (Tenover, 
2006). These mutations typically occur at a frequency of approximately 10'8 to 10‘9, or in other 
words, the common enteric bacteria develop resistance at the rate of one in a hundred thousand to 
one in a billion (Maiden, 1998).
1.2 Mutation and natural selection for antibiotic resistance
Mutation is a natural phenomenon that results in permanent changes in the genetic material 
brought about by alterations in the nucleotide sequences that make up the bacterial chromosome
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or plasmid DNA. Some mutations remain unrepaired as they are not DNA damage per se, even 
though they can result from damaged DNA, but changes in the sequence of the nucleotide bases 
are replicated as the cell divides (Denver et al., 2005).
In the presence of sufficient nutrients and in adequate environmental conditions bacteria 
continually replicate through binary fission, with each mother cell dividing into two genetically 
and phenotypically identical daughter cells (Holmes & Jobling, 1996). Therefore, each 
replication cycle results in a new generation of bacteria with the same DNA sequence as the 
original mother cell. When bacteria replicate in the presence of antibiotics (both anthropogenic 
and natural), mutations that naturally occur during the replication cycle may be selected for, 
leading to a new generation of bacteria that carry a slightly different genotype producing an 
antibiotic-resistant phenotype (Davies & Davies, 2010). These mutations are passed on to 
subsequent generations as each cell divides. This process of evolution in response to natural 
selection may result in mutated strains of a bacterial species that are more virulent or resistant to 
antibiotics than their non-mutant counterparts (Martinez & Baquero, 2002). However, not all 
mutations are favourable to the organism and even though the change is not detrimental their 
continued survival is very much dependent on the Darwinian theory of natural selection. 
Bacterial populations are in constant competition for food and habitat and those with the most 
favourable mutation to survive in antibiotic-laced environments have a reproductive edge over 
other species (Hibbing et al., 2010). Mutation at the frequency of one in a billion would take a 
very long time to grant drug resistance in response to natural selection, but the rapid rate of 
bacterial replication, coupled with the enormous numbers of clones within a population 
overcomes the low mutation frequency and in a very short time results in antibiotic resistance 
within a population of bacteria (Levy, 2002). Rapid proliferation of bacteria aids the development
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of resistance in mutant strains that eventually become dominant in an antibiotic-enriched 
environment. The next hurdle for a newly emergent antibiotic-resistant strain is to proliferate, as 
it is still under the risk of being destroyed by sudden changes in the environment where pure 
strains with the same genetic make-up tend to be more susceptible to antibiotic.
Recombination in bacteria (Schwesinger, 1977) also facilitates vertical gene transfer 
(VGT) with the added advantage of bringing in more genetic variation into the genome. 
However, widespread antibiotic resistance is not driven by vertical gene transfer alone, but by the 
acquisition of antibiotic resistant genes from other bacteria already having this property. This 
occurs by another phenomenon called Horizontal Gene Transfer (HGT).
HGT is possible because most o f these antibiotic resistance mechanisms acquired through 
spontaneous mutations are encoded on extra-chromosomal DNA called plasmids that can be 
transmitted across bacteria of not only the same or closely related species, but to other distantly 
related species (Woodgate et al, 1994).
1.3 Horizontal gene transfer and spread of antibiotic resistance
Horizontal gene transfer (HGT) is common in microorganisms, including bacteria, and results in 
the exchange of genetic material between several species, some of them distantly related 
(Nikolaidis et a l, 2014). The acquisition of a wide range of genetic adaptations favouring 
survival, such as antibiotic resistance, can be acquired more rapidly as a result of direct gene 
transfer compared to incremental inheritance of genetic mutations, which is also referred to as 
lateral gene transfer (LGT). This phenomenon is proving to be a challenge in the fight against 
antibiotic resistance in pathogenic bacteria. Multi-drug resistance, as well as increased virulence
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in some of the most common pathogenic bacterial strains, has resulted from LGT of antibiotic 
resistance and exotoxin-producing genes (Koch, 2014).
The increasing virulence of drug resistant bacteria can be partly attributed to mutations as 
in the case of extended-spectrum p-lactamase-producing (ESBL) in the famous strain of 
Escherichia coli (ST 131) that is causing an epidemic of extra-intestinal pathogenesis all over the 
world (Price et al., 2013). However, the Shiga toxin-producing capability acquired by E. coli is a 
classic example of HGT from the donor Shigella spp. bacteria (Ogura et al., 2015). Normally, a 
commensal bacterial species, such as enterohemorrhagic E. coli 0157:H7 (EHEC) develops a 
virulent phenotype by adopting genetic information from Shigella sp. that produces the toxin 
(Price et al., 2013).
HGT takes place through various mechanisms, such as transformation, conjugation and 
transduction. Other gene transfer and insertion agents, such as plasmids, bacteriophages, 
integrons and transposons may also play a role in the widespread occurrence of antibiotic 
resistance through HGT (Tennstedt et al., 2005) Another phenomenon that favours the drug 
resistance acquisition across bacterial species is the clustering of these genes to form Complex 
Resistance gene Loci (CRL), making its transfer as well as dissemination within the microbe 
much easier, efficient and can explain the formation of bacterial strains with multi-drug 
resistance (Szczepanowski et al., 2005).
1.4 Transformation
Transformation is a mechanism naturally found in many bacteria by which they directly take in 
genetic material from the surroundings and incorporate it into their own genome, resulting in the 
alteration o f the genetic makeup of the organism (Cohen et al., 1972; Griffith, 1928).
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Transformation requires only one active player as it involves the acquisition of genetic materials 
from the environment where this material may be present in abundance, through cell death and 
disintegration that takes place especially when an organism has been in a competitive mode for 
survival. However, for transformation to occur, the bacterium requires high energy expenditure 
and should also be in a specific state of transformation competence (Leisner et al, 2009). 
Limitation of nutrients and high population density are some of the factors that lead to the state of 
competence required. For example in Bacillus subtilis, scarcity of amino acids at the end of 
exponential growth brings about the competence for transformation. The intake of genetic 
material is likely to occur only in a specific set of conditions, which includes the presence of 
compatible material. Because of the restrictive nature of transformation, this method is not 
considered a great driving force in widespread antibiotic resistance. In several species of 
Streptococcus, transformation takes place in high-density conditions that result in the formation 
of bacterial biofilms that act as a reservoir of compatible genetic material (Li et al., 2001).
1.5 Conjugation
Following the experimental verification of transformation as a horizontal gene transfer 
mechanism, in 1946 Joshua Lederberg and Edward Tatum discovered that a donor bacterium can 
transfer its genetic material to another donor bacterium after establishing a physical contact 
through a bridge or pilus (Amabile-Cuevas & Chicurel, 1993; Lederberg & Tatum, 1946). The 
genetic material is in the form of a plasmid, which is capable of independent replication. This 
horizontal gene transfer is beneficial to the recipient bacterium as it facilitates the transfer of an 
antibiotic resistance phenotype from the donor to the recipient cell, which enhances the 
recipient’s ability to withstand the selective pressures from the environment. The bacterium
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possessing this copy becomes capable of transferring the donated genetic material to another 
recipient. Conjugation is a highly effective horizontal gene transfer mechanism with the potential 
to drive large scale development of drug resistance across bacterial species, because genetic 
transfer can take place between distantly related species. Since the process can occur multiple 
times and between multiple donor-recipient pairs, conjugation has the potential to result in 
bacterial strains with multiple drug resistance (MDR). Conjugation employs a mechanism that 
detects whether the recipient bacterium already contains genetic material of the same type. This 
ensures that only truly beneficial genetic codes are exchanged (Andam & Hanage, 2014). Certain 
essential coupling proteins, such as plasmid R388 TrwB, assist the transfer of DNA across the 
cell membranes for successful bacterial conjugation (Gomis-Riith et al., 2002). Plasmids are one 
of the most important agents of HGT as they can be exchanged between distantly related bacterial 
species, as in the case of IncP-1 and PromA group plasmids that drive HGT in soil bacteria 
(Zhang et a l, 2015).
1.6 Transduction
Transduction is a method of horizontal gene transfer which does not require direct contact 
between the donor and recipient bacteria, but involves a vector, most often viruses, capable of 
infecting bacteria also known as “bacteriophages” (Yasbin & Young, 1974; Zinder & Lederberg, 
1952). These phages use the hosts’ mechanism of genetic replication to make copies of the viral 
DNA. The virus containing the bacterial gene that codes for antibiotic resistance infects a new 
bacterial cell and introduces this genetic material (containing marker for antibiotic resistance) 
into the recipient. Occasionally, bacterial DNA gets packaged in a viral capsid and when these 
virions containing bacterial genes infect a new bacterium, the bacterial DNA recombines with the
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genetic material of the new host. This is a form of generalized transduction that happens 
accidentally, but another process called headful packaging by a bacteriophage (Coren et al., 
1995) also leads to generalized transduction. The virus fills the nucleocapsid with both viral and 
bacterial DNA, but on infecting another bacterium, the bacterial DNA may form plasmids within 
the recipient or recombine with its genetic material. Specialized transduction may also occur in 
some cases when the bacteriophage attaches to the host chromosome to make copies, but when 
the prophage detaches from the chromosome it takes a part of the host chromosome lying close to 
the point of excision and carries it to the next bacterium it infects. This type of transduction is 
observed particularly in the virulent enterohemorrhagic E. coli 0157 that has also acquired Shiga 
toxins 1 and 2 (Asadulghani et al., 2009). Transduction occurs in several other pathogenic 
bacteria species such as Staphylococcus, Salmonella, Pseudomonas, as well as in other 
Escherichia strains. Bacteriophages that mediate transduction can be virulent or temperate. 
Transduction can take place across families too. However, in most cases, it usually takes place 
between closely related bacterial species because of the involvement of the bacteriophages that 
may be species specific to some extent, which makes it a limited pathway for the spread of 
antibiotic resistance (Asadulghani et al., 2009).
Whatever may be the way of gene transfer, the development of antibiotic resistance 
occurs only when the gene expresses itself and produces a significant effect, which results in the 
loss of activity of the antibiotic.
1.7 Acquired antibiotic resistance in natural environments
Resistance genes are not only distributed randomly in bacterial population, but also clustered in 
multiple drug resistance strains. Anthropogenic activities play a significant role in the distribution
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of antibiotic resistance. Drug resistant strains initially appeared in hospitals, where use of 
antibiotics is common and in large quantity (Davies & Davies 2010). However, the frequency of 
international travel, combined with worldwide lack o f standards of antibiotic use, generation and 
illegal methods of dumping hospital waste and sewage, has accelerated the spread of resistance 
across the globe and in every environment (Allen et al., 2013; Levy, 2002). Antibiotic resistant 
bacteria are abundant in clinical environments and in farms of food producing animals (Vieira et 
al., 2011) as well as in the food we consume (McDermott et al., 2002). However, they are no 
longer restricted to the immediate human environment. The rampant use of antibiotics has 
resulted in the accumulation of drug-resistant genomes in various natural environments, including 
water bodies of such as rivers (Amaya et al., 2012), soil (D’Costa et al., 2007) and wildlife 
including wild birds (Hasan et al., 2012). In response to increasing antibiotic resistance, new 
drugs are being developed, but bacteria are proving to be rather adept in developing resistance to 
these drugs. Even bacteria that have had no direct exposure to the antibiotics exhibit resistant 
behaviour, probably because of HGT that helps them acquire resistant genes from other microbes 
that have already been exposed.
Animal husbandry is a major contributor to drug resistance in microbes, because of the 
indiscriminate use of antibiotics for medical and non-therapeutic purposes in the veterinary field 
(Allen et al., 2013). Antibiotics are frequently used in animals as part of the process to 
manufacture meats. Agricultural practices, such as the use of manure containing both low 
concentrations of antibiotics and antibiotic-resistant bacteria exacerbate the situation further 
(Ghosh & LaPara, 2007). Soil and water bodies in proximity to large animal farms are 
contaminated by a variety of pathogenic bacteria that can freely exchange genetic material with 
other naturally occurring bacteria to acquire multiple drug resistance (Da Costa et al., 2013).
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Treated waste water released into flowing water bodies is another major cause of 
contamination of natural environments since they carry human and animal pathogens, including 
antibiotic-resistant strains of bacteria, as well as antibiotics in low concentrations (Berglund, 
2015). A recent year-long study of the effluents released from waste water treatment plants in 
Spain (Ojer-Usoz et ah, 2014) found extended-spectrum P-lactamase-producing 
Enterobacteriaceae in 100% of the samples examined. This clearly shows that wastewater from 
various sources, including hospitals, needs to be disinfected far more meticulously than is being 
done, before releasing it to water bodies, because it has the potential of spreading antimicrobial 
resistance far and wide into natural environments. Use o f farm derived animal waste as manure is 
a widespread agricultural and aquacultural practice that can create a high risk for disseminating 
antimicrobial resistant pathogens to the environment (Omojowo & Omojasola, 2013) and wildlife 
(Blanco et al., 2009).
1.8 The role of livestock in antibiotic resistance and dissemination
Antibiotics are as essential in disease management in livestock as they are for treating bacterial 
infections in humans (Silbergeld et a l , 2008). Antibiotic use in domestic pets to treat a variety of 
bacterial infections ranging from diarrhoea, eye infections and otitis to serious respiratory 
diseases is common, but there are no fixed standards or uniformity in prescribing the drugs across 
countries (De Briyne et al., 2013; Wegener 2003). Intensive use and misuse of antibiotics in the 
veterinary field has contributed to the occurrence of bacterial resistance, regardless of whether 
these microbes are pathogenic, commensals or wild strains. Over recent years, antibiotic use has 
increased significantly in animal farms where large scale, intensive farming of food producing 
livestock is the norm to meet the massive demand for meat and other animal products (Landers et
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a l, 2012). The presence of large host populations in a small area can result in bacterial epidemics 
that can have high economic impact, which necessitates the use of antibiotics at community level 
not only for the treatment of the infections at times of disease outbreaks, but also as a 
prophylactic measure against potentially dangerous diseases (Laxminarayan et a l, 2013).
A proportion of the therapeutic dose of an antibiotic given to an animal will remain un­
metabolized and will then be excreted via urine and / or faeces. This will result in the 
environmental release of a high chemical load to the soil and water near large farms. The lower 
concentrations of the drug, while not preventing bacterial growth, will promote drug resistance in 
these microbes (Chee-Sanford et a l, 2009). There is evidence that P-lactam antibiotics, when 
used at lower concentrations, actually increase the rate of HGT in Staphylococcus aureus by 
conjugative transfer of plasmids (Barr et al, 1986). These chemical compounds break down 
during the treatment of waste water effluents and reach areas where pathogenic bacteria occur, 
thereby mediating lateral transfer of drug resistance among these organisms. Studies have proven 
the role of zinc oxide in promoting the proliferation of antibiotic resistance through many 
mechanisms including co-selection (Bednorz et a l, 2013), but many countries continue to use 
zinc oxide as an additive in animal feeds because of its significant ability to control weaning 
diarrhoea (Holm, 1996). The European Food Safety Agency (EFSA) allows 150 to 250 ppm of 
this chemical in animal feed and it is the most frequently used additive in medicated livestock 
feeds (De Briyne et a l, 2014). While disease management through antibiotics is an inevitable 
part of food production from farm animals, economic forces have led to the use of antibiotics in 
the feed to promote rapid growth and faster weight gain. Antibiotic usage began with sub- 
therapeutic dosages, when studies revealed a marked improvement in growth in broiler chickens 
that were administered these drugs through feed (Elam et a l 1953; Jacobs et a l 1953). The effect
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was attributed to the reduction of gut bacteria in response to the antibiotic administration through 
feed that also reduced nutrient loss resulting from the feeding of these organisms (Visek, 1978). 
The meat-producing animals were able to better utilize the nutrients in their food, resulting in 
higher growth rate (Gaskins et a l, 2002). The drugs were to be used at an optimum concentration 
that lies between the minimum effective concentration required for therapeutic effect and the 
minimum inhibitory concentrations (MIC) required for controlling the gut bacterial population. 
However, in practice, they were often used at much higher concentrations than the prescribed 
MIC. Prolonged use of low-dose antibiotics is found to enhance the development of drug 
resistance in bacterial populations exposed to them (Gilbert 2011). The use of antimicrobials as 
growth promoters is also known to prompt Escherichia coli strains to release Shiga toxins that 
increase cytotoxicity, as well as S7z/go-toxin-2-converting bacteriophages (Kohler et a l, 2000) 
that can spread this capability to other bacteria through transduction. Consequently, many 
European countries have banned the use of antimicrobial agents in livestock feed (Maron et al., 
2013), but 100% compliance has not been implemented and the practice still continues in 
countries where no such ban exists.
Alternatives to in-feed antimicrobials for growth promotion are being explored, but a 
drawback is that the exact mode of action of these drugs as growth promoters is unknown. The 
reduction in gut flora and consequent reduction in nutrient absorption by these microbes may not 
be the actual reason of the growth promoting effect. It was found that even though animals 
consuming feed fortified with the antimicrobial agent tylosin initially had significantly reduced 
microbial counts in faecal matter compared to the control group, the difference evened out after a 
period (Barug et al, 2006).
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Another alarming trend in veterinary medicine is the unrestricted use of Critically 
Important Antibiotics (CIA) to treat animal infections (WHO Advisory Group on Integrated 
Surveillance of Antimicrobial Resistance (AGISAR), 2011). The ever increasing occurrence of 
antibiotic resistance in bacteria and the corresponding increase in virulence in many new strains 
of pathogens has prompted the WHO to set aside certain important classes of antibiotics 
exclusively for human use. These important classes of antibiotics include: cephalosporins of the 
3rd and 4th generation, fluoroquinolones, glycopeptides, macrolides, oxalidinones, carbapenems, 
and lipopeptides as well as many of the newly developed antimicrobials (WHO Advisory Group 
on Integrated Surveillance of Antimicrobial Resistance (AGISAR), 2011). These are segregated 
for human use because they are essential for treating bacterial infections in humans such as 
meningitis and pneumonia. A voluntary survey of veterinary practitioners conducted on the use 
of CIA in veterinary practice across 25 countries in Europe, showed varying degrees of CIA 
usage in domestic pets and food animals (De Briyne et al, 2014). CIAs were often prescribed for 
treating respiratory infections in cattle and urinary infections in cats. This has the potential to 
cause the development of drug resistant bacterial strains in animals that can easily spread to 
humans (De Briyne et al, 2014).
In a cross-sectional survey on the antimicrobial prescription practices for horses among 
veterinarians in UK (Hughes et al, 2013) it was found that veterinarians in first-opinion practices 
prescribed broad-spectrum antimicrobials, such as trimethoprim-sulphonamide combinations 
more often for equine infections, because of their ease of use, lower cost and apparent lack of 
side effects. However, high levels of resistance to trimethoprim-sulphonamides have been 
reported in equine pathogenic bacteria (Maddox et al, 2012), particularly in enteric bacteria from 
faecal samples, which questions the efficacy of these antimicrobials in the treatment of equine
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infections. Veterinary clinicians who followed the guidelines of Veterinary Medicines 
Directorate (VMD) as their main resource for drug prescription are found to be less likely to 
prescribe trimethoprim-sulphonamides (Ahmed et al., 2010).
On the other hand, practitioners in referral hospitals are more likely to use 3rd and 4th 
generation cephalosporins and fluoroquinolones for treating equine infections. Although it is 
possible that this could be partly due to serious multi-drug resistant infections being brought to 
referral practices, probably after the failure of first-line treatments, the UK has not licensed 
fluoroquinolones for treating equine infections (Hughes et al., 2013). The use of these critical 
antimicrobials by referral practices were relatively low at 3.2% of all antimicrobials prescribed, 
but it was still nearly 10 times more than other practices. Moreover, the fluoroquinolone 
enrofloxacin, now available as Baytril™ for oral administration, is becoming more popular in 
equine practice in UK (Argyle, 2013).
The frequent and often indiscriminate use of antibiotics in the absence of correct protocols 
and monitoring mechanisms promotes the evolution of drug resistant strains with greater 
frequency among livestock (Johnson & Russo, 2002). The most frequent epidemics are caused by 
enteric bacterial species, such as E. coli, which can impact human health by causing 
gastrointestinal tract infections (Johnson & Russo, 2002).
Clear guidelines for antibiotic use in veterinary practice can go a long way in reducing the 
quantity of antimicrobials used, as well as the use of third-line drugs as demonstrated in a 
Canadian veterinary teaching hospital (Weese, 2006). This also reduces the prevalence of 
bacteria with antimicrobial resistance as demonstrated in human facilities with such guidelines 
for optimum antibiotic usage (Bantar et al., 2003).
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Besides the risks posed by direct contamination of human populations with drug resistant 
bacteria, a more widespread contamination of the environment, particularly soil and water, occurs 
through the disposal of animal waste products, including carcasses of animals dying of infectious 
diseases and manure put to agricultural use (Heuer et al, 2011). Large concentrations of drug 
resistant genomes coming together from various sources create the ideal competency conditions 
that trigger HGT through transformation and other means, facilitating the sharing of drug 
resistance to not only closely related bacterial species, but even to distantly related microbes in 
the soil and effluent that have not had any direct exposure to the antibiotics themselves (Heuer et 
al, 2011).
The anthropogenic antibiotic resistance in bacteria thus drives the evolution of microbial 
communities with multi-drug resistance, altering or destroying the ecosystem dynamics and 
shaping different bacterial lifestyles, resulting in significant consequences to human health (EU, 
2013; Pitout & Laupland, 2008).
Direct exposure to antibiotics is thought to be minimal in wildlife populations. However, 
wild animals can acquire a variety of drug-resistant bacteria through direct or indirect contact 
with domestic animals and humans (Radhouani et al., 2014). Typical examples are pests such as 
mice, rats and raccoons that raid farms that house livestock for food and come into contact with 
animals and their waste products that could be harbouring a number of antibiotic-resistant 
pathogens (Harwood et al., 2000). The most common of all is E. coll. The contamination of the 
water sources consequent to the mixing of the faeces of farm animals containing heavy loads of 
antibiotic resistant bacteria and ESBL, wild mammalian and avian populations are open to 
increasing exposure (Costa et a l, 2008). Due to their high adaptability to survival in various 
media, these primarily enteric bacteria are proving to be a novel form of environmental pollution
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(Guenther et al., 2011) as well as a biomarker for monitoring the distribution and effect of multi­
drug resistant microbes on wildlife.
One peculiar example of antibiotic resistance from wildlife is the study by Wildlife 
biologists (Cristobal-Azkarate et al., 2014). One study conducted to assess antibiotic resistance 
in bacteria in wildlife showed that antibiotic resistance was isolated among the wild Howler 
monkeys and other wild animals living freely in the Mexican region of Veracruz under different 
degrees of human influence (Cristobal-Azkarate et al., 2014). These areas are isolated national 
parks and are rarely inhabited by humans. The prevalence of antibiotic resistant bacteria was not 
only seen in howler monkeys, but also in tapirs, a dwarf leopard, jaguarondis, jaguars and spider 
monkeys (Cristobal-Azkarate et al., 2014). These results point to the fact that antibiotic resistance 
is inherent in nature and can take place independent from human activities.
1.9 The role o f river w ater as a reservoir for antibiotic resistance and 
dissemination
River water, being a direct source of drinking water for both wild and domesticated animal, can 
be a medium from which to acquire antibiotic resistance (Rinker et al., 1988). The river water 
receives processed effluents from factories as well as water processed from wastewater treatment, 
which may contain a cocktail of different antibiotics and other chemicals. This makes the river 
water a reservoir of low concentrations of antibiotics (Biyela et al., 2004). The constant presence 
of low-level antibiotic concentration will annihilate susceptible organisms present, while at the 
same time it selects for organisms resistant to the antibiotics present in the river water, thus 
making the river water an ideal breeding ground for antibiotic-resistant organisms. Water from 
rivers is also used for agriculture and grazing lands from which they might enter the bodies of
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domestic animals like cattle and sheep and hence, the human population (Ash et al., 2002). In a 
study in India it was found that the Ciprofloxacin concentration as high as 2.5mg/L were reported 
in river water downstream of a wastewater treatment plant. This river was found to receive water 
from 90 bulk antibiotic manufacturers. The antibiotics that were found in the river water included 
trimethoprim, ofloxacin, lomefloxacin, enoxacin and (Fick et al., 2009). When these resistant 
bacteria are excreted via animal faeces, they spread this resistance into the environment. Hence, 
the establishment of regulatory measures in the processing of wastewater from industries is of 
utmost importance.
1.10 The role o f hospitals in the dissemination o f antibiotic resistance
Hospitals and clinics are no less the responsible for the spread of antibiotic resistance amongst 
bacteria. Patients infected with bacteria come into the hospital and contaminate the hospital 
environment with contagious organisms that have a high probability of being antibiotic resistant 
already (Flaherty & Weinstein, 1996). These bacteria contaminate and infect other people and 
spread the resistance to the normal opportunistic microbial flora of the body (Wood et a l , 1996). 
Establishing clear guidelines for antimicrobial prescription in human and veterinary clinics and 
hospitals, and discouraging the non-therapeutic use of antibiotics, may help reduce drug-resistant 
bacterial concentration in the immediate human environment. However, whether this will 
considerably reduce observed drug-resistance, that is already established in the genomes of drug- 
resistant bacteria, and subsequently, its further distribution into natural environments is 
debatable.
The question as to whether antibiotics arose before antibiotic resistance or vice versa is 
highly debatable. Alternatively, antibiotic resistance may have co-evolved at the same time, since 
bacteria that produce the antibiotic are resistant to the antibiotic they produce. Over time, this
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trait is passed on to bacterial progenies which continue to collect mobile genetic elements that 
carry antibiotic resistance and eventually, they establish resistance to multiple antibiotics 
(Choffnes et a l, 2010). It is also difficult to say whether the exposure to antibiotics causes the 
resistance or it is a matter of chance and mutation that bacteria acquire resistance.
1.11 M ulti-drug and super drug resistance among bacteria
Unrestricted antibiotic use results in the spread of multi drug resistance (MDR) among number of 
bacteria that cause human infections (Alanis, 2005). The best-known example of this is 
MDR Mycobacterium tuberculosis (TB), which is a deadly organism prevalent in urban as well 
as rural settings (Almeida et a l, 2003; Ferrazoli et a l, 2000; Streicher et a l, 2004; Zaman et a l, 
2005). Hospitals are the source of many bacterial infections, such as those caused by 
Pseudomonas aeruginosa, Burkholderia cepacia, Salmonella spp. and Staphylococcus aureus 
(Lee & Greig, 2013; Lipowski et a l, 2008; Peleg & Hooper, 2010). The treatment options for 
these bacteria are restricted and may lead to longer duration of hospitalization and monitoring 
(WHO, 2015). The super-resistant strains have various characteristics, such as greater 
transmission rates, that have boosted their virulence capacity. TB bacteria are the models for 
human pathogen, since they exhibit antibiotic resistance at a high rate and are currently known to 
latently infect about 1/3 of the world’s population (WHO, 2013). M. tuberculosis has become 
resistant to successively introduced antibiotics, such as rifampicin and isoniazid (Somoskovi et 
a l, 2001). Recently, in addition to the MDR strains of tuberculosis, XDR (i.e. extremely drug 
resistant) and totally drug resistant strains (Shah et al, 2007) have been observed. The interesting 
feature of drug resistance in TB is that its origin is not anthropogenic, but it spontaneously 
evolved by random mutations (Davies & Davies 2010).
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The overuse of antibiotics in the Gram-negative pathogens, such as Escherichia coli, 
Klebsiella pneumoniae and Salmonella enterica, has made resistance a common phenomenon in 
these bacteria (Hopkins et al., 2005; Wiener et al., 1999). This resistance has become so 
prevalent that none of the antibiotics of the p-lactam class are effective against these organisms 
(Shaikh et al., 2015). In cases of hospital infections, Pseudomonas aeruginosa, Acinetobacter 
baumannii and Staphylococcus aureus are the prevalent resistant organisms (Barbe et al, 2004; 
Enright et al., 2002). Pseudomonas aeruginosa was earlier identified as an organism responsible 
for burn wound infections and has now become a serious threat as an opportunist pathogen (De 
Bentzmann & Plesiat, 2011). Methicillin-resistant Staphylococcus aureus (MRSA) is the leading 
causes of nosocomial infection (Maddox et al., 2012). Acquiring infections from antibiotic 
resistant bacteria has made it even more difficult to treat patients in hospitals. These infections 
have a chance of spreading to the healthy individuals as well making them agents of bacterial 
transmission. More deaths are associated with MRSA than with methicillin-sensitive strains 
(Levy and Marshall 2004).
1.12 Purpose and scope o f project
The primary aim of this project is to assess the significance of the natural environment in the 
development of antibiotic resistance in Gram-negative bacteria. The natural environment is the 
major habitat of the bacteria. Bacteria can gain resistance to antibiotics either by genetic 
mutations or by horizontal gene transfer. Multi drug resistance and presence of various virulence 
factors make bacteria potentially harmful and increases their invasiveness and transmissibility. 
Therefore we propose that multi-drug resistance and pathogenicity of bacteria go hand in hand. 
Gram-negative bacteria, owning their greater resilience power, can survive in harsh environments
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and are therefore more likely to evolve drug resistance towards antibiotics. Consequently, this 
makes multi-drug resistant Gram-negative bacteria the most potent pathogens responsible for 
widespread epidemics.
In this project, we aim to identify the characteristics of antibiotic resistance among the 
Enterobacteriaceae family. Finding the mechanisms of resistance practised by bacteria is the first 
step to develop effective therapy against that strain. The capacity of bacteria to withstand varying 
concentrations of different antibiotics is assessed by measuring the minimum inhibitor 
concentration (MIC) of antibiotics. The resistant bacteria identified can be used for further 
studies to understand the mechanism of antibiotic resistance, which may in turn help in devising 
suitable strategies to overcome the resistance.
River water is assumed to be the largest reservoir of both bacteria and antibiotics making 
it a perfect breeding ground for the antibiotic resistant strains. Furthermore rivers are also the 
final destination of the downstream processed chemicals from industries and wastewater 
emanating from the drainage system after the treatment. River water is a major source of drinking 
water for a large number of animals and humans, so pathogenic bacteria that are present in such 
water can easily find its way to its host. In this project, we aim to isolate and identify new 
bacterial isolates from a river that display resistance and investigate the mechanism of drug 
resistance.
1.13 The aims and objectives o f this research
• To investigate the contribution of the natural environment in the emergence of antibiotic 
resistance in Gram-negative bacteria.
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• To isolate and identify Gram-negative bacteria from a natural water environment, that 
display multi-drug resistance.
• To determine the role of plasmids in multidrug resistance mechanism of the newly 
identified isolates.
• To identify the possible mechanisms of multidrug resistance by expressing the proteins 
coded by the genes in the putative resistance plasmid isolated from the newly identified 
isolates.
1.14 Hypothesis
• Hypothesis: That the environment serves as a reservoir of antibiotic resistant bacteria.
• Hi= the environment is source reservoir of antibiotic resistant bacteria.
• Null hypothesis: That the environment does not serve as a reservoir of the antibiotic resistant 
bacteria.
• Ho = the environment is not a reservoir of antibiotics resistant bacteria.
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Chapter 2. Materials and Methods
2.1 Site for sample collection
Bacteria were collected from the Dighty Burn. Water samples were collected using the same 
procedure described for monitoring and providing special natural characteristics of watercourses 
as rivers (JNCC, 2014). The Dighty Burn is located in Dundee and Angus and flows from the 
Sidlaw Hills to enter the Tay estuary between Broughty Ferry and Monifieth. Samples were taken 
from this river at one site at the Strathmartine Road (OS 54; MR NO 378 353; Figure 2.1). The 
water sampling was performed on 13/11/2012 around 10.00am. The weather was partly cloudy 
with an average temperature of 7°C, 93% humidity, and 5 km/h wind speed. The site was chosen 
to provide a breadth of environments within the river based on location characteristics. The river 
is surrounded by many agricultural activities as well as many household activities that provide a 
rich environment for the growth of diverse microbial communities including multidrug-resistant 
bacterial species. The laboratory strains used in the study was procured from the national 
Collections of Industrial and Marine Bacteria (NC1MB), Aberdeen, UK.
2.2 Isolation and characterisation o f bacteria in water samples collected from the 
Dighty Burn by membrane filtration technique
Two litres of water samples from the river was collected in two pre-sterilized bottles of lOOOmL 
volume each, sealed and transported to the laboratory within 30 minutes from the time of 
collection for further processing. The Membrane Filtration Technique was used to analyse the 
microbial load of water sample collected and to isolate microorganisms for the study.
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Figure 2.1: The Dighty Burn is located in Dundee and Angus and flows from the Sidlaw 
Hills to enter the Tay estuary between Broughty Ferry and Monifieth. (W ater sampling 
location) Google maps (2015).
In the present study, bacteriological analysis was done using a membrane filtration technique 
following the procedure described in the Examination Guidance of Waters and Associated 
Materials (WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance 
(AGISAR), 2011). First, the membrane filtration apparatus was prepared by placing the sterile 
membrane filter on the filter base, grid side up and attached to the base so that the membrane 
filter is held between the sterile funnel and the base. This apparatus was then connected to the 
vacuum pump that facilitates the filtration process. Then, each of lOOmL water sample was 
gently poured on the funnel and filtered through membrane the sterilized cellulose filters. During
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filtration, the stop-cock was closed to avoid air being sucked through the membrane filter. After 
all the water samples were filtered, sterile water was gently poured into the sides to rinse the 
sides of the funnel and filter. After the water passed through the filter, the funnel was removed 
and filters were taken out with the use of sterile forceps and transferred to 47 mm diameter Petri 
plates previously prepared with Nutrient Agar (Oxoid, CM0003) or Malt Extract Agar (Oxoid, 
CM0059)t Petri plates with Nutrient Agar (Oxoid, CM0003) were then incubated aerobically in 
incubator (Stuart orbital incubator.S150) or incubated anaerobically using an anaerobic 
atmosphere generation system Anaerogen jar (Oxoid LTD. AG25). Plates were incubated at 
either 25°C or 37°C for 48 hours. Petri plates with Malt Extract Agar (CM0059) were also 
incubated aerobically and anaerobically using the same incubations chambers at 25°C for 48 
hours. After incubation the membrane filters were removed and the agar plates were examined 
for growth of colonies. Figure 2.2 diagrammatically represents the membrane filter apparatus 
and the procedure followed.
Figure 2.2: (a) Membrane filter apparatus, where (1) water sample and (2) filter, (b-c) 
Filter paper placed inside agar plate, (d-e) Bacterial colonies formed 
(http://elte.prompt.hu/sites/default/files/tananvagok/PracticalMicrobiology/ch05s03.html). 
(Accessed on October 27, 2015) (Attila Nafradi, 2013).
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Ten mL of water samples were added aseptically to 0.9L of physiological saline (0.85% NaCl) or 
R2A medium and was thoroughly mixed. Two tablets of NaCl were dissolved in 1 OOOmL of 
distilled water to prepare 0.85% of physiological saline. The preparation was incubated at 37°C 
for 24 hours when R2A medium was used. This was then serially diluted up to 12 tubes. The 
methodology followed is as given in Figure 2.3. The experiment was done in duplicates. This 
serially diluted suspension was used as the inoculums for various plating techniques. The isolated 
single colonies post incubation period was picked, and was purified on rich nutrient agar (NA) 
(Oxoid CM0003).
2.3 Viable plating techniques used for isolate bacteria from water samples
2.3.1 Sample preparation for isolation of bacteria and serial dilution
1 m L or 1 g 
sample
1 m L 1 mL 1 mL 1 mL 1 mL 1 mL 1 mL
Figure 2.3: Serial dilution and pour plate method used to isolate bacteria from water 
sample, (a) The sample is diluted in sterile 85% saline, (b) 10-12 fold dilution series is 
prepared and (c) Appropriate amounts of these dilutions are plated onto suitable growth 
medium in the Petri plate if necessary.
(http://elte.prompt.hu/sites/default/files/tananvagok/PracticalMicrobiology/ch05s03.htmn. 
(Accessed on October 27, 2015) (Attila Nafradi, 2013).
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100 pi of the bacterial inocula from each of the serially diluted samples were placed on the centre 
of an agar plate and was spread over the surface of the agar, using a sterile glass rod. The glass 
rod was sterilized by dipping in alcohol (70% ethanol) and flaming it to bum off the alcohol. 
Individual microorganisms get separated from each and grow into individual colonies represent a 
clone of the pure culture. Best results were obtained when the bacterial inoculums were diluted 
properly. Spreading of undiluted samples may result in overcrowding and the formation of 
confluent growth. The diagrammatic representation of spread plate techniques is as shown in 
Figure 2.4.
2.4 M icrobiological techniques used for isolating bacteria as pure cultures
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Figure 2.4: Spread plate method used to isolate and enumerate bacteria.
(httn://unendrats.blogspot.co.uk/2010/02/microbial-r>ure-culture.html). (Accessed on 
October 27, 2015) (Thapa, 2010).
2.4.2 Streak plate method to purify bacteria isolated through spread plate technique
This methodology was followed to ensure the purity of bacterial colonies isolated by spread plate. 
A loopful of inoculum is streaked across the surface of a sterile solidified agar plate that contains
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a nutrient medium. The course of streaking on agar plate is as shown in Figure 2.5. The plates 
are then incubated under favourable conditions to permit the growth of the bacteria. A dilution 
gradient is established across the face of the plate as bacterial cells are deposited on the agar 
surface. Dilution gradient achieved by the method allow individual isolated colonies to develop 
in the plate region, which is farthest from starting region. Separate microscopic colonies that can 
visualize easily. Each of the well-isolated colony is assumed to arise from a single bacterium and 
therefore to represent a clone of the pure culture.
2.5 Stocking and maintenance o f isolated and purified bacterial cultures
2.5.1 Temporary stocking of bacterial culture on nutrient agar slopes
The isolated organisms were maintained on rich nutrient agar (Oxoid CM0003) slopes in 
quadruplicate. Maintenance in multiple slopes helps in retrieving the culture in case of 
contamination. Slope number 1 was used for culturing overnight cultures for routine experiments. 
Slope number 2 was maintained as a backup slope to be used in case of accidental contamination 
of slope 1. Slope number 3 was used for further sub culturing purposes and slope number 4 was 
maintained as part of a stock culture collection. All the slopes inoculated with the bacteria were 
first incubated at 37°C for 24 hours. After incubation the slopes were transferred to a darkened 
cupboard maintained at room temperature. The slopes were renewed every month to maintain the 
viability and prevent the senescence of the cultures.
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Figure 2.5: Streak plate method used to purify the isolated bacteria.
(httn:/Avww.microbiol.org/resources/monogranhswhite-naners/streaking-for-single- 
colonies-an-essential-first-sten-in-microbial-identification). (Accessed October 27, 2015) 
(Sutton, 2006).
2.5.2 Glycerol stocking of purified bacterial culture
The isolates were grown in R2A media. Supplemented with 1% glycerol (Reasoner & Geldreich, 
1985) for 24 hours at 37°C in an orbital incubator (Gallenkamp, INA-SOS) at 220rpm After the 
incubation the broth was mixed with sterile glycerol to make 30% glycerol stock and kept at - 
80°C.
2.6 Identification and biochemical characterization o f isolated bacterial cultures
2.6.1 Gram staining technique to differentiate bacteria into Gram-positive and Gram­
negative classes
Slides were prepared by making a smear of the sub-culture on a clean, grease-free glass slide, 
followed by gentle heating to dry fix the film. Slides were initially stained with crystal violet dye 
for one minute and then flooded with Gram’s iodine solution in order to form a complex between 
dye and iodine, technically referred to as a mordant, and left for another minute. The slides were 
then rapidly decolourized with acetone/alcohol until no blue stain was released from the slide.
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Immediate rinsing under running water in order to remove the excess of acetone/ethanol then 
followed this. A secondary stain, safranin, was then added to the slides for 5 minutes and then 
slides are washed gently with a stream of water and blotted dry. The slides were examined under 
a microscope at 100X by using oil immersion lens. The following observations are expected:
i. Gram-positive Bacteria appear violet/purple.
ii. Gram-negative Bacteria appear red/pink
2.7 Biochemical characterization o f bacterial isolates using ready-made strips: API 
20E, API 20NE and API 50CH
API 20E, 20NE and 50CH (Biomerieux, France) was used for the biochemical identification of 
bacterial strains. API 20 NE strips were used to identify the non-Enterobacteriaceae, Gram­
negative bacillus that is oxidase positive and non-fastidious in nature. API 20 E strips were used 
to identify the Gram-negative bacillus belonging to Enterohacteriaceae family, which are 
Oxidase negative and non-fastidious. API 50CH was used to identify Gram-positive Bacillus and 
related genera. API test strips consist of microtubes (cupules) containing dehydrated substrates. 
The tests are based on the principle of pH change and substrate utilization. On incubation, the 
metabolic changes are observed by spontaneous colour change in the media that can be 
interpreted visually. Assimilation tests are inoculated with a minimal medium (API AUX 
medium) and the bacteria grow if they are able to utilize the corresponding substrate: a positive 
result is indicated by growth. Test results are entered into an online database to determine the 
bacterial identity.
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2.7.1 Inoculation of bacterial isolates on API 20E and API 20NE strips
A single well-isolated colony (2-3mm diameter) was picked up and inoculated into the saline 
tube (0.85% NaCl solution). This was then mixed well so that the suspension is homogenous and 
without clumps of floating.
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Figure 2.6: Schematic representation of the API 20E strip. Figure retrieved from 
instruction manual of API test strips (http://www.biomerieux-usa.com/clinical/api ). 
(Accessed October 27,2015) (Biomerieux, n.d.).
2.7.2 Procedure followed for inoculating API 20E strip
The strip was opened aseptically and labelled appropriately. Five mL of sterile distilled water was 
added into the tray to provide a moist atmosphere to prevent the drying of the strip. The strip was 
laid inside the tray. The strip was held at a slight angle up from the table top to inoculate the 
bacterial suspension into each well with the sterile pipette. The end of the pipette was gently 
introduced to the side of the cupule and inoculums were dispensed up to the neck cupules. After 
the inoculation the strips were incubated at 37°C for 18-24 hours. The schematic representation of 
the API 20E strip is as shown in Figure 2.6. The result of the test was read using the following 
Table 2.1 and Figure 2.7 that was provided with the strip.
The tests on the strip plus oxidase test result were used to determine the first seven digits 
of the profile number. The numerical profile thus obtained is then entered the APIweb™ 
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Figure 2.7: Positive and negative test results of API 20E strips. Figure retrieved from 
instruction manual of API test strips, (http://www.biomerieux-usa.com/clinical/ani ). 
(Accessed October 27, 2015) (Biomerieux, n.d.).
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Table 2.1: Interpretation table provided with the API 20E strips for reading the 
results
TEST REACTION NEGATIVE POSITIVE
ONPG p-galactosidase Colourless Yellow (maybe pale)
ADH Arginine dihydrolase Yellow Orange or red
LDC Lysine decarboxylase Yellow Orange or red
ODC Ornithine decarboxylase Yellow Orange or red
CIT Citrate utilisation Light green Blue-green or blue
H2S H2S production Colourless Black
URE Urea hydrolysis Yellow Pink
TDA Tryptophan deamination Yellow Dark brown
IND Indole production Colourless reagent Pink
VP Acetoin production Colourless Pink or red
GEL Gelatin hydrolysis Colourless Black diffuse pigment
GLU Glucose fermentation Blue Yellow
MAN Mannitol Blue Yellow
INO Inositol Blue Yellow
SOR Sorbitol Blue Yellow
RHA Rhamnose Blue Yellow
SAC Sucrose Blue Yellow
MEL Melibiose Blue Yellow
AMY Amygdalin Blue Yellow
ARA Arabinose Blue Yellow
Oxidase Cytochrome oxidase Colourless Purple
2.7.3 Procedure followed for inoculating API 20NE strip
The strip was opened aseptically and labelled appropriately. Five mL of sterile distilled water was 
added into the tray to provide a moist atmosphere, which prevent drying of the strip. The strip 
was laid inside the tray. The strip was held at a slight angle up from the table top to inoculate the 
bacterial suspension into each well with the sterile pipette. The end of the pipette was gently 
introduced to the side of the cupule and inoculums were dispensed up to the neck of capsules of
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the NO3 to PNPG microtubes. Tube and cupules of [GLU] to [PAC] where filled with bacterial 
suspension dispensed in AUX Medium. After the inoculation the strips were incubated at 37°C 
for 18-24 hours. The schematic representation of the API 20NE strip is as shown in Figure 2.8 
.The result of the test was read using the following Table 2.2 and Figure 2.9.
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Figure 2.8: Schematic representation of the API20 NE strips. Figure retrieved from 
instruction manual of API test strips, (http://www.biomerieux-usa.com/clinical/ani ). 
(Accessed October 27, 2015) (Biomerieux, n.d.).
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Figure 2.9: Positive and negative test results of API20 NE strips. Figure retrieved from 
instruction manual of API test strips.
(http://www.bionierieux-usa.com/clinical/api). (Accessed on February 30, 2014)
(Biomerieux, n.d.).
The tests on the strip were used to determine the first seven digits of the profile number. The 
numerical profile thus obtained is then entered the APIwebIM (Biomerieux, n.d.) to obtain the 
identity of the bacterial isolate.
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Table 2.2: Interpretation table provided with the API20 NE strips for reading 
the results
TEST REACTION NEGATIVE POSITIVE
n o 3->n o 2 Reduction o f potassium Colourless Red/pink Red
n o 2—»n 2 nitrate (NIT1+NIT2) 
Colourless (Zn)
TRP Indole production 
from tryptophan
Yellow Pink
GLU Glucose fermentation Blue/green Yellow
ADH Arginine hydrolysis Yellow Orange/pink/red
URE Urea hydrolysis Yellow Orange/pink/red
ESC Aesculin hydrolysis Yellow Grey/brown/black






GLU Glucose assimilation Transparent Opaque
ARA Arabinose assimilation Transparent Opaque
MNE Mannose assimilation Transparent Opaque




MAL Maltose assimilation Transparent Opaque
GNT Gluconate assimilation Transparent Opaque
CAP Caprate assimilation Transparent Opaque
ADI Adipate assimilation Transparent Opaque
MLT Malate assimilation Transparent Opaque




Oxidase Cytochrome oxidase Colourless Purple
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2.7.4 Procedure followed for inoculating API 50CH strip
The strips were opened aseptically and labelled appropriately. Five mL of sterile distilled water 
was added into the tray to provide a moist atmosphere to prevent the drying of the strip. The strip 
was laid inside the tray. Suspension for inoculation with turbidity equivalent to 2 McFarland was 
prepared in ampule of API 50CH. The tubes were then filled with the inoculated API 50CH. 
After the inoculation the strips were incubated at 29° C for 24 hours. A tube is scored positive test 
when the colour is changed to yellow by acidification revealed by the phenol red indicator 
contained in the medium. In case of esculent test (tube no. 25), a change in colour from red to 
black is scored as positive.
2.7.5 Oxidase test
The ampule containing the oxidase reagent (Oxidase reagont-bioMeriewc) was placed inside the 
reusable ampule crusher. The ampule was then crushed opened by gently pressing the middle of 
the dropper. The reagent was then dispensed (precisely 1 drop) onto a non-impregnated disc 
(diameter 6 mm). A well-isolated colony from a fresh (18 to 24 hours culture) culture was spotted 
onto the disc and was observed for colour change. Isolates were segregated as oxidase positive 
when the colour changed to violet to purple colour within 10 to 30 seconds.
2.8 Antibiotic sensitivity test using disc agar diffusion technique
Overnight cultures of bacterial isolates were adjusted to McFarland opacity 0.5 before inoculation 
onto Nutrient Agar plates with sterile glass spreader. After 10 to 15 minutes, antibiotic rings were 
laid on top of the inoculated agar surface. Thereafter, the plates were then inverted and incubated
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within 15 minutes of disc application at 30°C for 16-18 hours. The negative control plate was 
observed for semi-confluent growth in the absence of antibiotic and measurements of the zones 
of inhibition to the nearest millimetre were taken with a scale (Kirby et al., 1966; Dworkin & 
Falkow 2006). For each antibiotic present on Mastring 14 and Mastring 13, sensitivity scores were 
categorized as greater than zero or exactly zero. Antibiotics that display 0 mm zones of inhibition 
indicate the organism's resistance to metabolize the exposed antibiotic, whereas those display 
zones of inhibition greater than zero, indicates the organism's sensitivity to that particular 
antibiotic. SPSS version 20 and excel 2011 were used to analyse the data.
2.9 Determination o f minimum inhibitory concentration for bacterial species 
against antibiotics
2.9.1 Minimum inhibitory concentration assay by tube dilution technique
The Minimum inhibitory concentration assay by tube dilution technique as conducted as per the 
protocol of (Chitwood, 1969). The test strains were grown overnight on Luria-Bertani (LB, 
Oxoid, CM 1018) agar at 37°C. Concentrated stock solutions of all the drugs were prepared at 
256pg/mL. lOOpl of sterilized LB medium were dispensed into all the wells of a microtitre plate 
followed by adding lOOpl of antibiotic into the wells and subsequent mixing by pipetting up and 
down. Transferring lOOpl from the first well to the second well and so on up to the seventh well 
did serial dilutions; the eighth wells were used as controls (only medium and no antibiotic). lOpl 
of each bacterial sample were added to the mixtures, and then incubated at 37°C for 24 hours 
prior to reading (OD) at 450 nm.
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2.10.1 Bacterial DNA isolation for template preparation for PCR
The bacterial DNA was isolated following the protocol of (Ausubel et al., 2003). 2mL of log 
phase culture was centrifuged (Eppendorf 5804R) at 5000g for 10 minutes at 4°C. The resulted 
supernatant was discarded and the cell pellet was dried. The pellet was resuspended in 875pL of 
Tris EDTA (TE) buffer (pH: 8). 5pL Proteinase K (Sigma- Aldrich) (lOmg/mL) and lOOpL of 
10% SDS was added, mixed gently and incubated at 37°C for 1 hour. Equal volume of phenol- 
chloroform mixture (1:1) was added to this, centrifuged at 12000g (Eppendorf 5804R) for 10 
minutes at 4°C, and then the supernatant was transferred to another microtube. The extraction 
with phenol-chloroform was done thrice. To the resultant supernatant, 0.1 volumes of 5 M 
sodium acetate (pH 5.2) and double volume of ice-cold 100% isopropanol were added. This was 
then incubated at -20°C for 1 hour and was centrifuged at 12000 g for 10 minutes at 4°C 
(Eppendorf 5804R). The DNA pellet obtained was washed with 70% ethanol, air-dried, and 
dissolved in 50pL TE buffer (pH.8). The concentration and purity of DNA was estimated 
spectrophotometrically and appropriate dilutions (~80 -100 ng) were used as template for PCR 
reactions.
2.10.2 DNA quantification of isolated DNA by spectrophotometer
The DNA was quantified using a UV-Visible spectrophotometer (Thermo spectronic; 
Genesys.lO-S) as per (Sambrook & Russell, 2001). The spectrophotometric readings were taken 
at wavelengths of 260 nm, 280 nm, and 230 nm. The absorbance at 260 nm allows calculation of 
the concentration of nucleic acid in the sample. An absorbance value of 1 at 260 nm corresponds 
to approximately 50pg/mL for double stranded DNA and 40 ng/pL of RNA. The ratio between
the readings at 260 nm and 280 nm (OD260/OD280) indicates the purity of the DNA. Pure
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2.10 Identification o f bacteria by partial 16S rRNA gene sequence analysis
preparation of DNA has OD260/OD280 ratio in the range of 1.8-2.0, or else it indicates protein 
contamination.
2.10.3 Procedure for DNA quantification
500pL o f distilled w ater was taken in a cuvette and placed in the spectrophotom eter 
(Thermo spectronic; Genesys.lO-S). The w avelength was adjusted to 260 and the water was 
used to autozero the spectrophotometer. Next, lOpL of DNA was diluted in 490pL o f  
distilled  w ater in a cuvette and its absorbance was m easured at 260 nm. Each 
reading  was taken in trip lica te s  and the ir m eans w ere used for ca lcu la tin g  
concen tra tion  o f DNA using the form ula: A260 x Dilution factor (50) x 50 = pg/mL
2.10.4 Polymerase chain reaction of 16S rDNA gene using universal primers
Polymerase chain reactions were using a primer pair of 16S rDNA. A portion of the 16S rRNA 
gene (1.5kb) was amplified from the genomic DNA. PCR reaction mix was made on ice in 
PCR tubes (Fisher scientific) using commercially available PCR reagents (Promega).
PCR Mix composition
10X PCR buffer 2pL
2 mM each dNTPs 2pL
Forward primer (10 picomoles) (Sigma Aldrich) 2pL
Reverse primer (10 picomoles) (Sigma Aldrich) 2pL
T^D N A  polymerase (1 U/pL) (Sigma-Aldrich) 1 pL
Template DNA (50 ng/pL) 3pL
MgC12 (Sigma-Aldrich) 1.2pL
Sterile distilled water to a final volume of 20pL
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Amplifications were carried out in a Thermal Cycler (C1000™-Biorad) using the following 
program: a hot start cycle of 94°C for 5 minutes, then 30 cycles o f 94°C for 1 minute, annealing 
at 56°C for 1 minute and extension at 72°C for 90 seconds, ending with a final extension step of 
72°C for 10 minutes.
2.10.5 Agarose gel electrophoresis of the isolated DNA for testing integrity
Agarose gel electrophoresis as performed following the protocol of Sambrook & Russell (2001). 
For the analysis of the amplified products 1% agarose gels were prepared. They were prepared in 
Tris-Acetate-EDTA (TAE) buffer. Gel Green was added at a final concentration of 0.5mg/mL. 
The preparation is then melted in a microwave oven and was poured into the gel-casting tray after 
cooling to 65°C. Appropriate comb was placed within to create well. Once the agarose gel was 
set, the inserted comb was gently removed and the tray was placed in the electrophoresis tank. 
Aliquots (5jiL) of the amplified PCR products were analysed by electrophoresis. 1% agarose 
(make) gel containing Gel Green (5 pL of the GelGreenl0,000X stock reagent to 50mL agarose 
gel) was prepared in IX (Tris-acetate-EDTA) TAE buffer. The DNA sample was mixed with gel 
loading dye was and loaded into the wells. Electrophoresis was carried out at 80 V for 1 hour 
(Biorad). The gel was visualized under the transilluminator and gel pictures were captured using 
Gel documentation system (Biorad).
2.10.6 DNA sequencing of the PCR products of 16S rRNA sequencing
Nucleotide sequences of the PCR amplicon of 16S rRNA gene were determined. The identity was 
determined by comparing the sequences obtained with the gene sequences available in the 
Genbank database using Basic Local Alignment Search Tool (BLAST) software (Altschul et al, 
1997) at NCBI site (htty://blast,ncbi.nlm.nib. gov. Accessed 20/9/14).
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2.11 Isolation o f plasmids from bacterial cells
Plasmid isolation was performed by alkaline lysis method. The method depends on bacterial cell 
lysis by sodium hydroxide and sodium dodecyl sulfate (SDS), followed by neutralization with a 
high concentration of low-pH potassium acetate. This gives selective precipitation of the bacterial 
chromosomal DNA and other high molecular-weight cellular components. The plasmid DNA 
remains in suspension and is precipitated with ethanol.
Procedure for plasmid isolation by mini prep was carried out according to Kado & Liu 
1981; Sathyanarayana & Verma 1993. Briefly, bacterial cultures were grown at 37°C for 
overnight in 50mL LB broth at 220rpm in an orbital shaker incubator (Stuart.S150) until they 
reached an OD of 1.7 at 600 nm (Thermo spectronic; Genesys.lO-S). 15mL of each culture was 
harvested by centrifugation at 14000rpm for 15 minutes at 4°C (Eppendorf 5417 R). The bacterial 
pellet was then resuspended in 250pL of resuspension buffer (50 mM TrisHCl, pH 8.0, 10 mM 
EDTA) and lOOpg/mL RNase A, and stored at 4°C until required. This was followed by 
membrane solubilisation process, which was done by adding 250 pi of lysis buffer (200 mM 
NaOH, 1% sodium dodecyl sulphate (SDS); stored at room temperature not longer than one 
week). The sample was then mixed gently by inverting the tube several times and was then 
incubated at room temperature for 60 minutes. Then, 350pL of neutralization buffer (3.0 M 
Potassium acetate, pH 5.5) was added to each solution and then mixed gently by inverting six 
times, then centrifuged at 14000rpm for 15 minutes (Eppendorf 5804 R). The clear supernatant 
was then transferred into a new microfuge tubes containing 300pL of 1:1 phenol: chloroform 
solution. This was mixed thoroughly and then centrifuged at 16000rpm for 15 minutes at 4°C. 
The supernatant was carefully transferred into a fresh tube without disturbing the bulky 
interphase. The clear supernatant was taken and the plasmid DNA was precipitated by adding
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600jil of isopropanol followed by centrifugation at 16000rpm for 15 minutes at 4°C. The 
resulting pellets were washed with 70% ethanol and precipitated by centrifugation at 16000rpm 
(Eppendorf 5804 R) for 2 minutes at 4°C. The pellets were then dried and re-suspended in 60pL 
TrisHCl, pH 8.5 buffers or in double distilled water and stored in refrigeration at -20°C.
2.11.1 Preparation of competent cells for transformation experiments
E.coli DH5a was used for transformation and competent cell preparation. Competent cells were 
prepared following the procedure of (Sambrook & Russell, 2001). A single bacterial colony of 
E.coli DH5a was inoculated into lOOmL LB broth and incubated at 37°C in a 1 L flask with 
vigorous agitation. The bacterial culture was transferred to ice-cold centrifuge tubes and the tubes 
were kept on ice for 10 minutes. The culture was centrifuged at 4000g for 10 minutes at 4°C 
(Eppendorf 5804 R). The supernatant was decanted and the tubes were kept inverted for 1 
minute. The pellet was resuspended in lOmL of ice-cold 0.1 M CaCh solutions by gentle 
vortexing and stored on ice for 10 minutes. The cells were recovered by centrifugation at 4000 g 
for 10 minutes at 4°C (Eppendorf 5804 R). The medium was decanted and the tubes kept inverted 
for 1 minute. The pellet was resuspended by gentle vortexing in 2mL of ice-cold 0.1 M CaCh for 
each 50mL of original culture. The cells were then used immediately or were stored at -80°C.
2.11.2 Transformation of competent E.coli cells with the isolated plasmids
Bacterial transformation was performed using lpL of pUC19 vector (without insert) and 5pl of 
pUC19 (with insert) using DH5a™ competent E. coli cells. Bacterial transformation was done by 
temperature heat shock method as per the procedure of (Sambrook & Russell, 2001). Frozen 
™DH5a™ competent E. coli cells maintained at -80°C were taken out of freezer and
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immediately placed on ice. Cells were allowed to thaw slowly on ice and in the meantime the 
heat block was set to 42°C (1.5mL Eppendorf Thermomixer comfort).
After thawing, 25pL of competent cells were transferred to pre-chilled and pre-labelled
1.5 mL Eppendorf tubes. Then 2pl (lOng) of each of the plasmid was then added to each of the 
two tubes containing the 25pL of the competent cells. Two pre-labelled tubes were prepared as 
controls, one using lpl of sterilized water as the negative control and another 1.5 pi of pUC19 
plasmid as the positive control. After gentle mixing, the tubes were then placed back on ice and 
allowed to incubate at 0°C for 30 minutes. After incubation, the tubes were then placed on the 
heat block maintained at 42°C as a heat shock for 45 seconds during which transformation should 
occur. The tubes were then placed back on ice for 2 minutes and then at room temperature. Pre­
heated LB Broth at 37°C was taken out of a water bath and 500pL of the broth was gently added 
to the transformation tubes. The tubes were then placed in the shaking incubator (Stuart. S I50) at 
37°C and was incubated for 60 minutes at 225 revolutions per minute (rpm).
LB-agar plates were made with varying concentrations of ampicillin (16, 32, 64 and 
128pg/mL), lOOpL of the mixture from the transformation tubes was carefully transferred on to 
duplicate LB-agar plate and spread evenly with the help of a sterile glass spreader. The plates 
were then incubated overnight at 37°C to allow the transformed bacteria to form colonies.
2.12 Screening for efflux pump mediated antibiotic resistance in bacterial species
The screening assay was carried out as per the protocol of (Malek et al., 2009). The test strains 
were grown overnight on Luria-Bertani (LB, Oxoid, CM 1018) agar at 37°C. LB broth with 
varying concentration (5-128pg/mL) ampicillin and tetracycline where prepared in two sets. One 
set was without (carbonyl cyanide m-chlorophenyl-hydrazone (CCCP) and one set with CCCP at 
final concentration of 15pg/mL. These test tubes were then subsequently inoculated with the test
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organisms. The cultures were then incubated at 37°C for 24 hours. The MIC for ampicillin and 
tetracycline of different isolates were determined. The test was conducted in the absence and 
presence of CCCP as internal controls.
2.13 Determination o f penicillinase activity in bacterial species
2.13.1 Phenol red indication method for detecting penicillinase activity
One minute tube test (Escamilla, 1976) was performed by mixing phenol red solution with 
penicillin. This was then scarped over the bacterial cultures. Results of this method can be 
determined based on the colour change. The development of yellow colour is an indication of 
penicillinase production.
2.13.2 Tube dilution test for detecting penicillinase activity
The penicillinase activity test was carried out using varying concentration of ampicillin with and 
without 16ug/mL of clavulanic acid. The test strains were grown overnight on Luria-Bertani (LB, 
Oxoid, CM 1018) agar at 37°C. LB broth with varying concentration (16-128pg/mL) ampicillin 
prepared in two sets. One set was without clavulanic acid and one set with clavulanic acid at final 
concentration of 16pg/mL. These test tubes were then subsequently inoculated with the test 
organisms. The cultures were then incubated at 37°C for 24 hours. The MIC for ampicillin and 
tetracycline of different isolates were determined. The test was conducted in the absence and 
presence of clavulanic acid as internal controls.
2.14 Outer membrane protein extraction o f selected bacterial species
The outer membrane proteins were extracted as per the protocol of (Hobb et al., 2009). The 
bacterial suspensions were centrifuged at 5000rpm for 20 minutes (Eppendorf 5804R). The cells 
were then washed thrice in 25mM/l Tris buffer (pH 7.4) containing 1 mMMgCb followed by
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homogenization (Jencons 361-044) for 2.5 minutes in ice. Sarcosine (Sigma 131776) was added 
to a final concentration of 2% (w/v). The samples were then kept on ice for 20 minutes for 
precipitation of the proteins. The insoluble outer membrane was then sediment by centrifugation 
at 13000rpm for 1 hour at 4°C (Eppendorf 5417 R). The samples were stored in -80°C until use. 
For SDS-PAGE the pellets were resuspended in 50mM of Tris HC1 (lOOpl) (pH 6.8). The protein 
samples were diluted 1:1 with SDS buffer.
2.14.1 Protein estimation of the outer membrane protein
Protein concentration was calculated according to the method of (Bradford, 1976) using bovine 
serum albumin (BSA) as the standard and the concentration was expressed in mg/mL. Standard 
graph was plotted and the slope was calculated. Two points were chosen to find the y intercept. 
The slope of the standard graph was calculated using the equation (y = mx + b). Y is the 
absorbance, m is the slope, and x  is the concentration. The protein concentration of the samples 
was determined from the slope. The absorbance of the sample is divided by the value of the slope 
and the concentration is obtained. The value is adjusted by multiplying by the dilution factor.
2.14.2 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE) of outer 
membrane proteins
The gel plates were cleaned and assembled. Resolving gel (10%) was prepared by mixing lOmL 
of acrylamide: bis-acrylamide (30:0.8), 3.75mL of resolving gel buffer stock, 300pL of 10% SDS 
and 15.95mL of water .The solution was degassed and lOOpL of ammonium persulfate solution 
(10%) and TEMED (15pL) were added. The mixture was immediately poured into the cast and a 
layer of water was added over the gel and allowed to polymerize for at least one hour.
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Table 2.3: Stacking gel and separating gel composition for SDS PAGE
Stacking gel Separating gel
Gel % 4 Gel % 12
30% polyacrylamide (mL) 17 30% polyacrylamide (mL) 60
ImM Tris (pH 6.8) (mL) 12.5 ImM Tris (pH 6.8) (mL) 37.5
10 % Ammonium 1 10 % Ammonium 1.5persulphate (APS) (mL) persulphate (APS) (mL)
10% SDS (mL) 0.1 10% SDS (mL) 1.5
Water 68 Water 49.49
TEMED (mL) 0.1 TEMED (mL) 0.06
Total volume (mL) 100 Total volume (mL) 150
Water layer was poured out after polymerization. The stacking gel (2.5%) was prepared 
by combining 2.5mL of 30: 0.8 acrylamide: bis-acrylamide solution, 5mL of stacking gel buffer 
stock, 200pL 10% SDS and 12.3mL of distilled water, followed by lOOpL of ammonium 
persulfate and 15pL of TEMED. The stacking gel was then poured into the gel assembly, above 
the resolving gel and the comb was immediately inserted. Gel was allowed to polymerize for 30 
minutes, placed in the electrophoresis apparatus and upper and lower reservoirs filled with 
reservoir buffer and was pre run for 1 hour at 80 V. Sample was prepared by mixing 100pL of 1X 
sample buffer with protein sample. 25pL of this sample and 5pL low molecular weight marker 
mix was loaded on to the gel and run at 80 V. The current was increased to 100 V, when the dye 
front entered the resolving gel. The run was stopped when the dye front reached 1 cm from the 
lower end of the plate, the gel was removed and stained.
2.14.3 Coomassie blue staining of the SDS PAGE gel with outer membrane protein
After the electrophoresis run, the gel was immersed in a medium size microwave container with 
Coomassie blue stain (1 g of Coomassie Brilliant Blue in 1 litre of solution containing: Methanol 
(50% [v/v]), Glacial acetic acid (10% [v/v]) H2 O (40%) filtered through Whatman filter paper). 
The container was then placed in a microwave oven at the highest power for 1 minute. After that
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the gel was further incubated at room temperature for 5 minutes. The gel was then rinsed 
thoroughly in tap water and was destained in super destain solution (methanol, and acetic acid in 
a ratio of 50/40/10 (v/v/v). The destaining was carried out inside the microwave at the highest 
power for 1 minute. The destaining was continued up to 15 minutes after the removal from 
microwave oven and the destaining solution was replaced with fresh one. The incubation was 
continued up until the bands appeared at around 40 minutes.
2.14.4 Silver staining of the SDS PAGE gel with outer membrane protein
The silver staining of SDS PAGE gels were carried out as per the protocol of (Blum et al., 1987). 
The gel was fixed for 30 minutes in the fixing solution 1 (50mL methanol and 5mL acetic acid in 
45mL water), followed by incubation in fixing solution 2 (50mL methanol in 50mL water) for 15 
minutes. This gel was washed 5 times in water for of 5 minutes each. The gel was then sensitized 
with freshly prepared sensitizer Sodium thiosulphate (20mg/100mL) for 1 minute and was rinsed 
in water for two times for 2 minutes. It was then incubated in freshly prepared staining solution 
silver nitrate (200mg/100mL) for 25 minutes at 4°C, following by washing two times for 1 
minute each. The gel was then incubated in freshly prepared developing solution (Sodium 
carbonate (anhydrous) - 3g/100mL, Formaldehyde - 25pL/100mL and Sodium EDTA solution -
1.4 g/lOOmL) until the bands appeared. In order to prevent over-staining, the gel was treated for 
an additional 10 minutes with sodium EDTA solution and was washed in water for twice for 2 
minutes. The photo-image of the gel was taken using gel documentation system (gel doc 100, Bio 
Rad, Hercules USA). The images were analysed using Band scanner analyser (5.1 software).
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2.14.5 Molecular weight determination of outer membrane protein separated on SDS 
PAGE gel
The molecular weights of separated proteins are determined by measuring the relative migration 
distance (Rf) of the protein standards and the test protein.
The migration distance can be calculated using the following formula:
Rf=  Migration distance of the protein (mm)
Migration distance of the dye front (mm)
A standard curve was plotted using the logarithm of the molecular weight of standard protein 
markers and its corresponding R f  (Figure 5.5). A linear trendline was applied and the graph 
equation was calculated as y = -2.3855x + 2.2647. Molecular weight of outer membrane proteins 
were then calculated using equation MW = 10y, where x = R f  of unknown protein. By substituting 
Rf value (x) of each bands to the equation, MW=10~ 2 3855x + 22647, the molecular weight is 
calculated.
2.15 RNA extraction by TRIZOL method from selected bacterial species
The RNA extraction was carried using TRIZOL reagent as per the protocol o f (Hongbao et al.,
2008). An aliquot (lOmL) of each bacterial culture was grown overnight at 37°C at 220rpm in a 
shaking incubator (Stuart.S150). The bacterial cells were then sediment via by centrifugation at 
8000rpm for 10 minutes (Eppendorf 5417 R). The cells were then washed in DNase- and RNase- 
free distilled water twice to avoid the degradation of the fragile mRNA. The bacterial cells were 
then lysed in lmL TRIZOL reagent by repetitive pipetting. A homogenizer was used to disrupt 
the bacterial cells to aid in release of mRNA. The mixture was then incubated at room 
temperature for 5 minutes to permit complete dissociation of the nucleoprotein complex. After
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the incubation, 0.2mL of chloroform/lmL was added to it. The tubes were then shaken 
vigorously by hand for about 15 seconds and were incubated at room temperature for another 3 
minutes. After the incubation, the tubes were centrifuged at 12000g for 15 minutes at 4°C 
(Eppendorf 5417 R). The RNA gets collected in the top aqueous phase. This was then transferred 
to a fresh tube. The isolated RNA was then precipitated from aqueous phase by the addition of 
0.5mL of 100% isopropanol (isopropyl alcohol, C3H8O) solution. After the addition of 
isopropanol the tubes were incubated for 10 minutes at room temperature. The resultant 
precipitate contains RNA. The RNA is then harvested by centrifugation at 12000g for 10 minutes 
at 4°C (Eppendorf 5417 R). The isolated RNA forms a gel-like pellet at the bottom. The 
supernatant was removed and the RNA pellet was washed once with 75% ethanol and air-dried 
for 5-10 minutes. The pellet was then dissolved and mixed in 0.03-0.06mL RNase-free water or 
0.5% SDS solution followed by incubation for 10 minutes at 55-60° C. This was then re dissolved 
in 1 0 0 % formamide (deionized).
2.15.1 Purification of total after RNA extraction using RNeasy Mini Kit and DNase 
digestion by RNase- free DNA set
Purification of total RNA from bacterial lysate was done using the RNeasy Mini Kit and DNase 
digestion was performed using QIAGEN DNase digestion by RNase- free DNA set following the 
manufacturer's instruction. Briefly an aliquot (700pL) of each crude RNA lysate was transferred 
into minispin columns and was placed into 2mL collection tube. This was then centrifuged at 
8000g for 15 seconds (Eppendorf 5417 R) and the flow through was discarded. Presence of trace 
quantities of DNA in the RNA preparation may hinder RT-PCR analysis. DNase digestion was 
carried out to remove the contaminating DNA. For DNase digestion an aliquot (20pl) of DNase 1 
solution was mixed with 140pL Buffer RDD by gently inverting the tube. The residual liquid
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from the sides of the tube was then collected by brief centrifugation at lOOOg for 1 minute 
(Eppendorf 5417 R). This DNase incubation mix was then added to the RNeasy spin column 
membrane and was incubated at room temperature. After the incubation 350pl of RW1 was 
added to the RNeasy spin column. The columns were centrifuged at 8000g for 15 seconds 
(Eppendorf 5417 R) to wash the spin column membrane. This was followed by addition of 500pl 
RPE buffer and another round of centrifugation at 8000rpm for 15 seconds (Eppendorf 5417 R). 
The flow through was then discarded and the process was repeated with 500pl of RPE buffer. 
Finally 500pl of RNase free water was added to each sample and was centrifuged for 1 minute. 
The flow through was discarded. An aliquot (700|il) of RW1 buffer was added to the spin 
column. The column was then washed by centrifugation at 8000g for 15 seconds (Eppendorf 
5417 R). The spin columns were replaced in fresh 2mL collection tubes and 500pL of RPE buffer 
was added. This was followed by one more round of centrifugation at 8000g for 15 seconds. The 
resulting flow through was discarded and 500pl of RPE buffer was added followed by 2 minutes 
of centrifugation at lOOOOrpm (Eppendorf 5417 R). The columns were then placed in new 
collection tubes and 50pl of RNase free water was added and as centrifugation at 8000rpm for 1 
minute (Eppendorf 5417 R) to elute the purified RNA.
2.15.2 Procedure for RNA quantification by spectrophotometer
RNA dilution buffer (lOmM TrisHCl, pH 7) was taken in a sterile cuvette and placed in 
the spectrophotom eter (Thermo spectronic; Genesys.lO-S). The wavelength was adjusted to 
260 and the buffer was used to blank the spectrophotometer. N ext, 1 OpL o f RNA was dilu ted  
in 490pL; o f RNA dilution buffer in a cuvette and its absorbance was measured at 
A260nm. Each reading was taken in triplicate and concentration o f RNA was calculated 
using the formula.
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A260 x Dilution factor (50) x 44 = pg/mL
2.16 cDNA synthesis using total RNA extracted from selected bacterial species
cDNA synthesis was carried using the extracted and purified RNA. The integrity and purity of 
the isolated total RNA was confirmed using spectrophotometer (Thermo spectronic; Genesys.10- 
S). cDNA synthesis was performed using a commercially available kit - RT2 First Strand Kit -  
Qiagen.
2.16.1 Procedure for cDNA synthesis using RT2 First Strand Kit, Qiagen
Six pi of proprietary Buffer GE (gDNA elimination buffer) was mixed with 5pg of RNA. The 
reaction mixture was made up to 14pl using RNase-free H20. The mixture was incubated at 
37°C for 5 minutes and was immediately placed on ice for at 1 minute. After the incubation 6pl 
of the Reverse Transcriptase Mix was added and the mixture was incubated at 42°C for 15 
minutes. The reaction was immediately stopped by heating the reaction mixture at 95°C for 5 
minutes. Once the cDNA synthesis is over the product is stored in ice until commencement of 
PCR.
2.16.2 Designing of primers for virulence gene screening
Four pairs of primers were designed using the conserved stretches of the respective virulence 
genes that are already reported and available in the NCBI database. Primer designing was done 
using Primer3 software (Primer3, n.d.). The specificity of the primers was confirmed by the 
GenBank database Basic Local Alignment Search Tool (BLAST) program (Altschul et al., 1997) 
at NCBI site, (http://blast.ncbi.nlm.nih.uov. accessed on 17/03/15). Various properties of the 
primer including length, GC content, melting temperature, molecular weight and concentration 
were analysed using Oligonucleotide analyser tool from Integrated DNA technologies (IDT)
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(Integrated DNA Technologies 2014). The primer sequence and the expected amplicon sizes are 
as given in Table.5.1 of Chapter 5.
2.16.3 Polymerase chain reaction using cDNA synthesized to screen and quantify virulence 
gene
Polymerase chain reaction was using several primers (Table 5.6 of C hapter 5). PCR reaction 
mix was made on ice in PCR tubes (Fisher scientific) using commercially available PCR 
reagents (Sigma- Aldrich). The primers were diluted from the standard to required working 
concentration accordingly. Amplifications of cDNA were carried out in a Thermal Cycler (Cl 000 
touch thermal cycler, BioRad) using the following program: a hot start cycle of 94°C for 5 
minutes, then 30 cycles of 94°C for 1 minute, annealing at 59°C for 1 minute and extension at 
72°C for 90 seconds, ending with a final extension step of 72°C for 10 minutes.
PCR mix composition
Go Taq® Flexi Buffer 
MgCl2 (25mM)
Forward Primer (5uM stocks) 
Reverse Primer (5uM stocks) 
dNTP mix (2mM each)
DNA template
Go Taq® DNA polymerase
Nuclease Free water
3pL
3pL (final concentration 2.5mM) 
3pL (final concentration 0.5uM) 
3pL (final concentration 0.5uM) 




5pL of the PCR product samples were analysed by electrophoresis on 1.5 % agarose. The PCR 
was performed in triplicates for each of the strain and each of the genes used.
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2.16.4 Agarose gel electrophoresis of PCR products with virulence genes
For the analysis of the amplified products 1% agarose gels were prepared. They were prepared in 
Tris-Acetate-EDTA (TAE) buffer. Gel Green was added at a final concentration of 0.5mg/mL. 
The preparation is then melted in a microwave oven for a minute and was poured into the gel­
casting tray after cooling to 65°C. Appropriate comb was placed within to create well. Once the 
agarose gel was set, the inserted comb was gently removed and the tray was placed in the 
electrophoresis tank. Aliquots (5pL) of PCR product was mixed with gel loading dye and loaded 
into the wells. DNA markers (1 kb marker) were run along with the products. Electrophoresis 
was performed at a constant volt (5V/cm) and gel pictures were captured using Gel Doc 100 
(Bio-Rad, Hercules, USA) and the images were analysed by using Band scan analyser 5.1 
software.
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Chapter 3. Isolation and Identification of Bacterial Isolates with 
Multi-drug Resistance from the Dighty Burn
This chapter addresses the experimental processes designed to isolate and identify antibiotic 
resistant allochthonous bacterial strains from the Dighty Bum. The Chapter includes an 
introduction (Section 3.1), the experimental approach (Section 3.2), results (Section 3.3), 
discussion (Section 3.4) and a chapter summary and conclusions (Section 3.5).
3.1 Introduction
Rivers and streams have been shown to be major sources of antibiotic resistance in the 
environment. These freshwater bodies act as reservoirs for all possible anthropogenic inputs 
that contribute to the development of antibiotic resistance in environmental bacteria. Examples 
of anthropogenic inputs include waste water treatment plant effluent, which increases the 
prevalence of clinically important resistant bacteria and resistant genes(Amos et al., 2014; 
Amos, et al., 2014) agricultural pollution where antibiotic resistant bacteria reach the 
environment via animal faeces and slurry application (Byme-Bailey et al., 2009; Chee-Sanford 
et al., 2001; Kay et al., 2005) and finally, detergent found on industrial effluents that co-selects 
for Class 1 integrons (Gaze et al., 2005). The classes 1 integrons are genetic elements that 
routinely contain mobile antibiotic and biocide-resistance genes (Stokes & Hall, 1989), which 
have been found in a wide range of polluted environments, such as sewage-sludge-amended 
soil (Gaze et al., 2011) and waste water treatment effluent (Stalder et al., 2014). Class 1 
integrons are capable of integrating gene cassettes into a variable region and to date, there are 
130 known gene cassettes conferring a range of antibiotic-resistant phenotypes, thus Class 1 
integrons equip bacteria with the ability to become resistant to a wide range of antibiotics 
(Partridge et al., 2009).
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This chapter investigates the processes of bacterial isolation, identification, and 
characterization studies of environmental bacteria in order to assess the prevalence of antibiotic 
resistance in this river environment. Samples were collected using the same procedure 
described for monitoring and providing special natural characteristics of watercourses as rivers 
(JNCC, 2014).
3.2 Experimental approach
The method used for water sampling and analysis as recommended by several authoritative 
bodies is the Membrane filtration (MF) technique. This technique is widely used in standard 
bacteriological tests to assess water quality. Membrane filtration utilizes a physical barrier, a 
sterile porous membrane or a filter, to separate particles from a liquid. Particles and 
microorganisms are separated based on their size and shape with the use of pressure and 
specially designed membranes of different pore sizes. Microorganisms retained in the filter can 
then be grown on agar medium to produce visible colonies that can be isolated and further 
identified. One of the advantages of the MF technique is that it allows large sample testing with 
little preparation time compared to other analysis options. One of the drawbacks of membrane 
filtration is that it cannot be used to assess water quality from a turbid water source. However, 
this was not an issue for this experiment, since samples were obtained from a clear water 
source.
3.2.1 Membrane nitration technique
The technique involves collection and examination of bacteria on sterilized gridded cellulose- 
acetate membrane filters of 47 mm diameter with pore size 0.22pM (Advantec MFS, Inc). 
Filters were placed either directly on the nutrient agar or pads impregnated with agar broth for
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incubation at temperature 25°C or 37°C. After incubation the membrane filters were removed 
and the agar plates were examined for growth of colonies. The detailed methodology followed 
for membrane filtration of the Dighty river water sample is as given in C hapter 2, section 2.2.
3.2.2 Bacterial enumeration by viable plating techniques
In order to determine the extent of bacterial load, counting of viable cells in a sample is a 
standard procedure. The viable microbial cell count measures the concentration of living 
microorganisms present in the sample. The widely accepted definition of cell viability is the 
ability to multiply and produce either a macroscopic colony on an appropriate solid growth 
medium or generate visible turbidity in an appropriate culture (Heritage, 2011). The spread- 
plate technique is used for the separation of dilute, mixed population of microorganisms so that 
individual colonies can be isolated (Aneja, 2003). Each colony forming unit (CFU) represents a 
single bacterium in the original diluted sample (Kapoor & Yadav, 1986). Colonies appearing 
on the medium in a plate are visible to the naked eyes and can be counted. For better results, 
the original sample must be diluted so that an optimum number of colonies between 30 and 300 
are obtained on the medium (Heritage, 2011). It has been observed that fewer than 30 colonies 
make the interpretation of results statistically insignificant and greater than 300 colonies leads 
to overlapping colonies that leads to skew and imprecise colony counts (Heritage, 2011). The 
methodology followed for spread plating and quadrant streaking is as described in detail in 
C hapter 2, sections 2.4.1 and 2.4.2.
3.2.3 Pure culture and identification of selected bacterial isolates
In order to obtain pure bacterial cultures, a total of 400 isolated colonies were sub-cultured in 
nutrient agar or malt extract agar. Only those colonies that were single and non-overlapping 
were picked for streaking on another fresh agar plate. These petri plates were incubated having
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the same coding system and conditions for aerobic and anaerobic growth and same 
temperatures (25°C and 37°C) for 48 hours prior to further identification (Clinical and 
Laboratory Standards Institute., 2007).
3.2.4 Identification of colonies
Gram’s staining with subsequent microscopic examination, as well as biochemical 
identification using Analytical Profile Index (API), was conducted to identify the purified 
bacterial isolates. Identification procedures were then undertaken using the protocols of (Breed 
et al., 1957)
3.2.4.1 G ram ’s staining
The Gram stain is a differential staining technique used to classify and categorize bacteria into 
two major groups, Gram-positive and Gram-negative. The methodology followed for 
performing Gram staining is as given in C hapter 2, section 2.6.1.
3.2.4.2 Selective and differential culture media
MacConkey Agar (Oxoid, CM0007) was used for the isolation of Gram-negative enteric 
bacteria and for the differentiation of lactose-fermenting from lactose non-lactose-fermenting 
Gram-negative bacteria. Bile salts and crystal violet inhibit the growth of Gram-positive 
bacteria. Lactose provides a source of fermentable carbohydrate, allowing for differentiation. 
Neutral red is a pH indicator that turns red at a pH below 6.8 and is colourless at any pH 
greater than 6.8. Lactose-fermenting organisms will grow as pink colonies with or without a 
zone of precipitated bile. Non-lactose fermenting organisms grow as colourless or clear 
colonies.
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3.2.4.3 Preliminary identification process with API strips
The analytical profile index (API) is a detection system for bacterial classification and 
identification of closely related bacteria. There are more than 15 kinds of commercially 
available strips formulated to classify unidentified bacterial isolates up to the species level. 
Different test panels are prepared in dehydrated forms, which are reconstituted upon use by 
addition of bacterial suspensions. The most common strips used for identification and 
classifications of Gram-negative bacteria are API 20E and API 20NE. API 20E is used for the 
identification of enteric Gram-negative bacilli, while API 20 NE is a standardized system for 
the identification of non-fastidious, non-enteric Gram-negative rods. API 50CH is the 
corresponding API strip system used for identifying and classifying Gram-positive bacteria.
In order to further identify the purified cultures using the API strips systems, based on 
the Gram staining and MacConkey experiments 163 Gram-negative strains and 47 Gram­
positive bacterial isolates were grown overnight at 37°C in nutrient broth medium. Bacterial 
suspensions were compared side by side with McFarland as the API manufacturer 
recommended the determination of the appropriate turbidity of the inoculum. The API strips 
were then inoculated onto a saline suspension containing the pure culture and then covered 
with plastic impermeable container with a little sterile water inside it to avoid evaporation. 
After 24 hours of incubation in a humidity chamber at 37°C, colour reactions were developed 
as a result of rehydration reaction occurring inside each test compartments as well as due to 
changes in pH. Colour complexes can be developed directly either by chemical reaction with 
other chemicals present in the tube or by manual addition of special reagents. The results for 
each strip were recorded and analysed using the “APIweb” database (http://www.biomerieux- 
usa.com/clinical/api. Accessed March 9, 2016). The methodology followed for handling and 
inoculating the API strip is discussed in detail in C hapter 2, section 2.7.
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3.2.4.4 Oxidase test
The oxidase test is a biochemical reaction used to check the presence of cytochrome oxidase 
enzyme in bacteria that catalyses the oxidation of cytochrome C while reducing oxygen to 
water. In the presence of atmospheric oxygen and cytochrome C, the enzyme oxidizes the 
phenylenediamine reagent to form a purple coloured compound, indophenol. The procedure 
followed for conducting the oxidase test is described in C hapter 2, section 2.7.5.
3.2.5 Determination of antibiotic sensitivity using the M astring assay 
MASTRING-S™ is an antibiotic susceptibility ring device, designed for convenient and 
simultaneous testing of an equivalent of 6 or 8 antibiotics. The Mastring is composed of a 
filter paper circular ring with several attached peninsulae or tips. Each tip is impregnated 
with a different antibiotic and functions as an individual antibiotic sensitivity disc. Two 
different combinations of antibiotic disc rings were used in this study, M l3 and M14 (MAST 
Diagnostics Co., France). M13 contains the stock of rings of antibiotics for testing antibiotic 
susceptibility of Gram-positive bacteria and M14 contain susceptibility rings for Gram­
negative bacteria. Refer to Chapter 2, section 2.8 for the detailed procedure followed for 
antibiotic sensitivity using the Mastring assay.
3.2.6 Statistical analysis
SPSS version 20 was used to analyse the experimental data. Statistical Analysis tools used to 
process the data were determination of the Mean, Standard Deviation, and subsequent t-test to 
determine if the scores for the two categories have significant differences with each other. The 
Independent Samples T-Test table consists of the following: N shows the number of species 
belonging to that group. Mean shows the average sensitivity scores. SD stands for Standard
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Deviation and it shows the spread of the data with respect to the Mean (the higher the SD, the 
wider the data and vice versa), df stands for degrees of freedom. It is computed by subtracting 
1 to the N. This is used for Inferential Analysis in determining significant differences between 
the categories (greater than 0 and those who are exactly 0). T value is a value in the 
Independent Samples T Test, which tests the significant differences between the categories. P- 
value indicates the probability that the two categories are not significantly different. A rule is 
that a p-value of less than 0.05 indicates that there is a significant difference between the two 
categories. A higher p-value indicates that the two categories are not significantly different.
3.2.7 Determination of minimum inhibitory concentration (MIC)
Minimum Inhibitory Concentration (MIC) is defined as the lowest concentration of an 
antimicrobial agent that can inhibit microbial growth (Gharehbeglou et al., 2015). MIC values 
are frequently used by diagnostic laboratories to confirm specific microbial resistance against 
an antimicrobial agent and are used as an in vitro research tool in many university laboratories 
(Christofilogiannis, 2001). Standardised methods of performing MIC test either the tube 
dilution method or the 96 well plate method. In this study, all the bacterial strains demonstrated 
significant results with both M 13 and M14 Mastrings were subsequently tested with the tube 
dilution method or the 96 well plate method in order to determine their antibiotic sensitivity 
determined as MIC. The procedure for carrying out tube dilution test in microtitre plate is as 
given in C hapter 2, section 2.9.1.
3.2.8 Oxidase test
Following the MIC test, the selected strains were subjected to oxidase test. The strains were 
selected based on their exhibited antibiotic resistance via the 96 well plate test (Clinical and 
Laboratory Standards Institute., 2007).
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3.2.9 Identification of bacteria by 16s rDNA
For rRNA gene sequencing, two primer pairs were used (Table 3.1) to amplify 16s rRNA 
gene in Gram-negative bacteria using PCR (Greisen et al., 1994). After the purified PCR 
products of the 16s rRNA genes were obtained, they were processed for sequencing. The 
resulting DNA sequences were aligned against bacterial DNA gene database to identify the 
bacterial isolates. Refer to Chapter 2, sections 2.10.1, 2.10.4, 2.10.5 and 2.10.6 for the 
methodology followed for bacterial DNA isolation, 16s rRNA gene PCR, agarose gel 
electrophoresis and DNA sequencing/analysis respectively.
Table 3.1: Two sets of universal bacterial prim ers (forward and reverse) were 
selected as broad range and were used for 16s rRNA gene amplification of the 









3.3.1 Isolation and preliminary identification of bacteria
In this study, attempts were made to isolate antibiotic resistant bacteria from Dighty River using 
membrane filtration technique. Table 3.2 shows the finer details of the growth conditions used
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and observations of the experiment.
The isolated colonies generated from the membrane filters were then propagated in agar 
media and used to further identify the microbial constituents present in the water samples. For 
bacterial identification, Gram’s staining was initially performed to identify Gram-positive and 
Gram-negative bacterial isolates. For this experiment, 100 colonies were chosen from each agar 
plate and grown at 25°C for 48 hours. Overall, a total of 400 colonies were selected for further 
study.
Table 3.2: Details 
membrane filtratio 
(temperature, dural
of the culture parameters used in the isolation of bacteria using 
n technique. Details of growth medium, specific growth conditions 

















Then each isolate was further identified up to the species level using biochemical tests and API 
strips. All the strains that showed as Gram-negative bacteria with the Gram staining technique
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were grown and examined on MacConkey Agar prior to further identification using API strips 
(bioMerieux, France). 88 bacterial cultures that developed pink/red colonies on MacConkey 
Agar after 24 hours of incubation are lactose fermenters and were classified as non-fastidious, 
enteric bacteria, e.g. E. coli, and labeled for further identification with API 20 E. On the other 
hand, 75 isolates that displayed transparent, colourless colonies on MacConkey plates were not 
able to ferment lactose, although they may still be members of the family Enterobacteriaceae, 
e.g. Salmonella spp. Non-fastidious, non-enteric, Gram-negative rods (e.g. Pseudomonas, 
Acinetobacter etc.) cultures were then examined with API 20NE, a standardized system for the 
identification based on biochemical tests. API 50CH was used to identify lactobacilli and 
related genera.
3.3.2 Antibiotic susceptibility test by disc assay
The isolated bacteria were then subjected to antibiotic susceptibility testing using Mastring 
M13 and M14 and tube dilution methods to determine minimum inhibitory concentration 
(MIC) of antibiotics effective in inhibiting their growth. Statistical analyses of the results 
obtained from the Mastring 13 antibiotic sensitivity assay are presented in Table 3.3. A total of 
146 bacterial isolates were used for this assay. Bacterial cells were uniformly plated on the 
surface of 100 mm agar plates and exposed to different antibiotics using the M l3 ring disc 
impregnated with eight antibiotic tips containing chloramphenicol (25pg), erythromycin (5pg), 
fusidic acid (lOpg), oxacillin G (5pg), novobiocin (5pg), penicillin G (1 unit), streptomycin 
(10pg) and tetracycline (25pg). Statistical analyses of mean, standard deviation and p  values of 
their zones of inhibition are shown in Table 3.3. Results show that out of 146 bacterial 
isolates tested, 54 were sensitive, while 92 were resistant to chloramphenicol; 16 were 
sensitive, while 130 were resistant to erythromycin; 24 were sensitive, while 122 were resistant
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to fusidic acid; 11 were sensitive, while 135 were resistant to oxacillin G; 18 showed 
sensitivity, while 128 showed resistance to novobiocin; 13 showed sensitivity, while 133 
showed resistance to penicillin G; 101 were sensitive, while 45 showed resistance to 
streptomycin and 126 were sensitive, while 20 showed resistance to tetracycline. More 
importantly, differences in the zones of inhibition between the sensitive and resistant strains are 
all statistically significant indicating that the amount and potency of antibiotics used 
significantly inhibited the growth of sensitive isolates, while resistant isolates continued to 
grow without interruption in spite the presence of the drug. Interestingly, Table 3.4 shows 126 
isolates were sensitive, while 20 isolates were resistant to both penicillin G and tetracycline. 
These 20 resistant strains appear to possess an unknown mechanism that allows them to resist 
the antibiotic action of both drugs and are good candidates for further analysis for multidrug 
resistant phenotype.
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Table 3.3: Statistical analysis of differences in the size of zones of inhibition (zi) of bacterial isolates that were sensitive (zi > 0) or 
resistant (zi = 0) to the antibiotics of M13 using Independent Sample T-Test. Where; n = number; SD = standard deviation; df = degrees 
of freedom; p = probability.___________________________ ________________________ ________________ ____________________________
Chloramphenicol N Mean SD df T p-value Description
Isolates that were sensitive 54 0.96 0.34 53 20.67 0.00 Significant
Isolates that were resistant 92 0 0 92
Erythromycin Isolates that were sensitive 16 0.8 0.34 15 9.37 0.00 Significant
Isolates that were resistant 130 0 0 130
Fusidic Acid Isolates that were sensitive 24 0.6 0.3 23 9.64 0.00 Significant
Isolates that were resistant 122 0 0 121
Oxacillin G Isolates that were sensitive 11 0.93 0.37 10 8.21 0.00 Significant
Isolates that were resistant 135 0 0 134
Novobiocin Isolates that were sensitive 18 0.66 0.31 17 8.92 0.00 Significant
Isolates that were resistant 128 0 0 127
Penicillin G Isolates that were sensitive 13 0.61 0.28 12 7.96 0.00 Significant
Isolates that were resistant 133 0 0 132
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Table 3.3 (continued): Statistical analysis of differences in the size of zones of inhibition (zi) of bacterial isolates that were sensitive (zi > 0) or resistant 
(zi = 0) to the antibiotics of M13 using Independent Sample T-Test. Where; n = number; SD = standard deviation; df = degrees of freedom; p = 
probability.
Chloramphenicol N Mean SD df T p-value Description
Isolates that were sensitive 54 0.96 0.34 53 20.67 0.00 Significant
Isolates that were resistant 92 0 0 92
Streptomycin Isolates that were sensitive 101 0.8 0.33 100 24.22 0.00 Significant
Isolates that were resistant 45 0 0 44
Tetracycline Isolates that were sensitive 126 1.05 0.29 125 39.9 0.00 Significant
Isolates that were resistant 20 0 0 19
Total isolates examined against each antibiotic 146 0.9 0.45 125
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Overall, of 146 isolates tested, 129 isolates showed sensitivity to one or more of the eight 
antibiotics of Mastring 13 group, whereas 17 isolates resisted the action of all antibiotics 
(Tables 3.4). The number of species that are resistant and sensitive towards each antibiotic in 
Mastring 13 is as given in Figure 3.1. A substantial number of species was found to be 
resistant towards the antibiotics chloramphenicol, erythromycin, fusidic acid, oxacillin G and 
novobiocin.
Table 3.4: Statistical analysis of differences in the sizes of the zones of inhibition 
(zi) of bacterial isolates that were sensitive (zi > 0) or resistant (zi = 0) to the 
combination of the antibiotics Penicillin and Tetracycline using Independent 
Sample T-Test. W here; n = number; SD = standard deviation; d f = degrees ol
Penicillin and 
Tetracycline
N Mean SD df T p-value Description
Isolates that 
were sensitive
126 0.555 0.19 125 32.669 0.00 Significant
Isolates that 
were resistant
20 0.00 0.00 19
Total 146 0.479 0.26 144
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Figure 3.1: Graphical representation showing the number of isolates that are resistant and 
the number of isolates that were sensitive towards the specific antibiotics 
Chloramphenicol, Erythromycin, Fusidic acid, Oxacillin G, Novobiocin, Penicillin G, 
Streptomycin and Tetracycline on the M13 Mastring.
For antibiotic sensitivity assay using Mastring 14 ring disc, statistical analyses of the results 
are presented in Table 3.5. A total of 146 isolates were used for these experiments. All 
bacterial isolates were uniformly spread on the surface of separate 100 mm agar plates and 
exposed to different antibiotics using the M14 ring disc impregnated with eight antibiotic tips 
containing ampicillin (lOpg), cephalothin (5pg), colistin sulphate (25pg), gentamicin (10pg), 
streptomycin (lOpg), sulphatriad (200pg), tetracycline (25pg) and co-trimoxazole (25pg). 
Statistical analysis of mean, standard deviation and p  values of their zones of inhibition was 
undertaken. Based on the results, out of 146 bacterial isolates tested, 31 were sensitive, while 
114 were resistant to ampicillin; 16 were sensitive, while 130 were resistant to cephalothin; 99 
were sensitive, while 47 were resistant to colistin sulphate; 125 were sensitive, while 21 were
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resistant to gentamicin; 103 showed sensitivity, while 43 showed resistance to streptomycin; 8 
showed sensitivity, while 138 showed resistance to sulphatriad; 139 were sensitive, while 7 
showed resistance to tetracycline; and 14 were sensitive, while 122 showed resistance to co- 
trimoxazole. More importantly, differences in the zones of inhibition displayed by the 
sensitive versus resistant isolates are statistically significant. Antibiotic-resistant isolates 
displayed uninterrupted growth with zones of inhibition of zero. This result reveals that the 
amount and the potency of the antibiotics used significantly inhibited the growth of sensitive 
isolates, but did not show any significant change in the growth of the resistant isolates. Taken 
altogether, a total of 143 isolates showed sensitivity to all eight antibiotics belonging to the 
M14 group, while only 3 isolates showed active resistance to all eight drugs (Figure 3.2). 
These 3 isolates were selected as ideal candidates for further investigation of the multidrug 
resistant phenotype.
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Table 3.5: Statistical analysis of differences in the sizes of the zones of inhibition (zi) of bacterial isolates that were sensitive (zi > 
0) or resistant (zi = 0) to all the antibiotics of M14 using Independent Sample T-Test. Where, n = number; SD = standard 
deviation; df = degrees of freedom; p = probability.
Ampicillin N Mean SD Df t p-value Significance
Isolates that were sensitive 31 0.86 0.29 30 16.487 0.00 Significant
Isolates that were resistant 114 0 0 113
Cephalothin Isolates that were resistant 16 0.64 3 15 7.931 0.00 Significant
Isolates that were sensitive 130 0 0 129
Colistin Sulphate Isolates that were sensitive 99 0.79 0.65 48 12.034 0.00 Significant
Isolates that were resistant 47 0 0 43
Gentamicin Isolates that were sensitive 125 0.93 0.4 124 26.08 0.00 Significant
Isolates that were resistant 21 0 0 20
Streptomycin Isolates that were sensitive 103 0.76 0.3 102 17.502 0.00 Significant
Isolates that were resistant 43 0 0 42
Sulphatriad Isolates that were sensitive 8 0.96 0.36 7 7.514 0.00 Significant
Isolates that were resistant 138 0 0 137
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Table 3.5 (continued): Statistical analysis of differences in the sizes of the zones of inhibition (zi) of bacterial isolates that were sensitive (zi > 0) 
or resistant (zi = 0) to all the antibiotics of M14 using Independent Sample T-Test. Where, n = number; SD = standard deviation; df = degrees of 
freedom; p = probability.
Ampicillin N Mean SD Df t p-value Significance
Isolates that were sensitive 31 0.86 0.29 30 16.487 0.00 Significant
Isolates that were resistant 114 0 0 113
Tetracycline Isolates that were sensitive 139 0.93 0.33 138 33.53 0.00 Significant
Isolates that were resistant 7 0 0 6
Co-trimoxazole Isolates that were sensitive 14 1.07 0.34 13 11.928 0.00 Significant
Isolates that were resistant 132 0 0 131
Total isolates examinee against with each antibiotic 146 0.42 0.22 144
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Figure 3.2: Graphical representation showing the number of isolates that are resistant and 
the number of isolates that are sensitive towards the specific antibiotics Ampiciliin, 
Cephalothin, Colistin Sulphate, Gentamicin, Streptomycin, Sulphatriad, Tetracycline and 
Co-trimoxazole on the M14 Mastring.
A substantial number of species was found to be resistant towards the antibiotics ampicillin, 
cephalothin, sulphatriad and co-trimoxazole and sensitive towards colistin sulphate, gentamicin, 
streptomycin and tetracycline. In addition, with regard to the overall sensitivity, the 146 isolates 
tested showed higher sensitivity towards the M14 group of antibiotics (with 143 sensitive versus 
3 resistant) compared to M13 drugs (129 sensitive versus 17 resistant) (Figure 3.3). Finally, a 
total of 20 putative multidrug resistant isolates confirmed by both M l3 (Figure 3.1) and M14 
(Figure 3.2) sensitivity assays were selected along with 13 other promising isolates for further 
analysis of their antibiotic susceptibility using drug inhibition assay in 96-well plate system.
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Figure 3.3: Graphical representation showing the number of isolates that are resistant and 
the number of isolates that are sensitive towards M13 antibiotics (Chloramphenicol, 
Erythromycin, Fusidic acid, Oxacillin G, Novobiocin, Penicillin G, Streptomycin and 
Tetracycline) and M14 antibiotics (Ampicillin, Cephalothin, Colistin Sulphate, Gentamicin, 
Streptomycin, Sulphatriad, Tetracycline and Co-trimoxazole).
3.3.3 Antibiotic susceptibility test by MIC
The antibiotic resistance of bacterial isolates that displayed uninterrupted growth using 
M13 and M14 were further confirmed using antibiotic susceptibility assay using 96- 
well plates. Table 3.6 shows the results of MIC determination of selected antibiotics using the 
96-well plates at 450 nm of the preliminarily identified isolate strains. This assay was done in 
parallel with the Mastring assay to confirm antibiotic sensitivity of selected isolates to four 
antibiotics of interest, namely ampicillin, co-trimoxazole, novobiocin and tetracycline.
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T able 3.6: D eterm ination  o f  M in im um  Inhibitory C on centration  (M IC ; pg/m L ) oi 
antib iotics A m p icillin , C lotrim azole, N ovob iocin  and T etracyclin e against prelim inarily  
identified  bacterial isolates, using the 96 W ell P late m ethod.
Bacterial Isolates 









Aeromonas sobria >128 > 128 128 2
Vibrio alginolyticus >128 >64 64 8
Pseudomonas aureofaciens >128 > 128 128 8
Burkholderia cepacia >128 >128 128 128
Pseudomonas stutzeri >128 >128 >128 >128
Enterobacter spp. >128 >128 >128 >128
Citrobacter diversus >128 >128 128 32
Enterobacter sakazakii >128 >128 64 8
Proteus vulgaris >128 >128 16 8
Enterobacter agglomerans >128 >128 >128 >128
Escherichia vulneris >128 >128 64 16
Citrobacter freundii >128 >128 4 4
Aeromonas hydrophila >128 >128 128 128
Listonella damsela >128 >128 128 4
Salmonella arizonae >128 >128 128 8
Mannheimia haemolytica >128 >128 64 8
Chryseomonas iuteola >128 >128 64 2
Providencia rettgeri >128 >128 64 2
Plesiomonas shigelloides >128 >128 128 8
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Table 3.6 (continued): Determination of Minimum Inhibitory Concentration (MIC; pg/mL) 
of antibiotics Ampicillin, Clotrimazole, Novobiocin and Tetracycline against preliminarily 
identified bacterial isolates, using the 96 Well Plate method.










Pasteurella multocida >128 32 64 8
Pseudomonas aeruginosa 64 >128 32 4
Raoultella ornithinolytica 64 32 4 4
Tatumella ptyseos 32 >128 4 4
Vibrio mimicus 64 8 8 8
Lactobacillus salivarius 8 8 4 8
Lactobacillus plantarum 32 64 64 2
Lactobacillus pentosus 64 >128 64 2
Flavobacterium indologenes >128 32 32 8
Sphingomonas multivorum 64 64 128 16
Pseudomonas fluoresce ns 128 64 64 8
From this list (Table 3.6), it appears that the selected bacterial isolates conferred robust 
resistance to both ampicillin and co-trimoxazole as indicated by MICs at >128pg/ml, which is 
an indication of uninterrupted growth. However, they exhibited variable resistance towards 
novobiocin and tetracycline. More importantly, five bacterial species (Table 3.7) showed 
resistance to all four antibiotics as demonstrated by MIC values greater than 128pg/ml. These 
five species were selected for further experimentation, including oxidase test and 16S rDNA
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sequencing to confirm their taxonomic identification.
Table 3.7: Bacterial isolates exhibiting an MIC of >128 pg/mL for antibiotics Ampicillin, 
Clotrimazole, Novobiocin and Tetracycline, and were subsequently selected for further 
investigation.
Bacterial Isolates Minimal Inhibitory Concentrations (Clinical and Laboratory 









Burkholderia cepacia >128 >128 128 128
Pseudomonas stutzeri >128 >128 >128 >128
Enterobacter spp. >128 >128 >128 >128
Enterobacter agglomerans >128 >128 >128 >128
Vibrio metschnikovii >128 >128 128 128
3.3.4 Oxidase test
All the selected bacterial isolates tested positive for oxidase, except for Enterobacter 
agglomerans.
3.3.5 Identification of bacteria using 16s rDNA analysis
The agarose gel containing the amplified 16S rRNA gene of the selected bacterial species is 
as shown in Figure 3.4. An expected amplicon size of ~370 was found in all the samples 
tested.
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Figure 3.4: Agarose gel showing amplified 16S rRNA gene from selected bacterial species. 
Where; M & 11 = lk b  ladder; 1 = Enterobacter spp.; 2 = Burkholderia cepacia; 3 = 
Aeromonas hydrophila; 4 = Enterobacter agglomerans; 5 = Pseudomonas stutzeri; 6 = 
Enterobacter spp.; 7 = Burkholderia cepacia; 8 = Aeromonas hydrophila; 9 = Enterobacter 
agglomerans; 10 = Pseudomonas stutzeri. Lanes 1 to 5 using forward prim er DG74 and 
reverse prim er RW01 and lanes 6 to 10 using forward prim er RDR080 and reverse prim er 
PL06.
The amplicons were sequenced and analysed using the NCBI database 
(http://www.ncbi.nlm.nih.gov/. Accessed March 9, 2016) and BLAST software
(http://www.ncbi.nlm.nih.gov/guide/howto/run-blast-local/. Accessed March 9, 2016) to reveal 
the identity of the test organisms. The result of BLAST analysis is as given in Table 3.8. 
The five strains were identified Enterobacter spp. (NCIMB14479), Burkholderia cepacia  
(NCIMB13694), Aerom onas hydrophila (NCIMB9239), Enterobacter agglomerans 
(NCIMB9680) and Pseudomonas stutzeri (NCIMB 10783).
78
Table 3.8: Selected bacterial isolates identified by 16s rDNA 
gene sequencing method and subsequently selected for further 
experimental analysis.







The selection of the method used for the isolation of antibiotic-resistant strains from the river 
water is the single most important step in proving the hypothesis of this thesis. Among several 
methods available for water sampling, the membrane fdtration (MF) technique was chosen in 
order to maximize the water sample volume, which in turn helps to maximize the number of 
bacteria isolated. The antibiotic sensitivity of the isolated bacteria was performed employing the 
classic disc agar diffusion technique. Results obtained from both antibiotic sensitivity assay 
using both M13 and M14 ring discs demonstrate the existence of multi-drug resistance in Gram­
negative bacteria of this river environment. However, results also showed that different isolates 
display different sensitivities towards different antibiotics. For penicillin G, only 13 out of 146 
strains were sensitive, whereas 133 exhibited resistance, which indicates that 91.09% of 
organisms tested can resist the antibiotic action of penicillin G, which makes this antibiotic, 
ineffective against many organisms. One possible reason can be that the penicillin G is the 
oldest known antibiotic and bacterial resistance has evolved since it was first developed. Hence, 
decreasing its effectiveness as an antibacterial agent. Ampicillin on the other hand, showed
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some albeit less dramatic activity over that of penicillin G, displaying 21% efficacy. More 
importantly, bacterial isolates conferred significant resistance towards both P-lactam antibiotics, 
suggesting the presence of some unknown mechanisms that doesn’t allow these compounds to 
enter the cell.
Penicillins consist of a large group of bicyclic ring compounds which contain a 4- 
membered P-lactam ring (called penams) fused to a 5-membered thiazolidine ring, which 
interferes with bacterial cell wall mucopeptide synthesis (Wise & Park, 1965). When 
penicillin-sensitive bacterial cells were exposed to penicillin, it resulted in the loss of cell wall 
integrity, leading to cell lysis and cell membrane damage beyond repair (Wise & Park, 1965). 
Benzylpenicillin (penicillin G) was the first natural penicillin with potent activity against all 
Gram-positive pathogens, Gram-negative cocci and some spirochaetes and actinomycetes 
(Nathwani & Wood, 1993). In the past 50 years, penicillin G has been the mainstay of therapy 
for serious pneumococcal, streptococcal, and gonococcal infections (Nathwani & Wood,
1993). However, the last decade has seen the emergence of bacterial resistance in certain parts 
of the world, initially among gonococci, and more recently among pneumococci and 
meningococci. The discovery of 6-aminopenicillinamic acid nucleus has led to considerable 
manipulation of the basic ring structure, resulting initially in the synthesis of ampicillin and 
subsequently, the other aminopenicillins, analogues, esters and prodrugs (Nathwani & Wood, 
1993). These drugs have the advantage of improved oral bioavailability and superior activity 
against Haemophilus influenzae and certain Gram-negative bacilli including Salmonella spp. 
and Listeria monocytogenes, making these agents popular in the treatment of upper and lower 
respiratory tract infections and urinary tract infections(Nathwani & Wood, 1993). 
Cephalosporins were first introduced into chemical practice more than 30 years ago.
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Cephalosporins, like penicillins, possess a P-lactam structure that is the critical determinant of 
their antibacterial activity (Harrison & Bratcher, 2008). The five-member thiazolidine ring, 
which is characteristic of penicillins, is replaced by a six-member dihydrothiazine ring in the 
cephalosporins (Prober, 1998). This ring is responsible for the compound’s ability to resist 
inactivation by certain bacterial enzymes. Unlike the p-lactams, Cephalosporins are 
bactericidal. Following the penetration of the bacterial surface, they attach to the bacterial 
penicillin-binding proteins (PBPs), which catalyse reactions critical to cell wall synthesis and 
division (Prober, 1998). When the PBPs form complexes with cephalosporins, this catalytic 
activity is lost and cell wall synthesis and division are disrupted (Prober, 1998). The basic 
cephalosporin molecule has been modified extensively over the last three decades resulting in 
a proliferation of agents with diverse antibacterial, pharmacokinetic and pharmacodynamics 
properties (Nathwani & Wood, 1993; Harrison & Bratcher, 2008). Cephalosporins are grouped 
into “generations " based on the extent of their antimicrobial activity (Prober, 1998; Nathwani 
& Wood, 1993; Harrison & Bratcher, 2008). There are currently four generations of 
cephalosporins with numerous members per generation. Cephalothin, a first generation 
cephalosporin, was used in this study. Exposure of bacterial isolates to cephalothin showed 
11% efficacy where it only inhibited 16 isolates leaving the rest (130 isolates) unaffected by 
the drug. Taken altogether, all three p-lactam compounds used in this experiment exerted 
comparable antimicrobial effect owing to the similarities in their chemical structure. Since all 
three compounds were structurally unaltered or slightly modified in the case of ampicillin, 
their antimicrobial activities were not high when compared to the extensively modified future 
generation drugs. In addition, a majority of the bacterial isolates showed high resistance to all 
three p-lactam compounds suggesting some unknown mechanisms that prevent bacterial cells
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from taking up these drugs.
The tetracyclines are a family of antibiotics first discovered in the 1940s, which function 
to inhibit protein synthesis by preventing the attachment of aminoacyl-tRNA to the ribosomal 
acceptor (A) site resulting to the death of the organism (Chopra & Roberts, 2001). 
Tetracyclines are broad-spectrum antibiotics that target a wide range of Gram-positive and 
Gram-negative bacteria and other atypical organisms such as Chlamydiae, Mycoplasmas, 
Rickettsiae and protozoan parasites. The favourable antimicrobial properties of these agents 
and the absence of major adverse side effects have led to their extensive use in the therapy of 
human and animal infections (Chopra & Roberts, 2001). They are also used as prophylactic for 
the prevention of malaria caused by Plasmodium falciparum. In some countries, including the 
United States, tetracyclines are added at sub-therapeutic levels to animal feeds to act as growth 
promoters (Chopra & Roberts, 2001). Although tetracyclines retain important roles in both 
human and veterinary medicine, the emergence of microbial resistance has limited their 
effectiveness. In this study, exposure to tetracycline adversely inhibited the growth of 139 out 
of 146 bacterial isolates, which make tetracycline a potent antibiotic with 95% efficacy in 
these experiments.
Aminoglycosides are highly potent, broad-spectrum antibiotics with many desirable 
properties for the treatment of life-threatening infections. First developed in the 1940s, they 
are derived from antimicrobial substances produced by the soil-dwelling bacteria Streptomyces 
spp. and Micromonospora spp. (Avent et al., 2011). The most widely known member of this 
group, gentamicin, has been used for the treatment of serious Gram-negative bacterial 
infections since the early 1960s. Aminoglycosides are bactericidal. Their primary site of action 
is the 30s subunit of the prokaryotic ribosome, interrupting bacterial protein synthesis. In
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order to reach this active site, aminoglycosides bind to the bacterial cell wall and 
undergo active transport into the cytosol (Avent et al., 2011). Streptomycin was the first 
aminoglycoside agent in widespread use, along with netilmicin and kanamycin, but kanamycin 
is now be infrequently used. With the advent of broad-spectrum p-lactam antimicrobials, such 
as anti- pseudomonal penicillins, third generation cephalosporins and carbapenems, there was 
a noticeable shift away from prolonged administration of aminoglycosides. This change has 
been driven by the improved safety profile and improved pharmacokinetic parameters of these 
newer drugs (Avent et al., 2011).
In this experiment we used both streptomycin and gentamicin for the inhibition assay. 
There were duplicate experiments for streptomycin, since it was present in both M l3 and M14 
ring discs. Streptomycin exposure using the M 13 ring disc showed 70.5% efficacy, where 103 
isolates showed sensitivity and 43 were resistant. Similarly, streptomycin exposure, using the 
M14 ring disc showed 69% efficacy, where 101 isolates showed sensitivity, whereas 45 were 
resistant. These results affirm the reproducibility of both experiments. In addition, gentamicin 
displayed an improved antimicrobial efficacy of 85.6% compared to streptomycin, where it 
significantly inhibited the growth of 125 isolates, whereas 21 isolates were resistant to the 
drug. Despite the increase in drug efficacy, a small percentage of the isolates were able to 
confer resistance to these drugs, suggesting some unknown mechanisms that allow these 
organisms to exclude these substances or combat their bactericidal action.
Chloramphenicol is an antibiotic first isolated from cultures of Streptomyces venezuelae 
in 1947, but is now produced synthetically (Pongs, 1979). It was the first wide-spectrum 
antibiotic to be discovered and acts chiefly as a bacteriostatic agent (Pongs, 1979). It has a 
relatively simple structure and acts by interfering with bacterial protein synthesis more
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specifically, it irreversibly binds to a receptor site on the 50s subunit of the bacterial ribosome 
inhibiting the enzyme peptidyltransferase (Pestka, 1974). This prevents amino acid transfer to 
the growing polypeptide chain and ultimately leading to inhibition of protein synthesis 
(Pestka, 1974). Due to its capacity to cause fatal aplastic anaemia in humans, chloramphenicol 
is prohibited in food and animals in the US and many other countries. In this experiment, 
exposure to chloramphenicol showed 40% efficacy, where 54 isolates showed sensitivity, 
while 92 were resistant to the drug. So far, this is the only drug among those that affects 
protein synthesis that produced the lowest level of sensitivity, suggesting that 92 of the 
bacterial isolates possess some unknown mechanisms prevent chloramphenicol from entering 
the cells.
Novobiocin is a member of the coumermycin family of antibiotics and is a well- 
established inhibitor of DNA gyrase (Burlison et al., 2006; Luhrmann et a l, 1998). 
Novobiocin is produced by Streptomyces spp. (especially S. niveaus and S. spheroides) and its 
main targets are the Gram-positive bacteria. Novobiocin interferes with metabolic processes 
not only in bacteria, but also in eukaryotic cells. It has also been shown as a potent inhibitor of 
ADP ribosylation (Banasik et al., 1992). In the present study, novobiocin exposure exhibited 
12% efficacy, where only 18 isolates showed sensitivity, while the majority (128) of the 
isolates were able to resist the action of the drug.
The emergence of multidrug-resistant (MDR) Gram-negative bacteria in parallel with 
the lack of new antibacterial agents led scientists to discovery of polymyxins (Biswas et a l , 
2012; Falagas & Kasiakou, 2005; Giamarellou & Poulakou, 2009). There has recently been a 
marked increase in infections caused by MDR-resistant strains of bacteria, including those 
caused by Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumonia. For
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these species, polymyxins are often available as active antibiotics (Falagas & Kasiakou, 2005; 
Jain & Danziger, 2004; Karabinis et al., 2004; Michalopoulos et al., 2005; Obritsch et al., 
2005). Polymyxins consist of polymyxins A-E, of which polymixin B (PMB) and polymixin E 
are currently available on the market. When the use of p-lactams, aminoglycosides or 
quinolones becomes ineffective, polymixins, especially colistin, serve as the final alternative 
treatment (Biswas et al., 2012; Landman et al., 2008). Colistin is an old class of cationic 
peptides, which act by disrupting bacterial membranes resulting in cellular death (Bialvaei & 
Samadi Kafil, 2015). Despite the daily selective pressure in patients receiving colistin by 
inhalation, resistance to colistin is seldom observed (Jensen et al., 1987; Littlewood et al.,
2000) . There are two forms of colistin available in the market, colistin sulfate and colistin 
methanesulfonate (colismethate sodium or CMS). Colistin methanesulfonate or CMS was 
largely replaced by the use of aminoglycosides in the 1970s, because of concern about its 
neurotoxicity and nephrotoxicity (Littlewood et al., 2000). In the M14 sensitivity assay 
conducted in this project, 99 of the bacterial isolates showed inhibition of growth when 
exposed to colistin sulphate, while 47 were found to be resistant, suggesting that despite its 
efficacy some bacterial isolates can still obviate its bactericidal action of this drug by unknown 
mechanisms.
Pseudomonas stutzeri is a member of the genus Pseudomonas, that belongs to group I of 
Palleroni's DNA-rRNA homology group within the phylum Proteobacteria. P. stutzeri is now 
recognized as a member of class Gammaproteobacteria (Palleroni et al., 1973; Palleroni,
2001) . Phylogenetic studies of P. stutzeri strains' 16s rRNA sequences and other phylogenetic 
markers demonstrate that they belong to the same branch, together with related species within 
the genus, such as P. mendocina, P. alcaligenes, P. pseudoalcaligenes and P. balearica
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(Lalucat et al., 2006). Typically, P. stutzeri cells are rod shaped, about 1 to 3 pm in length and 
0.5 pm in width, and have a single polar flagellum (Lalucat et al., 2006). Phenotypic 
properties of the genus include a Gram-negative stain, positive catalase and positive oxidase 
tests, and a strictly oxidative metabolism. In addition, P. stutzeri strains are also defined as 
denitrifies (Lalucat et al., 2006). They can grow on starch and maltose and have a negative 
reaction in arginine dihydrolase and glycogen hydrolysis tests. In addition, P. stutzeri does not 
produce fluorescent pigments, which differentiates it from other members of the fluorescent 
Pseudomonas spp. (Lalucat et al., 2006).
Organisms of the Burkholderia cepacia complex (BCC) are Gram-negative bacteria of 
the p- proteobacteria subdivision that comprise at least 17 closely related species, which are 
genotypically distinct, but phenotypically similar. They include plant, animal and human 
pathogens, with a widespread distribution in natural and man-made habitats 
(Mahenthiralingam et al., 2005). These bacteria exhibit an extraordinary metabolic versatility, 
which allows them to adapt to a wide range of environments. Among the BCC bacteria, 
several environmentally relevant strains have been identified due to their ability to degrade 
pollutants in water and soils (e.g., crude oils, herbicides, recalcitrant aromatic compounds and 
xenobiotics) (Sousa et al., 2011). Several BCC strains are also able to produce antifungal 
compounds (Chiarini et al., 2006) and some studies suggested that members of the 
Burkholderia genus are ancient nitrogen-fixing symbionts of Mimosa legumes, particularly 
adapted to acidic infertile soils (Bontemps et al., 2010). Because of the ability of some strains 
to promote plant growth, BCC bacteria have attracted significant commercial interest as 
biocontrol, bioremediation and plant-growth promoting agents (Chiarini et al., 2006). 
However, these bacteria have also emerged as important human pathogens and the risks
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associated with the agricultural uses of BCC strains remain unclear. There is a general 
consensus that the large-scale use of organisms of the Burkholderia genus is imprudent until 
more is known about the fate of biocontrol strains after their release in the environment (Sousa 
et al., 2011). For example, the epidemic B. cenocepacia strain PHDC was recovered both from 
patients suffering from cystic fibrosis (CF) in the mid-Atlantic region of USA, as well as from 
agricultural soils (LiPuma et al., 2002). Aside from cystic fibrosis (CF), BCC bacteria are also 
important pathogens in compromised patients, such as patients suffering from chronic 
granulomatous disease (CGD) (Johnston, 2001), a rare hereditary disease caused by mutations 
in the subunits of the NADPH oxidase complex of the phagocytes, resulting in their inability to 
produce reactive oxygen species (Johnston, 2001). There are also some reports of BCC 
infections in immunocompromised patients of cancer and HIV and also among 
immunocompetent individuals (Mann et al., 2010; Marioni et al., 2006). In recent years, an 
increasing number o f bacteraemia cases caused by BCC among non-CF hospitalized patients 
have been reported. Among these hospitalized non- CF patients; haemodialysis, permanence in 
intensive care units, use of central venous catheters, indwelling urinary catheters and 
endotracheal tubes are now recognized as risk factors contributing for BCC acquisition.
Strains from all the BCC species have been isolated from cystic fibrosis patients as well 
as from the environment. However, their frequency of isolation is uneven. While the majority of 
the isolates obtained belong to the species B. cenocepacia and B. multivorans 
(Mahenthiralingam et al., 2005), the majority of the environmental isolates belong to the 
species B. cepacia, B. ambifaria, B. cenocepacia and B. pyrrocinia (Chiarini et al., 2006).
One of the major problems associated with BCC infection is their intrinsic resistance to 
most of the clinically available antimicrobials, including aminoglycosides, quinolones,
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polymyxins and P-lactams (Leitao et a l , 2008; Sousa et a l, 2011). The multi-resistance of BCC 
bacteria appears to result from various efflux pumps that efficiently remove antibiotics from the 
cell, decreased contact of antibiotics with the bacterial cell surface due to their ability to 
form biofilms and changes in the cell envelope that reduce the permeability of the membrane to 
the antibiotic (George et a l , 2009). BCC bacteria are also resistant to neutrophil-mediated non- 
oxidative killing and to the antimicrobial peptides produced by airway epithelial cells, including 
lysozyme, lactoferrin and phospholipase A2 (Baird et a l , 1999). Therefore, CF patients 
chronically infected with BCC are difficult to treat and, although current treatment strategies use 
double or triple antibiotic combinations to achieve bactericidal activity, they rarely result in the 
eradication of the pathogen, particularly in the case of chronic infection (George et a l, 2009).
Out o f the 33 strains (Table 3.6) that were identified to the species level by API strips and 
further analysed using inhibition assays, five strains (Table 3.7) scored the highest resistance 
pattern to the four antibiotics with MICs >128pg/mL and were chosen for further study and 
identification, because they showed promising signs for multidrug resistance towards ampicillin 
and tetracycline Their rDNA sequences were compared against previously known 16s rDNA 
sequences to confirm their species identification.
16s rDNA gene sequencing is the currently the most preferred technique for bacterial 
identification. Due to widespread use of polymerase chain reaction (PCR) and DNA 
sequencing in the past decade, 16s rDNA (reverse transcribed from rRNA) sequencing has 
played a pivotal role in the accurate identification of unknown bacterial isolates and the 
discovery of novel bacteria in clinical microbiology and research laboratories (Woo et a l, 
2008). 16s rDNA sequencing is particularly important for bacterial identification particularly 
in the case of bacteria with unusual phenotypic profiles, rare bacteria, slow-growing bacteria,
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uncultivable bacteria and culture-negative infections. Not only has it provided insights into the 
aetiology of infectious disease, but it also helps clinicians and researchers in choosing 
antibiotics and in determining the duration of treatment and infection control procedures.
All five strains were processed for 16s rDNA sequencing followed by DNA sequence 
analysis. This is the final step in the identification process. Possible mechanisms for 
antibiotic resistance will be further studied through molecular studies of plasmid DNA as 
well as studies for protein expression.
3.5 Chapter Summary & Conclusions
Results obtained from the API strip identification system revealed that the Dighty Burn was 
contaminated with over 35 antibiotic-resistant bacterial strains belonging to the family 
Enterobacteriaceae, possibly brought to the river by runoff contamination from agricultural 
land surrounding the sampling site. These are enteric bacteria that normally reside inside the 
intestines of animals and humans. Moreover, both antibiotic sensitivity assays using the 
Mastring system and the 96-well plate system proved to be efficient methods for the 
determination of multidrug-resistance phenotypes of selected bacterial isolates. The API strip 
system provided a cheap, fast and efficient way to identify a large number of isolates 
compared to 16s rDNA sequencing. However, the latter provided a more specific taxonomic 
identification by comparing the sequences of rRNA gene to known sequences across the entire 
kingdom Monera. Results of API identification were all confirmed by 16s rDNA sequencing 
and we have now identified five novel multidrug-resistant species, which will be utilized for 
further characterization.
The next step in the experimentation process is to determine whether the multidrug 
resistance phenotypes displayed by these five species are encoded in the bacterial
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chromosome or on a plasmid. After the determination of the origin of the multidrug resistance 
gene, subsequent experiments are required to investigate the presence o f efflux pumps and 
their roles in multidrug resistance.
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Chapter 4. Preliminary Analysis of Antibiotic Drug Resistance 
Mechanisms in Five Selected Gram-Negative Bacterial Species
This chapter addresses the experimental processes designed to identify the molecular 
mechanisms responsible for antibiotic resistance in the selected allochthonous bacterial strains 
isolated from the Dighty Bum. The Chapter includes an introduction (Section 4.1), the 
experimental approach (Section 4.2), results (Section 4.3), discussion (Section 4.4) and a 
chapter summary and conclusions (Section 4.5).
4.1 Introduction
The World Health Organization (WHO, 2015c) defines antimicrobial resistance as the ability of a 
microorganism to resist inhibition by an antimicrobial drug that was once able to treat an 
infection caused by that microorganism.
The evolution of resistance to antibiotics in bacteria is a powerful illustration o f natural 
selection. As a result of clinical, prophylactic and agricultural overuse of antibiotics, the 
frequency of antibiotic resistance in certain bacterial populations has risen from undetectable 
levels to greater than 50% in less than 20 years (Watanabe 1963; Anderson 1968; Falkow et al., 
1971).
There are many molecular mechanisms by which the bacteria achieve this feat. The most 
important means through which bacteria gain resistance include:
• Plasmid mediated antibiotic resistance (Carattoli, 2009; Svara & Rankin, 2011)
• Efflux pump mediated drug resistance (Rouveix, 2007; Webber, 2003)
• Production of P-lactamase enzyme (Dever, 1991; Livermore & Brown, 2001).
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Plasmid-mediated antibiotic resistance
An organism may exhibit resistance to one or multiple antibiotics as a dominant phenotype 
determined by the genes located on a plasmid. Plasmids are relatively small, circular DNA 
molecules, which replicate with some degree of autonomy in the bacterial cytoplasm. R-plasmids, 
which were initially called ‘resistance factors’ or R-factors, are small, extra-chromosomal genetic 
elements that play a central role in the dissemination and acquisition of resistance in bacteria. 
These resistant factors contain genes that facilitate the formation of sex pili, which are 
filamentous appendages on the cell surface (Petrocheilou et al., 1976; Corpet & Lumeau 1987). 
This process consequently drives bacterial conjugation, which enables the transfer of a copy of a 
plasmid from the resistant organism to one which may have previously been drug-sensitive 
(Stone, 1975). The resulting ex-conjugants are then capable of acting as plasmid donors during 
subsequent pairings. Hence, R plasmids are commonly responsible for the epidemic spread of 
multiple drug resistance (MDR) throughout an entire bacterial population. This can pose serious 
problems in antibiotic therapy particularly as plasmids are often transmissible between organisms 
of different species and even different genera (Stone, 1975).
Sequencing of early generations of R plasmids demonstrated that most of their antibiotic 
resistant genes are often associated with transposable elements or transposons (Davies & Rownd 
1972; Cohen et al., 1972).Transposons are short sequences of DNA capable of changing location 
within the genome of a single cell. The majority of the well-characterized resistant plasmids 
isolated from Gram-negative bacteria are self-transmissible (conjugative) and carry more than 
one resistance gene. It is now believed that antibiotic resistance genes and plasmids existed even 
before the human use of antimicrobial drugs (Davies & Smith 1978; Hughes & Datta 1983). The 
phenomenon of plasmid-mediated transmissible drug resistance was first discovered in Japan in
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late 1950s, following the isolation of dysentery causing strain of Shigella flexneri resistant to four 
drugs, namely chloramphenicol, tetracycline, streptomycin and sulphonamide (Kitamoto et al., 
1956). Multiple drug resistant Shigella strains were subsequently found with increasing 
frequency in clinical practice in Japan and became of particular interest, when it was observed 
that after administration of a single antibiotic, both sensitive and multi-drug resistant strains 
belonging to the same serological type could be isolated in specimens from either a single patient 
or multiple patients in the same outbreak (Meynell et al., 1968). In addition, resistance also 
spread into other normal host flora present as commensals like E. coli. Researchers soon 
discovered that these bacteria acquired resistance through the spread of genes from one organism 
to another through horizontal gene transfer. The plasmids that mediated this transfer are called 
Resistance factors or R-factors (Normark & Normark 2002; Chandler et al., 1977).
Organisms containing R plasmids carry genes that confer resistance to substances such as 
antibiotics (Ajamaluddin et al., 2000), heavy metals (Nakahara et al., 1977) or cellular toxins 
(Schmidt et al., 1995). R plasmids, such as the R100, R1 and R6, all contain two functionally 
distinct units: (i) the Resistance transfer factor (RTF), which includes genes for plasmid 
replication and conjugation and (ii) the re-determinant (r-det) factor, which has the resistance 
genes and encodes for the production of enzymes that inactivate certain drugs or toxic substances 
(Legrand et al., 1979). R-factors are usually assembled from multiple transposons. Tn21 for 
instance, is a particularly remarkable example of a large composite transposon found in R100 
plasmid, which contain mercury resistance genes in addition to genes for sulfonamide and 
aminoglycoside resistance (Liebert et al., 1999). Different R-factors, when present in the same 
cell can recombine to produce R-factors with a new combination of genes in their re­
determinants. Plasmids that carry genes to resist sulphonamides, streptomycins, chloramphenicol, 
tetracycline and mercury have been identified. This particular plasmid can be transferred between
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a number of enteric species including Escherichia, Klebsiella and Salmonella (Brau & 
Piepersberg, 1983).
R-factors pose serious problems in treatment of infectious diseases with antibiotics. The 
transfer of resistance between bacterial cells of a population and even between the bacteria of 
different genera also contributes to the problem (Cohen et al., 1972; Friesen et al., 2006; Stone, 
1975). Bacteria can conjugate and transfer plasmids and other genetic material to other cells 
within and outside their own species. For instance, it was previously found that resistance can be 
transferred widely among Enterobacteriaceae, Vibrio cholerae, Pasteurella pestis and Serratia 
marcescens (Farrar, 1985). It is thought that Neisseria spp. may have acquired its penicillinase 
producing plasmid from Streptococcus, and / or Agrobacterium spp. (Goh et al., 1985). 
Specialized plasmid mediated transfer of DNA between certain bacterial species and plants cells 
have been characterized (Frtindt et al., 1998). Recombinant plasmids derived from cloning 
vectors are frequently lost from the host cells, even when they exist at high copy numbers. On the 
contrary, most natural R plasmids are remarkably stable and are rarely lost during multiplication 
of host cells, even when the copy number is low (Nordstrom & Austin, 1989). This is because R 
plasmids contain genes that ensure the correct partitioning of copies to daughter cells (Nordstrom 
& Austin, 1989). Moreover, some natural plasmids contain the “killer elements” composed of a 
stable killer protein or mRNA and an unstable inhibitor protein or antisense RNA, such that the 
loss of plasmids will result in the death of the host cells (Nordstrom & Austin, 1989).
Classic experiments by Avery and his group (1944) showed that Pneumococcus bacteria 
are " transformed” from normal to virulent when they take up DNA from virulent strains. 
However, natural transformation is a rare event, so Cohen and co-workers in 1973 (Cohen et al., 
1973) used a chemical method developed in 1970 by Mandel and Higa (1970). This involved 
mixing the bacteria and DNA in a suspension of cold CaCfe at freezing temperature. Then, Boyer
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and Cohen rapidly raised and lowered the temperature to generate a “heat shock”. This technique 
induces the competence in bacteria to take up the plasmid DNA. These transformed bacteria were 
spread onto a culture plate containing the antibiotics tetracycline and kanamycin. Only 
transformed bacteria containing both kinds of resistance genes could grow in the presence of both 
antibiotics. This result was consistent with the bacteria being transformed with a recombined 
plasmid containing both the tet (tetracycline) and the kan (Kanamycin) resistance genes. 
However, it was also possible that some bacteria had been doubly transformed by re-ligated 
versions of the original plasmids. They can be easily differentiated from the transformed bacteria 
through restriction digestion of plasmid with subsequent visualization on agarose gel.
Antibiotic resistance prevents bacteria from antibiotic-induced damage and it can persist 
for long periods (Neu, 1992). The micro-ecological pressure exerted by the presence of an 
antibiotic is a potent stimulus to elicit a bacterial adaptation response and is the most common 
cause of bacterial resistance to antibiotics (Davies & Davies, 2010; Levin et al., 2000; Normark 
& Normark, 2002). Antibiotic resistance could also be divided into (i) genetic drug resistance and 
(ii) phenotypic drug resistance. Genetic drug resistance is to the result of chromosomal mutations 
or the acquisition of antibiotic resistance genes on plasmids or transposons (Alanis, 2005).
4.1.1 Using bacterial transformation to identify the potential presence of antibiotic- 
resistance plasmids
Transformation involves the acquisition of genetic materials from the environment where it may 
be present in abundance, through cell death and disintegration, especially when an organism has 
been in competitive mode for survival (Boto, 2015; Lorenz & Wackemagel, 1994; Ochman et al., 
2000). There are certain conditions that need to be fulfilled for transformation to take place. 
Firstly, a competent cell capable of undergoing transformation must be available. Secondly, a
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genetically active material must be provided and third, environmental conditions must be suitable 
for the union of two components of the system (Austrian, 1952). For transformation to occur, the 
bacterium requires high levels of available energy and should also be in a specific state of 
transformation-competence. Limitation of nutrients and high population density are some of the 
factors that lead to the state of competence required for this method of horizontal gene transfer 
(Thomas & Nielsen, 2005). In Bacillus subtilis, scarcity of amino acids at the end of exponential 
growth phase brings about the competence for transformation (Leisner et al., 2008).
The intake of genetic material will only occur when compatible material, usually from the 
same species and suitable conditions are available (Nielsen, 1998). Although there are a few 
exceptions, this method cannot be a great driving force in widespread antibiotic resistance. In 
several species of Streptococcus, transformation takes place in high-density conditions (Li et al, 
2001) that result in the formation of bacterial biofilms that act as a reservoir of compatible 
genetic material.
Bacterial transformation systems can be divided into two categories, natural (or 
physiological) and artificial (Low & Porter, 1978). In naturally transformable species, the cells 
become competent (able to take up DNA from the environment) at a particular stage in the 
growth cycle. However, some species do not become naturally competent under normal culture 
conditions and must be rendered permeable to transforming DNA by artificial means. This may 
involve treating the whole cells with high concentrations of divalent cations such as Tris or 
Polyethylene glycol (PEG). Alternatively, all or part of the cell envelope exterior to the 
cytoplasmic membrane may be removed to form bacterial protoplasts or spheroplasts, which can 
then be induced to take up DNA by treatment with divalent cations or PEG.
In general, bacteria that can be transformed by chromosomal DNA can also be 
transformed by plasmid DNA. Transformation can be divided into three stages: First, is the
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binding of the DNA to the cell surface receptors; second, involves the transport of DNA across 
the cell envelope; and third, is the establishment of the transforming DNA either as a replicon 
itself or by the combination with a resident replicon (Trautner & Spatz 1973; Weston et al., 
1981).
Two fundamentals elements have to be provided in order to perform bacterial 
transformation. The first element is an appropriate host bacterium. For this, E. coli™ DH5a™ 
can be used as host organism. Plasmid is the other vital component in the transformation 
technique. Plasmids usually encode for enzymes and antibiotic resistant markers that are 
expressed in the bacterium after transformation (Bimboim & Doly, 1979; Cohen et al., 1973). 
The cells which have taken up the plasmid can be differentiated from cells, which have not taken 
up the plasmid by growing it on medium with ampicillin. Only the cells with the plasmid 
containing the ampicillin resistance (ampK) gene will survive. Furthermore, the transformed cells 
containing the plasmid with the gene of interest can be distinguished from cell with the plasmid, 
as well as those without an insert by the colour of the colony on media supplemented with IPTG 
and X-gal. Recombinants are white, whereas non- recombinants are blue in colour. The following 
is the diagrammatic representation of the pUC19 used in the present study Figure 4.1.
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Figure 4.1: Map of the pUC19 plasmid. The pUC19 contains the ampicillin resistance gene 
(AmpR) (colour purple), the LacZ which has the multiple cloning sites (MCS) and the LacI 
genes. Absence of an insert at the MCS will result to the uninterrupted expression of the 
LacZ gene (blue colonies) while successful insertion at the MCS will disrupt LacZ gene 
expression resulting to white colonies. Adapted from Kaushik (2008).
4.1.2 Principal mechanism
DNA transformation is a naturally occurring phenomenon, by which DNA is transferred into a 
bacterial cell. However, under normal circumstances, this process rarely occurs in bacteria. The 
bacterial cell membrane is made up of lipid molecules that have negatively charged phosphate 
groups. During logarithmic growth, the cell membrane of E. coli contains hundreds of pores 
called “adhesion zo n es '’. Even though adhesion zones are physically large enough to admit small 
loops of DNA, the negatively charged phosphate groups on the DNA helix are repelled by those 
on the lipids. Researchers use a combination of factors to make a bacterial cell capable of taking 
up new DNA. In 1970 Mandel and Higa discovered a way to make E. coli more “com petent” in 
transforming foreign DNA by calcium chloride method and heat shock (Mandel & Higa, 1970).
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When calcium chloride is added to the medium, it will interact with the negative charges 
of DNA helix of plasmid and the lipid membrane of bacterial cell to create an electrostatically 
neutral situation. Additionally, reduction in temperature aids in stabilising the negatively charged 
phosphates of lipid membrane such that calcium ions can easily shield them. A heat shock which 
creates a temperature imbalance of the bacterial membrane can then aid the extracellular DNA to 
pass through the adhesion zones.
4.1.3 Investigation of potential efflux pump mediated drug resistance
The term efflux pump is used to describe a family of transport proteins located on the 
cytoplasmic membrane of eukaryotic and prokaryotic cells (Wong et al., 2014). They are also 
referred to as active transporters, because the transport function performed by these proteins is 
dependent on available chemical energy. Research has revealed that efflux pumps may be used 
specifically for the transport of a particular molecule or can transport various molecules with 
dissimilar structures (Fernandez & Hancock, 2012). These efflux pumps are of two types, the 
primary active transporters, and secondary active transporters. Some of the active transporters use 
hydrolysis of adenosine triphosphate (ATP) as an energy source and are known as primary active 
transporters. Other types of pumps are known as secondary active transporters (also known as 
anti-porters/symporters/uniporters), where a difference in electrochemical potential across the 
cell membrane is created through pumping of ions, such as sodium or hydrogen (Fernandez & 
Hancock, 2012).
There are five main super families of bacterial efflux transporters on the basis of the 
sequence of amino acids and the source of energy utilized for the export of substrates (Figure 
4.2). They are:
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• The Major Facilitator Superfamily (MFS) (Marger & Saier, 1993; Saidijam et a l, 2006)
• The ATP-Binding Cassette superfamily (ABC) (Konings & Poelarends, 2002; Mendez & 
Salas, 2001)
• The Small Multidrug Resistance family (SMR) (Chung & Saier, 2001)
• The Resistance-Nodulation-cell Division superfamily (RND)(Daniels & Ramos, 2009; 
McKeegan et a l , 2003)
• The Multi Antimicrobial Extrusion protein family (MATE) (Kuroda & Tsuchiya, 2009). 
Only the ABC superfamily are primary transporters (utilising ATP), whereas the other
four families are secondary transporters utilising proton differentials or sodium ion gradients as 
their energy sources (Sun et a l, 2014). In Gram-positive bacteria, most of the efflux transporters 
are MFS transporters, while the Gram-negative bacteria are mostly the RND family. Previously, 
it was thought that the RND family transporters were confined to Gram-negative bacteria, 
however they have now been shown to be located in every major kingdom of life (Morita et al, 
2006; Pao et a l, 1998; Lee et a l, 2001).
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Figure 4.2: Schematic diagram showing of the five fundamental super-families of bacterial 
efflux systems: NorM, multi-antimicrobial extrusion protein family (MATE); QacA, m ajor 
facilitator superfamily (MFS); QacC, small multidrug resistance family (SMR); MexAB, 
resistance-nodulation cell division superfamily (RND); LmrA, ATP-binding cassette 
superfamily (ABC). Adapted from Kourtesi et at. (2013).
4.1.4 Efflux pump mediated mechanism of antimicrobial resistance
Nikaido and Pages (2012) indicated in their study that in the case of multidrug resistant 
Pseudomonas aeruginosa , the efflux pump plays a significant role in conferring drug resistance. 
There are four types of well-characterized efflux pumps systems in Pseudomonas aeruginosa. 
They are (i) MexE-MexF-OprN, (ii) MexX-MexY-OprM, (iii) MexC-MexD-OprJ and (iv) 
MexA-MexB-OprM (Sadeghifard et al., 2012). The substrate specificities of these four pumps 
are different and the production of these pumps along with their activities can be heightened due 
to various factors that are usually present in case of infections (for example high bacterial 
inocula, stationary phase of growth, low pH etc.). Furthermore, constitutively Mex-Opr efflux 
pump system producing mutants are usually selected by fluoroquinolone antibiotics. Recent 
studies suggest that the higher prevalence of the efflux pumps is in the range of 14 to 75% in 
clinical strains of Pseudomonas aeruginosa (Aendekerk et al., 2002; Aeschlimann, 2003; Evans
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et al., 2001; Hocquet et al., 2003; Kohler et al., 1997; Li & Nikaido, 2009; Sugawara & Nikaido, 
2014).
Some multidrug efflux pumps have the ability to expel a vast array of molecules from the 
periplasm or cytoplasm of bacterial cells, e.g. organic solvents, secondary metabolites and almost 
all clinically used antibiotics. Therefore, the significance of efflux mechanisms for providing 
antibiotic resistance to bacteria cannot be underestimated. Efflux, at a basic level is responsible 
for conferring intrinsic antibiotic resistance against specific antimicrobial agents. The observed 
resistance against antimicrobial drugs or agents is indicated by an observed increase in minimum 
inhibitory concentration (MIC). The constitutive increase of the efflux-pump protein expression 
is the major factor for increased MIC (Da Silva et al., 2011). There are some clear instances 
which indicate that the efflux induced increase in MIC are enough to provide antibiotic resistance 
to the bacteria against the drug’s breakpoint concentration (the concentration of antibiotic above 
which any bacterium in considered to be resistant) recommended to treat the infection. 
Fluoroquinolones most often exhibit this type of phenomenon (Piddock 2006; Fernando et al., 
2013).
The efflux pumps that confer antibiotic resistance to Gram-positive bacteria mainly 
belong to the MFS family, whereas those in Gram-negative bacteria mainly belong to the RND 
family (Mahamoud et al., 2007). E. coli AcrAB-TolC drug substrate profile (RND family) 
includes various substances ranging from antibiotics, such as P-lactam antibiotics that are 
lipophilic, chloramphenicol, rifampin, tetracycline, nalidixic acid, fluoroquinolones, novobiocin 
and fusidic acid to other substrates like SDS, ethidium bromide, acriflavine, Triton X-100, short- 
chain fatty acids, bile salts and triclosan 27- 30.
Gastroenteritis is typically caused by Salmonella typhimurium and S. enteritidis 
{Salmonella enteric serovar enteritidis). 1 to 4% of all infections in humans are invasive
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salmonellosis. Fluoroquinolones (e.g.: ciprofloxacin) or cephalosporin ceftriaxone are the most 
commonly administered antibiotics for treatment of this disease. In S. typhimurium, the AcrAB- 
TolC system functionally resembles the AcrAB-TolC system present in E. coli and its substrates 
are antibiotics such as quinolones, tetracycline, and chloramphenicol, as well as other compounds 
like acriflavine, ethidium bromide, Triton X-100, SDS and triclosan 38- 40 (Piddock, 2006). 
Many researchers have demonstrated that in the case of laboratory generated S. typhimurium 
mutants, along with human and veterinary S. typhimurium isolates, over expression o f AcrB is 
related to MDR. The MICs of tetracycline, nalidixic acid and chloramphenicol for such strains 
were well above the recommended range (Kumar et al., 2013; Du et ah, 2014; Ge et al., 2009; 
Bavro et al., 2008; Tikhonova & Zgurskaya 2004).
Clinically relevant Gram-positive bacteria like Streptococcus pneumoniae and 
Staphylococcus aureus express MDR efflux pumps (Piddock, 2006). Generally, soft-tissue and 
skin infections are caused by S. aureus and S. pneumoniae is responsible for meningitis, 
bronchitis and pneumonia. These types of infections are often fatal in both elderly and children 
(Appelbaum, 2002; Pintado et a l , 2012; Wardenburg et al., 2007). The MFS efflux pump of S. 
pneumoniae usually exports antibiotics like ciprofloxacin, norfloxacin and fluoroquinolones 
along with the dyes such as ethidium bromide and acriflavine (Poole, 2000). The occurrence of 
pmrA over-expression in S. pneumoniae clinical isolates from various geographically discrete 
areas, have been determined by several research groups (Piddock, 2006). They located that the 
over-expression of pmrA is not only associated exclusively with S. pneumoniae isolates that are 
norfloxacin resistant, but also seen in the norfloxacin susceptible isolates. Recent studies have 
further noted the association of ABC-superfamily transporter over expression with resistance 
against ciprofloxacin, although their occurrence in clinical isolates is not yet confirmed (Garvey 
et al., 2011). Additionally, the MFS efflux pumps Mef and the ABC superfamily transporter Mel
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of S. pneumoniae confer macrolide resistance. In the pneumococcal genome, the location of the 
mel and m ef genes is on the conjugative transposons related element suggesting that although 
initially they are not linked to the location of the chromosome, but later on these genes are 
attained and subsequently passed to the daughter cells (Piddock, 2006).
4.1.5 Tetracycline and Ampicillin resistance in different bacterial species
Tetracycline and ampicillin are two important antibiotics, which are widely used for clinical 
purposes. However, most of the Gram-positive and Gram-negative bacteria have the ability to 
develop resistance against these antibiotics. There are different mechanisms that are involved in 
the microbial resistance; however, the most clinically important mechanism is efflux pump 
mediated (Gottesman, 2002). The efflux pumps that confer ampicillin or tetracycline resistance to 
Gram-positive bacteria belong to MFS family of efflux pumps, whereas those efflux causing 
resistance in Gram-negative bacteria belong to RND family.
4.1.6 Efflux pump systems in Enterobacter spp.
Enterobacter spp. are Gram-negative, rod shaped, motile organisms located in diverse 
environmental conditions. They can be acquired from both exogenous and endogenous sources. 
The genome of this organism is closely associated with that of Klebsiella spp. and it is technically 
challenging to distinguish one from another. The Enterobacter species were rarely considered to 
be pathogens prior to the initiation of widespread usage of antibiotics. These species have been 
found to be responsible for nosocomial infections since the 1970s. A large focus has been given 
to their intrinsic antibiotic resistance and their role in neonatal infection. Enterobacter 
agglomerans contain the following genes for efflux transporters: acrB, efrA, sugE, mepA , norE, 
efrB that produce several efflux pump systems.
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4.1.6.1 The multi-drug efflux pump, EmmdR
There are twelve predicted multidrug efflux pump transmembrane, EmmdR in Enterobacter 
cloacae. A physiological investigation of efflux activities of antimicrobial agent has illustrated 
the EmmdR to be an H+ / drug antiporter. However, it is not an efflux pump driven by Na+, 
suggesting that it may be responsible for conferring multidrug resistance. Quinolones are actively 
pumped out of E. cloacae cells by EmmdR and pose as a key mechanism to provide multidrug 
resistance in these bacteria. This pump is most significant among all other pumps because it has 
the ability to induce resistance many drugs especially against antibiotics (Gao et ah, 2012) . In 
virulence cases of E. cloacae, the AcrAB-TolC efflux pumps are involved. The association of 
RobA, RamA and SoxS (regulatory proteins) in the acrAB up-regulation and providing 
antimicrobial resistance was established in E. cloacae by cloning and sequencing of the genes 
encoding these proteins.
4.1.6.2 SugE multidrug efflux pump
This efflux pump of E. cloacae is similar in nature and belongs to the SMR transporter family. 
They provide resistance against different antiseptics that are structurally distinct (Doumith et al.,
2009). At the same time they actively help in Ethidium bromide extradition. Thus, SugE has been 
shown to be an efflux pump for multiple drugs and falls under secondary active transporter that is 
proton driven (H+ /drug antiporter). In six Enterobacter isolates (including two belonging to the 
genus Pantoea and two to the genus Salmonella) the efrB and efrA genes were decoded. The 
ABC multidrug efflux pump EfrAB was first described in Enterococcus faecalis and is involved 
in resistance to antimicrobial agents that are structurally unrelated, for instance
105
tetraphenylphosphonium chloride, doxycycline, norfloxacin, doxorubicin, acriflavine, 40,6- 
diamidino-2-phenylindole, ciprofloxacin and daunorubicin (Lee et al., 2001). The Enterobacter 
species have the capability to develop resistance against these antibiotics. Paterson (2006) had 
revealed that the most important mechanism responsible for drug resistance in most of the 
Enterobacter spp. is the efflux mechanism. The efflux systems that are involved in the 
tetracycline and ampicillin resistance in this species are SugE multidrug efflux pump, the AcrAB- 
TolC efflux pump system, the multi-drug efflux pump, EmmdR etc. Among these entire efflux 
pump, the most significant is the multi-drug efflux pump, EmmdR and SugE. Multi-drug efflux 
pump possess ten transmembrane sections that are responsible for the resistance o f many 
antibiotics including the classes under consideration. The suppression activity of the multi-drug 
efflux pump is based on the production of quinolones (Piddock, 2006). The development of the 
resistance in this species is conferred by the increased production of quinolones and membrane 
protein, both of which has the property to suppress the activity of antibiotics by developing 
resistance. The SugE multidrug efflux pump is proton driven efflux pump which generates the 
resistance against these two classes of antibiotics with the aid of ethidium bromide extradition 
(Lee et al., 2001).
Aeromonas spp. are Gram-negative bacilli that thrives in diverse aquatic environments 
(Khor et al., 2015). They are opportunistic pathogens that cause infections in humans if they 
come into contact via derived products or contaminated water (Illanchezian et al., 2010). Clinical 
manifestations of Aeromonas infection include infections in soft tissues and skin, as well as 
various clinical syndromes in patients that are (Gold & Salit, 1993). Multidrug resistance (MDR) 
phenotypes were noted among Aeromonas spp., a number of which were reversed through the use 
of phenylalanine-arginine-P-naphthylamide (PApN), an inhibitor of efflux pumps (Giraud et al., 
2004; Lomovskaya & Watkins, 2001). Regarding MDR efflux pumps, no functional data has
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been identified in Aeromonas species. However, the system of the RND family are said to key 
role in conferring antibiotic resistance to different Gram-negative bacilli present in diverse 
environmental conditions and act as opportunistic pathogens (Hernould et al., 2008; Giraud et al., 
2004; Goni-Urriza et al, 2002).
Until now ten systems belonging to RND family have been identified that include seven 
of the hydrophobic/amphiphilic efflux-1 family (Saier & Paulsen, 2001; Seshadri et al., 2006). 
Among them, the efflux pump that is most closely linked with the major AcrB system of 
Escherichia coli is the efflux B of Aeromonas hydrophila or AheB (Hemould et al., 2008). They 
are phylogenetically related to the AcrA efflux pump, the E. coli AcrB efflux pump (69%) or 
RND efflux pump and TtgC, which is the outer-membrane protein of Pseudomonas entomophila 
(58%). The aheR gene displays sequence identity with TetR family transcriptional repressors 
(Hemould et al., 2008).
There is less functional data available on the efflux mechanism of Aeromonas hydrophila 
due to the lack of research (Hemould et al., 2008). The major efflux mechanisms identified in 
this species are MDR phenotypes, amphiphilic efflux-1 family, and Aeromonas hydrophila efflux 
B. There are ten systems belonging to RND family have been identified that include seven of the 
hydrophobic/amphiphilic efflux-1 family causing the resistance against ampicillin and 
tetracycline (Seshadri et al., 2006; Srikumar et al., 1998). The minimum inhibitory concentration 
of both of these classes of antibiotics is affected by the amphiphilic efflux-1 family and 
Aeromonas hydrophila efflux B mechanisms. AheABC efflux pump is an important efflux pump 
which acts on different substrates and has the ability to induce resistance against nine different 
classes of antibiotics (Hemould et al., 2008). This is the mechanism, which is used by 
Aeromonas spp. for developing resistance against the clinically used antibiotics. There are 
different levels of expression for this mechanism and therefore, the intensity of this mechanism
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also differs (Hiroshi Nikaido & Pages, 2012). Amphiphilic efflux-1 family is also associated with 
the resistance mechanism of different antibiotics (including tetracycline and ampicillin). 
However, the over expression of both of these pumps may lead to toxicity and serious clinically 
adverse effects in humans and other species (Drusano & Craig, 1997).
4.1.7 Efflux mechanisms in Pseudomonas stutzeri
In a study by Martinez et al., (2010) it was found that isolates of P. stutzeri that exhibits 
fluoroquinolone resistance was linked to a minimum of parC and gyrA topoisomerase gene 
mutations. Studies related to plasmid mediated resistance to quinolone in P. stutzeri did not show 
positive results for genes such as qnrS, qnrA, qnrB, qnrWC, qepA and xlb-cr (Poirel et al., 2010).
Antimicrobial susceptibility testing with or without the involvement of an efflux pump 
inhibitor, such as phenylalanylarginyl-P-naphthylamide (PApN) (20mg/L), was performed in 
order to investigate the role of efflux pumps in resistance in the selected isolates. The MICs of 
ofloxacin, nalidixic acid, ciprofloxacin, norfloxacin, pefloxacin, moxifloxacin, enrofloxacin and 
levofloxacin are significantly decreased by PApN addition (Poirel et al., 2010). Similar findings 
were noted with rifampicin, tetracycline, chloramphenicol a number of P-lactams and 
trimethoprim. This suggests the involvement of efflux pump overexpression. In this case, no 
effect was noted for the aminoglycosides, such as gentamicin and tobramycin. This may be 
attributed to the TbtABM efflux pump of P. stutzeri that has already been identified previously as 
the factor responsible for conferring resistance to nalidixic acid, sulfamethoxazole, 
chloramphenicol and n-hexane (Poirel et al., 2010).
TBT resistance in P. stutzeri is associated with an operon, known as tbtABM (Jude et al., 
2004). This has been demonstrated by E. coli cloning and overall increase of TBT MIC level by 
20 folds. TbtABM is similar to proton-dependent efflux pumps of the membrane fusion (TbtA
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analogue), RND (that is similar to TbtB), and outer membrane (TbtM type) proteins. These 
proteins function collectively to eliminate substrates across membranes of the Gram-negative 
bacteria. TBT is removed from P. stutzeri 5MP1 by TbtABM. In fact, other efflux pumps of 
RND from Pseudomonas sp., (MexAB-OprM system in P. aeruginosa) were cloned in E. coli. 
There they have shown to accommodate a similar substrates range as they do in the original host 
(Jude et al, 2004).
The efflux pump that results in antibiotic resistance in Aeromonas hydrophila is the 
TbtABM efflux pump. The tributyltin, tetracyclines, and ampicillin resistance in these bacteria is 
caused by a multidrug resistant efflux pump, TbtABM efflux (Li & Nikaido, 2009). This efflux 
pump belongs to RND transporter family and uses TBT as the substrate. It was reported that 
different replicated form of this bacterial species are resistant to ampicillin and tetracyclines and 
reason behind this resistance was associated with the presence of TbtABM operon. There is a 
remarkable resemblance between this efflux pump and the efflux pump found in the other species 
described above. This efflux system is also tolerant to organic solvents and has high degree of 
homology with other multidrug resistant efflux mechanisms. Another important point of 
consideration for this efflux pump is that, this pump is specific to Aeromonas spp. only and 
differential expression is reported for the different members of this species.
The initial research carried out to understand the mechanism of drug resistance has made 
it clear that many bacterial species uses efflux mechanisms for drug resistance. Efflux pumps 
were studied for different species and classes and results in the resistance of most of antibiotics, 
for instance, for tetracycline and ampicillin, it is the dominant method for resistance. There are 
different efflux mechanisms in Burkholderia cepacia, e.g. in case of Burkholderia pseudomallei, 
there are genomes that encode several efflux systems, but important one is RND pumps, AmrAB- 
OprA, BpeEF and BpeAB-OprB (Mima & Schweizer, 2010).
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AmrAB-OprA: This efflux pump is associated with the development of multidrug resistance in 
the different species and the most important targets of this efflux pump are the aminoglycosides, 
the tetracyclines, and ampicillin. Furthermore, this pump also has the capability to develop 
macrolide resistance (Kumar et al., 2008).
4.1.8 Extended spectrum p-lactamases (ESBLs)
Members of the family Enterobacteriaceae commonly express plasmid-encoded P-lactamases 
(e.g.: TEM-1, TEM-2 and SHV-1). They confer resistance to penicillins, but not to extended- 
spectrum cephalosporins (Bradford, 2001). ESBLs are a group of enzymes that break down 
antibiotics belonging to the penicillin and cephalosporin groups and render them ineffective. 
ESBLs have generally been defined as transmissible P-lactamases that can be inhibited by 
clavulanic acid, tazobactam or sulbactam, and which are encoded by genes that can be exchanged 
between bacteria (Paterson & Bonomo, 2005; Walsh, 2003). In typical circumstances, they derive 
from genes for TEM-1, TEM-2 or SHV-1 by mutations that alter the amino acid configuration 
around the active site of these P-lactamases (Shaikh et al., 2015). Therefore, antibiotic options in 
the treatment of ESBL-producing organisms are extremely limited.
4.1.8.1 Types of ESBLs 
4.1.8.L I  Sulfhydryl variant (SHV)
The SHV family of p-lactamases appears to be derived from Klebsiella spp and is responsible for 
up to 20% of the plasmid-mediated ampicillin resistance in this species (Haanpera et al., 2008).
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4.1.8.1.2 Plasmid encoded Transposable element p-lactamases (TEM-1)
TEM-1 is capable of hydrolysing penicillins and first generation cephalosporins, but is unable to 
attack the oxyimino cephalosporin. It is responsible for the ampicillin and penicillin resistance 
observed in H. influenzae and N. gonorrhoeae (Shaikh et al., 2015).
4.1.8.1.3 Oxacillinases (OXA)
The OXA-type p-lactamases are so named because of their oxacillin-hydrolysing abilities. These 
P-lactamases are characterized by hydrolysis rates for cloxacillin and oxacillin greater than 50% 
as that for benzyl penicillin. They predominantly occur in P. aeruginosa, but have been detected 
in many other Gram-negative bacteria (Naas & Nordmann, 1999).
4.1.8.1.4 Cephalosporinases
Cephalosporinases are among the most abundant p-lactamases on the basis of the number of 
organisms that produce these enzymes. These cephalosporinases, frequently called species- 
specific AmpC enzymes, are often found in most Enterobacteriaceae as chromosomal 
enzymes. AmpC P-lactamases, in contrast to ESBLs, hydrolyse broad and extended-spectrum 
cephalosporins (cephamycins as well as to oxyimino-P-lactams), but are not inhibited by P- 
lactamase inhibitors such as clavulanic acid (Bush, 2010a).
4.1.8.1.5 Studies into the role o f  potential p-lactamase involvement in observed antibiotic 
resistance
The integrity of the bacterial cell wall is essential to maintaining cell shape in a hypertonic and 
hostile environment (Massova & Mobashery, 1998). P-Lactam antibiotics exhibit their 
bactericidal effects by inhibiting enzymes involved in cell wall synthesis (Drawz & Bonomo,
111
2010). The p-lactam nucleus, 6-aminopenicillanic acid (6-APA) proved to be the key in penicillin 
synthesis and modification (Kong et al., 2010). Among the P-lactam antibiotics of clinical utility 
for the treatment of infections caused by susceptible Gram-negative bacteria are penicillins such 
as amoxicillin, oral cephalosporins (such as cefpodoxime and cefuroxime and axetil), parenteral 
cephalosporins (such as cefepime and ceftriaxone) and the carbapenems (such as doripenem, 
ertapenem, imipenem and meropenem).
Unfortunately, the efficacy of these life-saving antibiotics is significantly threatened by 
bacterial ‘P-lactamases’ (Drawz & Bonomo, 2010). It is the most effective way for bacteria to 
counteract P-lactam antibiotics is by producing p-lactamases. These are enzymes that inactivate 
the drugs by hydrolysing the p-lactam ring (Kong et al, 2010). Through hydrolysis, the 
lactamase enzyme breaks the P-lactam ring open, deactivating the molecule's antibacterial 
properties. Penicillinase was the first p-lactamase to be identified h (Queener, 1986). It was first 
isolated by Abraham and Chain in 1940 from Gram-negative E. coli even before penicillin 
entered in the clinical use. These enzymes have the ability to hydrolyse the P-lactam chemical 
bond that distinguishes p-lactam antibiotics from other antibacterial agents, thereby rendering the 
molecules incapable of killing bacteria. Today, over 890 unique P-lactamases have been 
identified in naturally occurring bacterial isolates (Bush & Jacoby, 2010 & 2015) p-lactamases 
are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, 
and carbapenems (Bush, 2010).
4.2 Experimental Approach
It is important to distinguish the several ways in which a microorganism may demonstrate 
resistance. This chapter therefore will investigate and elaborate the bacteria resistance 
mechanism. Resistant pathogens use several strategies to avoid the effects of antimicrobial
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agents, biochemical, or genetic aspects and have evolved highly efficient means for clonal spread 
and for the dissemination of resistance traits. The major objective of this chapter is to 
experimentally analyse the underlying mechanism of antibiotic resistance in a group of 
preselected bacterial pathogens.
4.2.1 Bacterial culture
The five bacterial isolates were selected for the study based on their resistance towards specific 
antibiotics. Pseudomonas stutzeri, Burkholderia cepacia, Aeromonas hydrophila, Enterobacter 
agglomerans and Enterobacter spp. were the bacterial isolates used.
4.2.2 Screening for plasmid mediated antibiotic resistance
4.2.2.1 Plasmid extraction
Plasmid DNA extraction was carried out as previously described (Kado & Liu 1981; 
Sathyanarayana & Verma 1993) with some modifications. The methodology followed for 
plasmid extraction from bacteria is given in C hapter 2 section 2.10.7.
4.2.2.2 Bacterial transformation
E.coli DH5a was used as host organism for transformation and competent cell preparation was 
done using calcium chloride. Bacterial transformation was performed with lpL of pUC19 vector 
(without insert) as positive control and plasmids isolated from test organisms using DH5a™ 
competent E. coli cells. Bacterial transformation was done by the temperature heat shock method. 
The competent cell preparation and transformation experiment was conducted as per (Sambrook 
et al., 1989). The procedure followed is described in C hapter 2 sections 2.10.8 and 2.10.9. The 
transformed cells were then plated onto ampicillin containing LB agar plates. LB-agar plates
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were made with varying concentrations of ampicillin (to give final concentrations of 16, 32, 64 
and 128 pg/mL), lOOpl of the mixture from the transformation tubes was carefully transferred on 
to duplicate LB-agar plate and spread evenly with the help of a sterile glass spreader. The plates 
were then incubated overnight at 37°C to allow the transformed bacteria to form colonies.
4.2.3 Screening for efflux pump mediated antibiotic resistance
The efflux inhibitor, carbonyl cyanide m-chlorophenyl-hydrazone (CCCP) was used is order to 
determine the role of efflux pumps in conferring antibiotic resistance in the five selected bacterial 
isolates. The five isolates were individually grown overnight in LB broth containing ampicillin 
and tetracycline with or without the CCCP and the resultant MIC was determined. The procedure 
followed for screening the presence of efflux pump is as described in C hapter 2 section 2.10.10.
4.2.4 Determination of penicillinase activity
Penicillinase activity and beta-lactamase production was the determined using the one minute 
tube test and the tube dilution test employing a wide range of ampicillin concentrations (0.5- 
128pg/mL), with and without the P-lactamase inhibitor, clavulanic acid (16pg/mL). The 
clavulanic acid concentration used was the lowest MIC breakpoint for the isolates. Two methods 
employed include phenol red indication method and tube dilution test. Refer C hapter 2 section 
2.11 for the detailed procedure followed for screening penicillinase production in test organisms.
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4.3 Results
4.3.1 Plasmid mediated drug resistance
The results of the transformation experiment are as given in Table: 4.1. DH5a E. coli 
transformed with Burkholderia cepacia and Aeromonas hydrophila plasmids were able to grow 
in ampicillin containing LB agar plates indicating the role of plasmids in transfer of drug 
resistance. DH5a E. coli transformed with Enterobacter agglomerans, Enterobacter spp. and 
Pseudomonas stutzeri plasmids however failed to grow in ampicillin containing LB agar plates.
Table 4.1: Results of the transformation of plasmids from Pseudomonas stutzeri, 
Burkholderia cepacia, Aeromonas hydrophila, Enterobacter agglomerans and 
Enterobacter spp. via heat shock technique using DH5a E. coli as the competent cell. 
Growth and determination of MIC for transformed E. coli in the presence of varying 
concentrations of Ampicillin in LB-agar plates.




MIC 16 32 64 128
Enterobacter agglomerans 64 - - - - No growth
Burkholderia cepacia 128 + + + + Growth
Aeromonas hydrophila 128 + + + - Growth
Enterobacter spp. 128 - - - - No growth
Pseudomonas stutzeri 16 “ - - “ No growth
Negative control 
(Sterilized water)
- - - - - No growth
Positive control 
(PUC19)
- + + + + Growth
The results of the experiment exhibited the role of plasmids in mediating drug resistance in 
Burkholderia cepacia and Aeromonas hydrophila. However, the mechanism of drug resistance in
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Enterobacter agglomerans, Enterobacter spp. and Pseudomonas stutzeri still remains to be 
identified.
Recent studies have suggested that efflux pumps play a prominent role in the multidrug 
resistance in many clinically important Gram-negative bacteria. Thus, the following study was 
undertaken in an attempt to determine the role of efflux pumps in multi-drug resistance in the 
selected group of Gram-negative organisms. The presence o f more than one type o f drug 
resistance mechanism is also possible; so all the bacterial group of the previous study was 
included.
4.3.2 Efflux pump mediated drug resistance
The result of the experiment is as given in Table 4.2. In Enterobacter agglomerans and 
Enterobacter spp. there was a 4 and 3 fold reduction in MIC of antibiotics respectively, strongly 
suggesting the role of efflux pumps in conferring drug resistance. In the case of Burkholderia 
cepacia, Aeromonas hydrophila and P. stutzeri there was no reduction in MIC suggesting the 
absence of an efflux pump mediated resistance mechanism.
116
Table 4.2: Comparative analysis of MIC of ampicillin and tetracycline with and without 
the efflux pump inhibitor, CCCP for Pseudomonas stutzeri, Burkholderia cepacia, 
Aeromonas hydrophila, Enterobacter agglomerans and Enterobacter spp. Where, Tet. = 
Tetracycline














Enterobacter agglomerans 64 32 4 4 4
Burkholderia cepacia 128 128 128 128 0
Aeromonas hydrophila 128 0.5 128 0.5 0
Enterobacter spp. 128 0.5 8 1 3
Pseudomonas stutzeri 16 0.5 16 0.5 0
The previous two studies focussing on role of plasmids and efflux pumps in mediating antibiotic 
resistance revealed that plasmid mediate drug resistance in Burkholderia cepacia and Aeromonas 
hydrophila and efflux pump mediate drug resistance in Enterobacter agglomerans and 
Enterobacter spp. Pseudomonas stutzeri was found to harbour neither of the above said 
mechanisms. Production of (3-lactamase enzymes that degrade p-lactam antibiotics is reported to 
be one of the most widespread mechanisms of antibiotic resistance. Thus, the following study 
focussed on determining the presence o f (3-lactamase activity in the selected group of antibiotic 
resistant isolates. The presence of more than one type of drug resistance mechanism is also 
possible, so all the bacterial isolates from the previous studies were included in this study.
117
4.3.3 P-lactamase mediated drug resistance
The results of the MIC tube dilution method for screening the presence of p-lactamases are given 
in Table 4.3. No positive correlation between the presence of clavulanic acid and the MIC was 
observed in this study. In the case of B. cepacia, Aeromonas hydrophila and Enterobacter spp. 
the MIC remained the same (i.e. 128 pg/mL) suggesting the absence of P-lactamase enzymes. In 
the case of Enterobacter agglomerans and P. stutzeri there was an increase in MIC suggestive of 
a negative result.
Table 4.3: Comparative analysis of MIC of Ampicillin in presence and absence 
of Clavulanic acid (16 pg/mL) for Pseudomonas stutzeri, Burkholderia cepacia, 
Aeromonas hydrophila, Enterobacter agglomerans and Enterobacter spp.
Bacterial isolates MIC of Ampicillin 
(pg/mL)




Enterobacter agglomerans 64 128
Burkholderia cepacia 128 128
Aeromonas hydrophila 128 128
Enterobacter spp. 128 128
Pseudomonas stutzeri 16 32
4.4 Discussion
The role of plasmids in antibiotic resistance in environmental bacterial isolates has been proven 
through this study. This study also describes the development and use of a novel method for the 
isolation of plasmids. The original protocol developed for plasmid extraction from conventional 
bacterial models, like DH5a may not necessarily yield good results with other bacterial species.
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Hence, major changes in incubation period and centrifugation speed/time were incorporated. In 
conventional methods after the treatment with cell lysis buffer the incubation period is only 5 
minutes. In the present study it was prolonged to one hour, which provides better results in terms 
of isolating plasmids from bacteria under study. Furthermore, the centrifugation speed and time 
were also increased, which in turn resulted in better yield bacterial plasmids.
The pUC19 vector containing the ampicillin resistance genes from Burkholderia cepacia 
and Aeromonas hydrophila made the DH5a cells resistant towards ampicillin as evidenced by its 
growth in ampicillin containing agar plates. This strongly indicates the role of plasmid in 
transferring drug resistance. The failure for DH5a containing other bacterial plasmids to grow in 
presence of antibiotic can be attributed to several factors. First, the transformation may not have 
occurred, as not all types of bacterial cells are capable of engaging in the transformation 
processes. Secondly, it is possible that the bacterial isolates tested carry antibiotic resistance via 
other mechanisms and not via a plasmid. Finally, sometimes bacteria lose their ability to maintain 
the plasmid in the newly transformed cells (Al-Allaf et al., 2013). In the case of the transformed 
DH5a containing B. cepacia plasmid growth was observed in 128pg/pL ampicillin. In case of 
DH5a containing plasmid from Aeromonas hydrophila, the growth was inhibited at 128pg/mL 
concentration of ampicillin, which implies that addition of plasmid does not improve the 
resistance of this organism to the antibiotic ampicillin.
The failure of E. agglomerans, Enterobacter spp. and Pseudomonas stutzeri to transform 
suggests a role of other molecular mechanisms conferring resistance, e.g. efflux pump mediated 
drug resistance. Therefore, the next experiment was planned and executed to study more about 
the role of efflux pumps in conferring drug resistance. Drug efflux is a key multi-drug resistance 
mechanism reported among Gram-negative bacteria. Efflux pumps allow the microorganisms to 
regulate their internal environment by removing toxic substances, including antimicrobial agents.
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These systems actively pump antibiotics out of the bacterial cell, hence maintaining a sub-MIC 
internal level of antibiotic and conferring protection against the antibiotic therapy. The role of 
efflux pumps in drug resistance is thus proven in this study.
The presence of CCCP in the medium resulted in a reduction of minimum inhibitory 
concentration from 64pg/mL to only 4pg/mL in the case of E. agglotnerans bacteria. This 
indicates a correlation between the inhibition of the efflux pumps and resistance to antibiotics. It 
is thus proven that efflux pumps have a significant role in conferring resistance to E. 
agglomerans against ampicillin. Enterobacter spp. exhibited a 3-fold decrease in MIC on the 
addition of an efflux pump inhibitor. Therefore, we can conclude that there is a significant role of 
efflux pumps in the resistance of both the Enterobacter species.
In the case of B. cepacia no change in resistance was found when the inhibitor was added. 
This might be due to the presence of a different antibiotic resistant mechanism in these bacteria. 
The resistance of A. hydrophila and P. stutzeri was also found to be unaffected by the addition of 
CCCP. Both of these microorganisms were found to be highly susceptible to tetracycline, as 
compared to ampicillin, with an MIC of only 0.5|ig/mL. It is clear that the efflux pump has no 
role in the resistance mechanism of these organisms.
With the above two studies, the role of plasmid mediated and efflux mediated drug 
resistance have been proven. However, B. cepacia was found to have none of the above stated 
drug resistant systems. Another important method by which bacterial pathogen achieves multi­
drug resistance is via production of p-lactamase enzyme. P-lactams are the most commonly used 
antibiotics and therefore, p-lactamases are the most important source of resistance to them. 
Therefore, the next set of experiments was focused on understanding more about the p-lactamase 
enzyme and its subsequent identification in the bacterial groups under study.
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The potential role of P-lactamases in conferring the observed antibacterial resistance was 
screened using clavulanic acid, a broad-spectrum inhibitor of enterobacterial p-lactamases. P- 
lactam antibiotics have been studied in combination with clavulanic acid. Three bacterial stains, 
B. cepacia, A. hydrophila and Enterobacter spp. exhibit minimum inhibitory concentrations 
(MIC) of 128pg/mL when ampicillin was used alone. However, no change was observed in MIC, 
when clavulanic acid was used in combination. This indicates that these organisms do not 
produce P-lactamases enzyme and therefore, p-lactamases inhibitors have effect in conferring 
anti-bacterial resistance.
The lower MIC value observed for Enterobacter agglomerans and P. stutzeri than 
indicates their susceptibility against ampicillin. An increase in the MIC by 2 fold, i.e. 128 and 32, 
in the presence of clavulanic acid is interpreted as a negative result. The presence o f a sub- 
inhibitory level of clavulanic acid (8pg/mL) may sometimes lower the minimum inhibitory 
concentration of ampicillin for many resistant Enterobacteriaceae (Finlay et al., 2003). The large 
differences among various bacterial species and different strains of the same species in their 
response to clavulanic acid cannot be predicted. The effect of the P-lactamase inhibitor also 
depends on the type and amount of P-lactamase produced (if formed), the location of the 
lactamase (intra- or extracellular), the penetration of the P-lactam antibiotic into the cell, the 
stability of the -lactam antibiotic to p-lactamases, and the activity of the P-lactam antibiotic used.
4.5 Chapter Summary & Conclusions
Thus, it can be concluded that plasmid and efflux pump mediated drug resistance mechanisms 
have an important role in conferring resistance to various Gram-negative microorganisms under 
study. The resistance in Burkholderia cepacia and Aeromonas hydrophila was found to be 
plasmid mediated and in the case of Enterobacter agglomerans and Enterobacter spp. it was
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efflux pump mediated. The antibiotic resistance mechanism of Pseudomonas stutzeri still remains 
to be elucidated.
The next logical step was to identify and characterize the major protein families, which 
play an important role in making bacterial pathogens resistant towards antibiotics. The main 
methodology adopted includes extraction and purification o f bacterial proteins, molecular 
characterisation of purified proteins by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) and genomic characterisation of bacterial DNA by polymerase 
chain reaction (PCR).
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Chapter 5. Proteomic and Genomic Characterization of Five 
Isolated and Selected Bacterial Species
This chapter describes the experimental processes designed for proteomic and genomic 
characterization of the selected allochthonous bacterial strains isolated from the Dighty Burn. 
The Chapter includes an introduction (Section 5.1), the experimental approach (Section 5.2), 
results (Section 5.3), discussion (Section 5.4) and a chapter conclusions and summary (Section 
5.5).
5.1 Introduction
Hosts and their symbiont bacteria have coevolved for many years to achieve their present status 
of mutually beneficial co-existence. During this long period the bacteria have updated their 
virulence mechanisms in order to counter the host defence systems and therefore, they have 
become generally more pathogenic (Beceiro et al., 2013). The efficiency of various bacterial 
pathogens to infect and cause disease in their corresponding host often depends upon a number of 
virulence factors acting individually or together at different stages of infection. Virulence factors 
of pathogenic bacteria aid in successful interactions with the host tissues by effectively masking 
the bacterial surface from the host’s defence mechanisms (Wu et al., 2008). Thus, identifying the 
virulence factors is of paramount importance in understanding the bacterial pathogenesis and 
their interactions with the host. This knowledge will help in devising new methods to counter act 
bacterial infections (Wu et al, 2008).
The cell envelope of bacteria is a complex multi-layered structure that serves as a 
protective barrier to ensure the organism’s survival in diverse unfavourable environments 
(Silhavy et al., 2010; Martorana et al., 2014). Bacterial cell envelopes fall into two major
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categories: Gram-negative bacteria are surrounded by a thin peptidoglycan cell wall, which itself 
is surrounded by an outer membrane (OM) containing lipopolysaccharide (LPS) (Silhavy et al., 
2010). On the other hand, Gram-positive bacteria lack an outer membrane (OM), but are 
surrounded by layers of peptidoglycan many times thicker than those found in Gram-negative 
bacteria (Silhavy et al., 2010). Bacterial membranes and other structures that protect and 
encapsulate the cytoplasm do not resemble a simple membrane. Unlike the cells of eukaryotic 
organisms, the bacterium is constantly subjected to unpredictable, dilute and often unfavourable 
environments (Silhavy et al., 2010). In order to survive, bacteria have evolved a sophisticated and 
complex cell envelope that not only acts as a protective barrier, but also allows selective transport 
of nutrients from the outside of the cell and waste products from the inside of the cell (Silhavy et 
al., 2010). There are three principal layers of the bacterial cell envelope: the outer membrane 
(OM, in Gram-negative cells only), the peptidoglycan cell wall and the cytoplasmic or inner 
membrane. The two membrane layers confine the aqueous cellular components of the Gram­
negative bacterial cell (Silhavy et al, 2010) (Figure 5.1).
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Figure 5.1: Schematic diagram showing Gram-positive (left) and Gram-negative (right) 
bacterial cell wall structures. Gram-positive bacteria are surrounded by a thick 
peptidoglycan layer and Gram-negative bacteria are surrounded by a thin peptidoglycan 
cell wall and outer membrane (OM, containing lipopolysaccharide (LPS). 
(http://medimoon.com/2013/04/why-is-it-more-difricult-to-treat-gram-negative-bacteria/) 
(Accessed on 20/11/2015) (Hayat, 2013).
5.1.1 The Outer membrane (OM)
The outermost layer that surrounds most Gram-negative bacteria is the outer membrane (OM), 
which separates the bacterial periplasm from the extracellular milieu. This organelle is the 
distinguishing feature of Gram-negative bacteria, because Gram-positive bacteria do not possess 
this organelle (Silhavy et a l, 2010). The OM in Gram-negative bacteria is a unique lipid bilayer. 
It is asymmetric in nature; where phospholipids are restricted only to the inner leaflet of the OM, 
while the outer leaflet is composed of glycolipids mostly, lipopolysaccharide (LPS) (Nakamura et 
al., 1987; Raetz & Whitfield 2002; Wu et al., 2014). Embedded in the OM are outer membrane 
proteins (OMPs), such as lipoproteins and (3-barrel proteins that perform activities crucial to OM 
function. Based on its structural composition, the OM provides an effective barrier that is crucial
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for the survival of organisms in many distinct environments and also renders Gram-negative 
bacteria more resistant to antibiotics than their Gram-positive counterparts (Wu et al., 2014).
5.1.2 Outer membrane proteins
Proteins embedded within the OM are divided into two classes: lipoproteins and p-barrel proteins 
(Sankaran & Wu, 1994). Bacterial lipoproteins are a set of membrane proteins with many distinct 
functions. They have been shown to perform various roles including nutrient uptake, signal 
transduction, adhesion, conjugation and sporulation (Alloing et al., 1994; Lampen & Nielsen, 
1984; Mathiopoulos et al., 1991; Perego et al., 1991; Sutcliffe & Russell, 1995) and participate in 
antibiotic resistance transport (such as ABC transporter system) and extra-cytoplasmic folding of 
proteins (Kovacs-Simon et al., 2011; Alloing et al., 1994; Hussain & Lampen 1983; 
Mathiopoulos et al., 1991; Sutcliffe & Russell 1995). In the case of pathogens, lipoproteins have 
been shown to play a direct role in virulence-associated functions, such as colonization, evasion 
of host defences and immunomodulation (Hutchings & Willett 2009; Khandavilli et al., 2008). In 
Gram-negative bacteria, two of the three lipoproteins biosynthetic enzymes appear to be essential 
for viability (Gan et al., 1993; Paitan et al., 1999; Tjalsma et al., 1999).
There are about 100 OM lipoproteins identified in E. coll (Miyadai et al., 2004). Nearly 
all of the proteins in the OM assume a P-barrel conformation (Silhavy et al., 2010). These 
proteins are P-sheets that are wrapped into cylinders (Silhavy et al., 2010). Some of these OMPs 
such as the porins, OmpF, and OmpC function to allow passive diffusion of small molecules 
(mono- or disaccharides and amino acids) across the OM (Cowan et al., 1992).
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5.1.3 Proteomic approaches for analysis of virulence
In the pre-genomic era, systematic identification of virulence factors was routinely done 
employing biochemical approaches. The development of novel molecular approaches, such as 
genomics, transcriptomics and proteomics, has accelerated the speed with which we can identify 
virulence factors (Wu et al, 2008). Among the various novel approaches, gel based techniques, 
such as proteomic techniques are of great use to investigate the protein-based virulence factors of 
pathogenic bacteria. In addition, it also aids in identification and characterization of proteins 
belonging to separate compartments of bacterial systems. The knowledge gained from the 
proteomic analysis helps us in deciphering the precise role and function each and every protein 
components (Wu et a l, 2008; Lee et a l , 2008).
5.1.3.1 Sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS- PAGE)
Sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) is a type of 
electrophoretic technique used mainly to characterize and/or separate proteins and nuclide acids 
according to their molecular size (Laemmli, 1970; Sambrook & Russell, 2001). Electrophoresis, 
as the name implies, is the process of movement of charged molecules in a predefined medium 
under the influence of an electric field (Magdeldin, 2012). The mobility of particles in an electric 
field mainly depends upon the following factors; charge, shape and size of the molecules 
(Westermeier, 2005). SDS, as an anionic detergent, masks the charge of the proteins and gives a 
net negative charge per unit mass, such that the proteins move along the gel solely based on their 
molecular weight (Garfin 2009; Maizel 2000). Figure 5.2 shows the basic methodology and 
principle of protein separation in SDS-PAGE.
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Figure 5.2: SDS-PAGE. Protein samples are loaded into the separate wells of the gel. Under 
electric charge the negatively charged SDS-protein complexes migrate in the direction of 
the anode, at the bottom of the gel. The sieving action of the porous polyacrylamide gel 
separates proteins according to their size.
(www.chem.fsu.edu/chemlab/bch40531/character/mwdetermination/background.html) 
(Accessed on 20/11/2015) (Department of Chemistry and Biochemistry 2015).
5.1.4 SDS-PAGE for outer membrane protein analysis
Protein samples are loaded into the separate wells of the gel. Under the influence of an electric 
field the negatively charged SDS-protein complexes migrate in the direction of the anode, at the 
bottom of the gel. Subsequently, the sieving action of the porous polyacrylamide gel separates 
proteins according to their size.
OMPs play a key role in the pathogenicity, physiology and virulence of Gram-negative 
bacteria (Nikaido, 1994). The expression of these proteins change constantly in response to the 
variations in the environmental growth conditions they are exposed to (Puente et al., 1991; 
Contreras et al., 1995). Substantial changes in synthesis of their outer membrane proteins have 
been observed when bacteria are transferred to a new environment (Provenzano et al., 2001;
128
Wibbenmeyer et al, 2002). Effective changes in outer membrane protein thus equate to increased 
survival rate and pathogenicity. SDS-PAGE can thus be used to track and identify these changes.
5.1.5 Genomic characterization of virulence
During the last two decades the incidence of virulent multidrug-resistant (MDR) Gram-negative 
bacteria has increased considerably to become a significant health problem (Moxon & Tang 
2000). Antibiotic resistance generally evolves through a series of complex interactions and 
resistance arises by mutation under clinical antibiotic selective pressure or via possession of 
mobile genetic elements from the environment over time (Landecker, 2015). The reservoir o f 
such genes in the environment is a result of mixing of naturally occurring resistance in bacterial 
pathogens and selective effects of environmental pollutants, which can aid the bacteria in 
acquisition of multiple resistant genes (Wellington et a l, 2013). The identification of genes that 
provide certain traits to the bacterial pathogens has been facilitated by the development of 
molecular tools to search for genes that may be indispensable for virulence (Moxon & Tang, 
2000). The search for the molecular genetic basis of virulence has led to the development of 
technology to look for multiple genes that may ultimately shed light on the regulation of 
virulence at molecular level (Salama & Falkow 1999; DiRita et a l, 2000; Fenwick 1990; 
Unsworth & Holden 2000). Reverse transcriptase PCR is one such methodology.
5.1.6 Reverse transcriptase PCR
Reverse transcriptase PCR (RT-PCR) has revolutionized the way clinical microbiologist detect 
the presence and level of expression of bacterial virulence genes (Coutard et a l , 2005). High 
sensitivity and high specificity are the advantage of RT-PCR technology over the conventional 
culture-based methods and PCR. PCR is amplification of a specific DNA sequence in vitro (Da
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Costa, 1998). This process comprises of many cycles of template denaturation, primer annealing, 
and primer elongation to amplify DNA sequences (Santos & Ochman, 2004). Reverse 
transcriptase PCR has a similar principle as that of PCR. Reverse transcription is a process by 
which single stranded RNA (ssRNA) is transcribed into complimentary DNA (cDNA). The 
template used for this is total cellular RNA and the enzyme used for amplification is reverse 
transcriptase enzyme. This is the major difference between conventional PCR and reverse 
transcriptase PCR. In conventional PCR the template used is DNA and the polymerase enzyme 
used is DNA polymerase. Thus, RT-PCR combines cDNA synthesis from RNA templates with 
PCR to provide a rapid, sensitive method for analysing gene expression (Santos & Ochman, 
2004). The ability to convert mRNA to DNA in vitro has made RT-PCR possible. The reverse 
transcriptase enzyme was discovered and isolated independently by Tenim and Baltimore in 1970 
(Baltimore, 1970; Temin & Mizutani, 1970). Figure 5.3 diagrammatically represents the 
synthesis of complementary DNA (cDNA) from mRNA by reverse transcriptase enzyme. 
Synthesis and quantification of cDNA from the mRNA of the bacterial cells can thus be used to 
identify and analyse the differences in level of expression of various genes in bacteria that are 
exposed to different conditions.
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Figure 5.3: Schematic diagram showing the synthesis of double stranded cDNA from 
mRNA by reverse transcriptase enzyme (https://www.mun.ca/biolonv/scarr/MGA2-08- 
04.htm l, Accessed on 20/11/2015) (Steven, 2012).
5.2 Experimental approach
The main objective of this chapter is to characterize and compare various bacterial outer 
membrane proteins of test microorganisms. Standard laboratory strains where used as controls to 
see what difference the changes in environmental condition will bring upon on the outer 
membrane proteins of pathogenic bacteria belonging to the same species.
SDS-PAGE was employed to achieve this objective. The results from protein profiling 
will provide us this with information, such as total number of different proteins present and 
molecular weight of the proteins. The similarity/differences observed may help to identify 
whether there is variation among proteins with changes in thriving conditions. The next step 
was to characterize/compare and analyse the level of expression of specific virulence genes in 
selected Gram-negative pathogens isolated from the environment with the laboratory bacterial
strains that are pre characterized. RT-PCR as the main analytical tool used to achieve this 
objective.
5.2.1 Bacterial cultures
Five pairs of bacterial species consisting of previously described environmental isolates and their 
corresponding laboratory strain were selected for this study. Burkholderia cepacia, Enterobacter 
agglomerans, Aeromonas hydrophila, Enterobacter spp. and Pseudomonas stutzeri were the 
bacterial species included. The culture collection codes for laboratory strain of test organisms are 
as follows: Burkholderia cepacia (NCIMB13694), Enterobacter agglomerans (NCIMB 9680), 
Aeromonas hydrophila (NCIMB9239), Enterobacter spp. (NCIMB 14479) and Pseudomonas 
stutzeri (NCIMB 10783).
5.2.1 O uter membrane protein extraction
The outer membrane proteins of the test organisms were isolated using sarcosine as a solubilizing 
agent. The precise protocol followed for isolation of outer membrane protein is as described in 
C hapter 2 section 2.12.
5.2.2 Protein estimation
Protein concentration was calculated according to the method of Bradford (Bradford, 1976) using 
bovine serum albumin (BSA) as the standard and the concentration was expressed in mg/mL. 
Standard graph was plotted and the slope was calculated Figure 5.4. Refer C hapter 2 section
2.12.1 for the procedure followed for estimation of protein concentration.
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5.2.3 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (PAGE) of purified phage 
proteins was performed for evaluating the nature of the isolated protein using vertical slab 
electrophoresis (BioRad, USA) by the method of Laemmli (1970).The methodology followed 
preparation of stacking gel/ resolving gel, sample loading and gel running parameters as 
described in detail in section 2.12.2 of Chapter 2.
5.2.4 Gel staining
Coomassie blue and silver staining of the gel after electrophoresis was performed by the 
methodology as described in sections 2.12.3 and 2.12.4 respectively of C hapter 2.
5.2.5 Molecular Weight Determination
The molecular weights of separated proteins are determined by measuring the relative migration 
distance (Rf) of the protein standards and the test protein. The details of calculation performed in 
order to determine the molecular weight is described in section 2.12.5 of C hapter 2.
5.2.6 Preparing bacterial cultures for RNA extractions
Tris-EDTA (TE) buffer (30mM Tris-HCl, ImM EDTA, pH 8) containing 15mg/mL of lysozyme 
and lOpl of RNA-protect-reagent was pipetted into 15mL tubes. RNA protect reagent provides 
immediate stabilization of RNA from bacterial cells. Five mL of each bacterial culture were 
added to it and the mixture was vortexed (Fisons scientific equipment sgp-202-01OJ) for 5 
seconds. Then it was incubated at room temperature for 5 minutes. After incubation the cultures 
were centrifuged at 8000rpm for 10 minutes (Eppendorf 5417 R). The supernatant was decanted 
completely and the pellet was kept for further processing.
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5.2.7 RNA extraction and purification
The bacterial pellet obtained after the lysozyme and RNA-protect-reagent treatment was used 
directly for extraction of RNA. RNA was extracted using trizol reagent. Trizol reagent is a 
monophasic solution of phenol and guanidine isothiocyanate. During sample homogenization or 
lysis. TRIZOL reagent maintains the integrity of the RNA, while disrupting cells and solubilizing 
cell components. Isolation of RNA was followed by purification of the extracted RNA. 
Purification of total RNA from bacterial lysate was done using the RNeasy Mini Kit and DNase 
digestion was performed using QIAGEN DNase digestion by RNase-free DNA set following the 
manufacturer's instruction. The procedure followed for RNA extraction and purification is as 
given in C hapter 2 section 2.13.
5.2.8 cDNA synthesis
The cDNA was synthesized by reverse transcribing total RNA using RT2 First Strand Kit, 
Qiagen following the manufacturer’s instructions. Refer to section 2.15 of C hapter 2 for the 
protocol followed for cDNA synthesis.
5.2.9 Design of primers
Four pairs of primers were designed using the conserved stretches of the respective virulence 
genes using Primer3 software (http://simgene.com/Primer3. Accessed 11/04/14) (Primer3, n.d.). 
The methodology used design the primers are described in detail in section 2.15.2 of Chapter 2. 
The primer sequence and the expected amplicon sizes are as given in Table 5.1.
134
Table 5.1: List of primers designed for amplifying specific virulence genes from 
Pseudomonas stutzeri, Enterobacter agglomerans, Burkholderia cepacia, 
Enterobacter spp. and Aeromonas hydrophila and their estimated amplicon size.












































The primers as listed in Table 5.1 were used to amplify the cDNA obtained from all the bacterial 
strains. The primers were diluted from the standard to required working concentration 
accordingly. Amplifications of cDNA were carried out in a thermal cycler (BioRad Cl 000). Five 
pL of the PCR product samples were analysed by electrophoresis on 1.5% agarose. The PCR 
was performed in triplicate for each of the strains and each of the amplified genes used and 
presence of amplicons were visualized by agarose gel electrophoresis. The procedure followed 




5.3.1 Protein extraction and estimation
Proteins were extracted successfully following both the total protein method and outer membrane 
protein method. After protein extraction, the concentration of each sample was determined 
following Bradford method (Bradford, 1976). Figure 5.4 shows the standard graph obtained 
using BSA as standard.
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Figure 5.4: Standard graph for protein estimation, plotting BSA concentration (pg/mL) and 
its corresponding absorbance at 600nm. A marked scatter plot was drawn using Excel to 
obtain y and R2 values.
From the absorbance value of the test proteins, the concentration of proteins was calculated. The 
results of protein concentration calculation, estimation and volume required to equalize their 
concentrations for carrying out SDS-PAGE is calculated as given below in Tables 5.2 and 5.3.
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Table 5.2: Calculation of protein concentration of the isolated outer membrane protein 
using the equation: y = 0.0371x + 0.2639, X = (y-0.2639) / 0.0371, y = Sub-mean of OD. 
W here; OD1 = Optical Density replicate 1; OD2 = Optical Density replicate 2, Mean = 
mean of OD 1 and OD2.
Sample 1 2 3 4 5 6 12 14
OD1 0.40 0.25 0.28 0.29 0.33 0.26 0.34 0.301
OD2 0.40 0.27 0.31 0.27 0.28 0.27 0.30 0.295
Mean 0.40 0.26 0.29 0.28 0.30 0.27 0.32 0.298
Sub-mean 0.39 0.25 0.28 0.27 0.2 0.25 0.3 0.28
E rro r 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Concentration
(Hg/^L)
7.17 4.645 5.24 4.96 5.39 4.73 5.76 5.21
Table 5.3: Results of protein concentration estimation and determination of required 
volume for preparing samples with uniform concentration for SDS-PAGE analysis. W here; 

















9.3 27.0 25 48.0 52.0 100.0
Burkholderia cepacia 
(laboratory strain)
7.9 31.5 25 43.5 56.5 100.0
Enterobacter agglomerans 
(environmental isolate)
6.6 37.8 25 37.2 62.8 100.0
Enterobacter agglomerans 
(laboratory strain)
5.8 43.1 25 31.9 68.1 100.0
Aeromonas hydrophila 
(environmental isolate)
5.8 43.3 25 31.7 68.3 100.0
Aeromonas hydrophila 
(laboratory strain)
5.2 48.4 25 26.6 73.4 100.0
Enterobacter spp. 
(environmental isolate)
4.8 51.9 25 23.1 76.9 100.0
Enterobacter spp. 
(laboratory strain)
4.0 62.5 25 12.5 87.5 100.0
Pseudomonas stutzeri 
(environmental isolate)
3.7 66.8 25 8.2 91.8 100.0
Pseudomonas stutzeri 
(laboratory strain)
3.4 72.9 25 2.1 97.9 100.0
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5.3.2 SDS-PAGE
The result of SDS-PAGE of proteins extracted from environmental isolates as well as standard 
laboratory strains of P. cepacia , E. agglomerans, A. hydrophila , Enterobacter spp. and P. stutzeri 
is as shown in Figure 5.5.
Figure 5.5: SDS-PAGE of outer membrane protein: Lane M = protein molecular weight 
m arker; lane 1 = Burkholderia cepacia (environmental isolate); lane 2 = Burkholderia 
cepacia (laboratory strain); lane 3 = Enterobacter agglomerans (environmental isolate); lane 
4 = Enterobacter agglomerans (laboratory strain); Lane 5 = Aeromonas hydrophila 
(environmental isolate); lane 6 = Aeromonas hydrophila (laboratory strain); lane 7 = 
Enterobacter spp. (environmental isolate); lane 8 = Enterobacter spp. (laboratory strain); 
lane 9 = Pseudomonas stutzeri (environmental isolate); lane 10 = Pseudomonas stutzeri 
(laboratory strain).
Lane 1 is protein molecular weight marker used to compare and estimate the molecular weight of 
the test proteins. Lanes 2 and 3 correspond to proteins extracted from environmental isolate and
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standard strain of P. cepacia. Lane 4 and 5 correspond to proteins extracted from environmental 
isolate and standard strain of E. agglomerans. Lane 6 and 7 correspond to proteins extracted from 
environmental isolate and standard strain of A. hydrophila. Lane 8 and 9 correspond to proteins 
extracted from environmental isolate and standard strain of Enterobacter spp. and lane 10 and 11 
correspond to proteins extracted from environmental isolate and standard strain of P. stutzeri.
5.3.3 Molecular weight estimation
The molecular weight of the separated proteins was calculated using R f  value measured using 
protein marker as standard. Figure 5.6 shows the Rf values of markers plotted against Log 10 
molecular weight values. A linear trendline was applied and the graph equation was calculated as 
y = -2.3855x + 2.2647.
Figure 5.6: Standard curve. Rf values of markers were plotted against LoglO molecular 
weight values. A linear trend line was applied and the graph equation was calculated as y =
-2.3855x + 2.2647.
The R f  is as given in Table 5.4. Molecular weight of outer membrane proteins were then 
calculated using equation MW = 10y, where x = Rf of unknown protein. By substituting Rf value
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(x) of each bands to the equation, MW=10-2 3855x + 2 2647, the molecular weight can be calculated. 
The result of molecular estimation is as shown in Table 5.5.
In the case of the environmental isolate of B. cepacia 13 bands were present with 
molecular weights varying from 109.40 to 4.32 and for laboratory strain, 12 bands were present 
with molecular weight ranging from 118.11 to 3.71. In case of E. agglomerans environmental 
isolate 8 bands appeared with molecular weights ranging from 93.80 to 3.71, where as in case of 
its laboratory counterpart the total number of bands was found out to be 11 with molecular 
weights ranging from 101.30 to 4.67. The next group under study, A. hydrophila showed the 
presence of 13 and 14 bands for environmental and laboratory strain respectively. The outer 
membranes of Enterobacter spp. were found to comprise of 14 bands for both environmental 
isolates and laboratory strains. The protein profiling of the last group under study, P. stutzeri 
revealed presence of 13 bands in both environmental isolates and laboratory strains.
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Table 5.4: R f measurements of standard molecular weight m arker and protein extracted from environmental isolates and 
standard strains for Burkholderia cepacia, Enterobacter agglomerans, Aeromonas hydrophila, Enterobacter spp. and 
Pseudomonas stutzeri. W here; E l =  Environmental isolate; LS =  Laboratory strain; - =  no band.
Band
No:
M arker B. cepacia bands
m ________________
E. agglom 
b an d s (Rf




ter spp. P. stutzeri bands
m
E l LS E l LS E I LS E I LS E I LS
1 0.03 0.09 0.07 0.11 0.10 0.09 0.09 0.11 0.11 0.11 0.13
2 0.18 0.13 0.16 0.16 0.14 0.14 0.13 0.14 0.16 0.16 0.17
3 0.23 0.16 0.19 0.19 0.19 0.17 0.17 0.17 0.19 0.20 0.23
4 0.27 0.17 0.20 0.24 0.02 0.19 0.21 0.20 0.21 0.23 0.26
5 0.34 0.20 0.24 0.31 0.31 0.26 0.26 0.23 0.24 0.26 0.29
6 0.63 0.30 0.29 0.49 0.37 0.31 0.33 0.33 0.29 0.29 0.39
7 0.76 0.36 0.31 0.61 0.41 0.36 0.39 0.44 0.34 0.34 0.44
8 - 0.41 0.47 0.71 0.47 0.46 0.44 0.47 0.40 0.40 0.47
9 - 0.46 0.53 - 0.50 0.49 0.50 0.51 0.43 0.44 0.53
10 - 0.51 0.60 - 0.59 0.53 0.53 0.54 0.46 0.49 0.56
11 - 0.54 0.66 - 0.67 0.60 0.54 0.59 0.49 0.53 0.59
12 - 0.61 0.71 - - 0.66 0.59 0.61 0.53 0.59 0.63
13 - 0.69 - - - 0.73 0.61 0.64 0.56 0.63 0.69
14 - - - - - - 0.66 0.69 0.5 - -
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Table 5.5: Molecular weight determination of protein extracted from environmental and standard isolates for Burkholderia 
cepacia, Enterobacter agglomerans, Aeromonas hydrophila, Enterobacter spp. and Pseudomonas stutzeri using equation MW = 
10y, where x = R f of unknown protein. By substituting R f value (x) of each bands to the equation, MW=10-2’3 55x + 2,2647, the 
molecular weight was calculated. Where; E l = Environmental isolate; LS = Laboratory strain; MW = Molecular weight; kD = 
kilo Daltons; - = no band.
Band
No:












El LS El LS El LS El LS El LS
1 188 109.40 118.11 93.80 101.30 109.40 109.40 93.80 93.80 93.80 86.86
2 62 86.86 74.47 74.47 80.43 80.43 86.86 80.43 74.47 74.47 68.96
3 49 74.47 63.86 63.86 63.86 68.96 68.96 68.96 63.86 59.13 50.70
4 38 68.96 59.13 46.95 155.48 63.86 54.75 59.13 54.75 50.70 43.47
5 28 59.13 46.95 31.96 31.96 43.47 43.47 50.70 46.95 43.47 37.27
6 6 34.51 37.27 12.70 23.50 31.96 29.59 29.59 37.27 37.27 21.76
7 3 25.38 31.96 6.36 18.66 25.38 21.76 16.00 27.40 27.40 16.00
8 - 18.66 13.72 3.71 13.72 14.81 16.00 13.72 20.15 20.15 13.72
9 - 14.81 10.08 - 11.76 12.70 11.76 10.89 17.27 16.00 10.08
10 - 10.89 6.86 - 7.41 10.08 10.08 9.34 14.81 12.70 8.65
11 - 9.33 5.05 - 4.67 6.86 9.34 7.41 12.70 10.08 7.41
12 - 6.35 3.71 - - 5.05 7.41 6.36 10.08 7.41 5.89
13 - 4.32 - - - 3.44 6.36 5.45 8.65 5.89 4.33
14 - - - - - - 5.05 4.33 7.41 - -
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5.3.4 RNA isolation
The result for agarose gel electrophoresis of the RNA isolated from environmental isolates and 
standard laboratory strains of P. stutzeri, E. agglomerans, B. cepacia, Enterobacter spp. and A. 
hydrophila  is as shown in Figure 5.7.
Figure 5.7: Agarose gel electrophoresis of the isolated RNA products. Lane M = 1 kb 
molecular weight m arker ladder; lane 1 = Pseudomonas stutzeri (environmental isolate); 
lane 2 = Pseudomonas stutzeri (laboratory strain); lane 3 = Enterobacter agglomerans 
(environmental isolate); lane 4 = Enterobacter agglomerans (laboratory strain); iane 5 = 
Burkholderia cepacia (environmental isolate); lane 6 = Burkholderia cepacia (laboratory 
strain); lane 7 - Enterobacter spp. (environmental isolate); lane 8 = Enterobacter spp. 
(laboratory strain); lane 9 = Aeromonas hydrophila (environmental isolate); lane 10 = 
Aeromonas hydrophila (laboratory strain).
5.3.5 PCR Amplification of virulence genes
The primers designed from conserved stretches of virulence genes for the bacteria were 
successful in amplification of specific genes. The agarose gel electrophoresis of the PCR product 
of environmental isolates as well as standard laboratory strains of B. cepacia, E. agglomerans, A. 
hydrophila, Enterobacter spp. and P. stutzeri is as shown in Figure 5.8.
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Figure 5.8: Agarose gel electrophoresis of the PCR product of virulence. Lane M = 1 kb 
molecular weight ladder; lane 1 = Pseudomonas stutzeri (environmental isolate); lane 2 = 
Pseudomonas stutzeri (laboratory strain); lane 3 = Enterobacter agglomerans
(environmental isolate); lane 4 = Enterobacter agglomerans (laboratory strain); lane 5 = 
Burkholderia cepacia (environmental isolate); lane 6 = Burkholderia cepacia (laboratory 
strain); lane 7 = Enterobacter spp. (environmental isolate); lane 8 = Enterobacter spp. 
(laboratory strain); lane 9 = Aeromonas hydrophila (environmental isolate); lane 10 = 
Aeromonas hydrophila (laboratory strain); lane 11 = housekeeping gene (control); lane 12 = 
housekeeping gene (control).
Lane M is 1 kb molecular marker used to compare and estimate the molecular weight of the 
amplified PCR products. Lanes 1 and 2 correspond to OprC  gene amplified from environmental 
isolate and laboratory strain of P. cepacia. An amplicon was observed at the expected range of 
213 bp in lane 1, whereas in case of lane 2 no band was observed. The results indicate that the 
OprC  gene is highly expressed in environmental isolates of P. stutzeri, whereas in the laboratory 
strain it is not expressed at substantial levels.
Lanes 3 and 4 correspond to the tetracycline resistance gene amplified from 
environmental isolate and laboratory strain of E. agglomerans. The expected amplicon size was 
211 bp and bands of that size appeared in both lanes. Thus E. agglomerans isolate from
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environment isolate and laboratory strain expressed the tetracycline resistance gene. However, a 
markedly higher rate of expression was observed in case of the environmental isolate.
Lanes 5 and 6 correspond to cation multidrug gene amplified from environmental isolate 
and laboratory strain of B. cepacia. A virulence gene of size 265 bp was expected, however no 
bands appeared in the gel indicating the absence of the cation multidrug in both environmental 
isolate and laboratory strain of B. cepacia.
Lanes 7 and 8 is that of tetracycline resistance gene amplified from environmental isolate 
and laboratory strain of Enterobacter spp. The PCR amplicon of size 211 bp was expected 
however the absence of bands in both the lanes indicates the absence of tetracycline resistance 
gene in both environmental and laboratory strain.
Lanes 9 and 10 correspond to AheB gene extracted from environmental isolate and 
laboratory strain of P. stutzeri. Absence of amplicon products at the expected range (233bp) 
indicates the absence of AheB gene in environmental and laboratory strain of P. stutzeri.
The last two lanes 11 and 12 correspond to the RecA and RecG gene amplification 
products. Housekeeping genes RecA and RecG was used as an internal positive control for the 
PCR analysis.
5.3.6 Gene expression and quantification by Gel densitometry
The gel picture obtained after agarose gel electrophoresis was then analysed through Gel 
densitometry analysis using gel Doc™ imager (Life Technologies, Carlsbad, CA, USA). The 
results obtained are as given Table 5.6. Figure 5.9 depicts the diagrammatic representation of 
the results.
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Table 5.6: Densitometric analysis of PCR amplicons to analyze and quantify gene 
expression of virulence genes from environmental isolates and laboratory strains for 
Pseudomonas stutzeri, Enterobacter agglomerans, Burkholderia cepacia, Enterobacter spp. 
and Aeromonas hydrophila. The level of expression is given in percentages.
Bands obtained in agarose gel electrophoresis 
of the PCR product of virulence genes from 
environmental isolates and standard 
laboratory strains (Figure 5.8)
Gene expression 
based on intensity 
values for each 




Lane 1 - Pseudomonas stutzeri 
(environmental isolate)
11596.45 13.7%
Lane 2 - Pseudomonas stutzeri 
(laboratory strain)
1767.21 2.1%
Lane 3 - Enterobacter agglomerans 
(environmental isolate)
23738.49 28.1%
Lane 4 - Enterobacter agglomerans 
(laboratory strain)
10259.62 12.1%
Lane 5 - Burkholderia cepacia 
(environmental isolate)
1767.21 2.1%
Lane 6 - Burkholderia cepacia 
(laboratory strain)
1767.21 2.1%
Lane 7 - Enterobacter spp. 
(environmental isolate)
1767.21 2.1%
Lane 8- Enterobacter spp. 
(laboratory strain)
1767.21 2.1%
Lane 9 - Aeromonas hydrophila 
(environmental isolate)
1767.21 2.1%
Lane 10 - Aeromonas hydrophila 
(laboratory strain)
1767.21 2.1%
Lane 11 - housekeeping gene (control) 14397.28 17.0%
Lane 12 - housekeeping gene (control) 12103.47 14.3%
The OprC gene was found to be highly expressed in environmental isolate of P. stutzeri, with an 
expression rate of 11596.45, whereas in the case of its corresponding laboratory strain it was 
substantially low (1767.21). Markedly higher rate of gene expression was seen in the case of E. 
agglomerans environmental isolate, 23738.49. The level of gene expression was comparatively
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low in case E. agglomerans laboratory strain (10259.62). Expression of cation multi drug 
virulence gene in B. cepacia was not found to be significant in both environmental isolate and 
laboratory strain. A base line expression level of 1767.21 was recorded for both of them. The 
level of expression of tetC gene in environmental isolate and laboratory strain of Enterobacter 
spp. was also found to be not significant. A base line expression level of 1767.21 was recorded 
for both of them. Similar result was obtained for A. hydrophila (environmental isolate and 
laboratory strain) also. There was not significant expression and the expression level was 
1767.21 for both of them.
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B acteria l species
Figure 5.9: Graphic representation of gene expression of virulence genes from 
environmental isolates and laboratory strains for Pseudomonas stutzeri, Enterobacter 
agglomerans, Burkholderia cepacia, Enterobacter spp. and Aeromonas hydrophita.
The results of densitometric analysis of PCR amplicons to analyse and quantify gene expression 
of virulence genes from environmental isolates and laboratory strains for P. stutzeri E. 
agglomerans, B. cepacia , Enterobacter spp. and A. hydrophila  was found to be in general 
agreement with the visual observation of agarose gel with PCR amplicons.
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5.4 Discussion
The occurrence of Gram-negative bacterial mediated infections is on a rise and deserves special 
attention owing to multiple reasons. They have a very effective up-regulation or acquisition of 
genes that mediate antibiotic drug resistance, especially under antibiotic selective pressure 
(Donskey, 2006). Furthermore, bacteria have available to them a wide range of resistance 
mechanisms and often use multiple mechanisms to counter the same antibiotic and they can also 
use a single mechanism to affect multiple drugs (Peleg & Hooper, 2010b). According to the US 
National Healthcare Safety Network, Gram-negative bacteria account for about 30% of 
nosocomial (hospital-acquired) infections (Hidron et a l, 2008). The outer membrane of these 
organism have a major role in host pathogen interaction, e.g. during adherence, nutrient uptake 
from the host and overcoming defence mechanisms of the host during the establishment of an 
active infection (Seltmann & Holst, 2002). Therefore, the main objective of the present study 
was to compare and analyse the differences in outer membrane protein composition of various 
known Gram-negative pathogens of environmental origin and standard laboratory strains. The 
study microorganisms included in the work are B. cepacia, E. agglomerans, A. hydrophila, 
Enterobacter spp. and P. stutzeri.
SDS-PAGE is widely used for the analysis of bacterial outer membrane proteins (Dresler 
et a l , 2011). SDS-PAGE protein profiling aids in comparing closely related bacterial species and 
also help us to learn more about the protein biochemistry at the molecular level in an easy and 
rapid way. In addition to that, one-dimensional SDS-PAGE offers the combination of high- 
resolution and good reproducibility and therefore, is much better than lower resolving non­
denaturing systems (Sambrook et al., 1989).
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Bacterial proteins are separated based on their molecular weight. Proteins with lower 
molecular weight will travel faster when compared to proteins of higher molecular weight. As a 
result, protein with small molecular weight will be at lowest position on the gel and larger 
molecular weight proteins will be at higher positions (Tuasikal & Wibawan, 2013).
In case of B. cepacia (isolate) a total of 13 types of proteins were isolated with molecular 
weight ranging from 109.396 kD to 4.32 kD. However, in case of the laboratory strain 
counterpart only 12 bands were present. A previous study by Zhou et al., (2013) reported a 
similar finding in which B. cepacia exhibited altered protein profiling between wild-type and 
laboratory strains. The protein profiling of E. agglomerans also followed a similar trend with 
varying molecular weights. The total number of bands was also different with laboratory strain 
having more bands (11) as opposed to the environmental isolate with only 8 bands, ranging from 
molecular weight 93.799 kD to 3.71 kD. Similar results were obtained in a study conducted by 
Gayet et a l, (2003) on outer membrane protein of Enterobacter aerogenes. Where SDS-PAGE 
analysis of the outer membrane proteins showed a low level of expression of the major non­
specific porin proteins in each of the clinical strains (strains 117 and 119) compared to that in 
reference strain ATCC 1304 of Enterobacter aerogenes. In the case of Enterobacter spp. protein 
profiling of both the environmental isolate and laboratory strain has same number of protein 
bands, but had a stark difference in the OMP pattern. Some of the proteins were found in higher 
concentrations, while others where present in lower concentrations, as evidenced by the 
thickness o f the corresponding band. There were also subtle changes in the molecular weight of 
closely related proteins. The molecular weight of the environmental isolate of Enterobacter spp. 
varied from 93.799 kD to 4.327 kD, whereas in case o f the laboratory strain the molecular 
weight varied from 93.799 kD to 7.413 kD. This finding is of special importance as the role of
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Enterobacter s efflux pump mediated drug resistance has already been proved in this study 
(C hapter 4). It has been previously reported that in E. aerogenes drug resistance is acquired by 
the loss or alteration of a major porin protein or from altered porin expression in the constriction 
area, which decreases the diameter and modifies the electrostatic field or the expression of an 
efflux mechanism (Bornet et al., 2000; Charrel et al., 1996; Chevalier et al., 1999; De et al., 
2001).
The protein profiling of A. hydrophila also showed a higher level of heterogeneity in 
banding patterns, with a total of 13 bands appearing in the environmental isolate (molecular 
weight ranging from 109.396 kD to 3.436 kD). 14 bands were observed in case of standard 
laboratory strain, with proteins having molecular weight range same as that of environmental 
isolate. The difference in banding pattern and absence of bands observed in case of A. hydrophila 
is in general agreement with the previous findings of Santos et a l (1996), Dooley & Trust (1988) 
and Kuijper et a l (1989). The variations in protein profiling of A. hydrophila can be attributed 
the fact that they are complex and diverse in their environmental condition of high selective 
pressure (Kuijper et al, 1989).
The outer membrane protein analysis of P. stutzeri also revealed the variations in proteins 
between the environmental isolate and laboratory strain. A total of 13 prominent bands were 
observed in both the isolates, but prominent differences in concentration were noted for 
individual bands thicker bands, thinner bands and absence of bands. The results of comparison of 
these strains were similar to those reported in previous studies in P. aeruginosa (Goldberg & 
Ohman 1987; Goldberg et al, 2000).
Thus, the proteomic analysis exhibits the marked variations in protein expression in 
bacterial strains of the same species under different environmental conditions. The next part of
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this thesis was designed to confirm and quantify the differences in expression of various genes 
that are closely associated with bacterial virulence. RT-PCR was chosen as a methodology, 
which helps in accurately quantifying the mRNA representing each virulence related protein. In 
this study, real time PCR was used as a molecular tool to achieve to characterize/compare and 
analyse the level of expression of specific virulence genes in selected Gram-negative pathogens 
isolated from the environment with the laboratory bacterial strains. The major advantages o f RT- 
PCR include high sensitivity, specificity and quantification of genes amplified (Bustin 2002; 
Gachon et al., 2004). Gram-negative bacterial pathogens, which exhibited various drug 
resistances, were selected for the study. E. agglomerans, A. hydrophila, Enterobacter spp., B. 
cepacia, and P. stutzeri isolated from the river were included. Standard laboratory strains of B. 
cepacia, E. agglomerans, A. hydrophila, Enterobacter spp. and P. stutzeri were also included for 
comparative purposes. The virulence genes selected for each bacterial species are as follows:
OprC gene coding for the outer membrane protein was selected for screening and 
comparing its level of expression in Pseudomonas species. The result showed an increased level 
of expression of OprC in environmental strain of P. stutzeri when compared to that of the 
laboratory strain, thereby confirming its increased virulence. The marked increase in level of 
expression in environmental P. stutzeri might be due to the higher level of environmental stress 
faced by this organism. High levels of outer membrane protein expression equate to a better 
chance of survival and virulence.
TetC is the gene selected for screening virulence in E. agglomerans and Enterobacter 
spp. Resistance mechanisms encoded by tetracycline-resistant genes include energy dependent 
efflux, ribosomal protection and enzymatic inactivation (Roberts, 2005). Presently about 35 
classes of tetracycline-resistant genes have been identified (Roberts, 2005). Major facilitator
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superfamily (MFS) of efflux pumps for tetracycline operate by removing tetracycline in an 
energy-dependent fashion from bacterial cell (Chopra & Roberts, 2001). Tet pumps are classified 
into six groups based on amino acid sequence, with Tet {A), Tet (B), Tet{C), Tet (D) and Tet{E) 
placed in group 1 due to amino acid sequence similarity. TetB encodes a pump that is able to 
extrude both tetracycline and minocycline (Guay & Rothstein 1993; Petersen et a l, 1999). TetC 
was expressed substantially in both the environmental isolate and the laboratory strain of 
Enterobacter agglomerans. This observation confirms the importance of TetC in conferring 
resistance in Enterobacter agglomerans. The level of expression in environmental isolate was 
23738.489, whereas in the case of laboratory strain it was comparatively low at 10259.619. This 
result also indicates the role of external physico-chemical stress faced by Enterobacter 
agglomerans in harsh environmental conditions forcing it to undergo effective mutations to 
survive and increase its virulence. These results are in agreement with the result obtained in the 
previous chapters of this thesis confirming the presence of various drug resistances in the 
isolated bacterial species. Cation multi-drug genes have been used to screen the virulence of B. 
cepacia. It is known to code for the efflux pumps capable for effectively eliminating various 
classes of antimicrobial compounds from the bacterial cell, promoting multidrug resistance 
phenotype (Magnet et a l, 2001; Piddock 2006).
The aheB gene was used to screen the level of virulence gene expression in A. 
hydrophila. AheB is known to encode a resistance-nodulation-cell division (RND) protein. It is 
responsible for aminoglycoside, fluoroquinolones, tetracyclines, chloramphenicol, erythromycin, 
trimethoprim and ethidium bromide resistance (Alekshun & Levy, 2007). The qPCR with cation 
multi-drug, TetC and AheB virulence genes for screening the virulence in Enterobacter spp., A.
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hydrophila and B. cepacia only give base line level of expression suggesting the lack of 
significant expression of the genes in the respective bacterial groups.
5.5 Conclusions
In this study marked variation in expression of outer membrane proteins were observed in all of 
the isolates studied. The outer membrane plays an important role in making Gram-negative 
bacteria competitive when exposed to various harsh environmental conditions. It is the site where 
constant changes take place to make bacteria adapt to the ever changing novel environmental 
conditions. This notion has been proven in the present study where significant variation were 
seen when closely related bacterial group belonging to the same species exhibited different 
protein banding pattern. The studies employing RT-PCR also confirmed the findings of 
proteomic analysis. The level of gene expression can be analysed via quantifying the mRNA via 
RT-PCR. The concentration of mRNA is directly proportional to the rate of gene expression. 
Recent advances in molecular approaches have given environmental microbiologists an upper 
hand in analysing the activities of bacterial pathogens at a much appreciated finer level of gene 
expression (CEFIC, 2004). Real time PCR is such a tool. In the present study the enhancement 
and over expression of virulence genes in environmental isolates of medical importance, P. 
stutzeri, E. agglomerans was proven employing the RT-PCR method. This confirms the idea of 
enhanced drug resistance and survival of bacterial pathogens in natural environments.
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Chapter 6. General Discussion
“It is not the strongest o f  the species that survives, nor the most intelligent, but rather 
the one most adaptable to change. ” (Megginson, 1963).
Present day bacteria fit directly into this famous description in gaining antibiotic resistance and surviving 
well enough in the antibiotic era. According to WHO “Anti-Microbial Resistance is a natural phenomenon 
accelerated by use of antimicrobial medicines” (WHO, 2014). The incidence of antibiotic resistance is 
ever increasing and does not show any signs of slowing down (Tang et al., 2014). The achievements of 
modem medicine are put at risk by antimicrobial resistance. Without effective antimicrobials for 
prevention and treatment of infections, the success of organ transplantation, cancer chemotherapy and 
major surgery would be compromised (WHO, 2015).
It is estimated that approximately 5 to 12% of patients acquire an infection during their 
hospital stay in the European Union (EU), Norway and Iceland. Approximately 400,000 hospital 
patients in the EU contract a resistant strain and 25,000 die of the complication arising from these 
infections annually (World Health Organization 2015). The economic burden associated with 
management of antimicrobial resistant strain infections is tremendous. Multidrug-resistant 
(MDR) bacteria in the EU are estimated to cause an economic loss of more than €1.5 billion each 
year (World Health Organization 2015).
Antibiotic-resistance mechanisms in bacteria have evolved by two major pathways, (1) 
mutation (Martinez & Baquero, 2000) and (2) attainment of resistance genes from the natural 
environment by horizontal gene transfer (Davies, 1994). Among these two, horizontal gene 
transfer plays a major role in the rapid spread of resistance among microbial species (Martinez,
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2009) and in most cases the antibiotic resistance genes originate in the environmental microbiota 
(Davies, 1997).
Thus, this study was designed to focus upon assessing the role of the natural environment 
in acting as a stage for the development of and a reservoir for antibiotic resistance genes and 
antibiotic-resistant pathogens. The thesis hypothesis was: The environment serves as a reservoir 
of antibiotic resistant bacteria and the Null hypothesis set was: The environment does not serve as 
a reservoir of the antibiotic resistant bacteria.
A river with an associated high anthropogenic and agricultural activity was chosen for the 
study to test the hypothesis. The presence of antibiotic resistance genes and pathogens in aquatic 
ecosystems has been proven by many scientists previously (Hamelin et al, 2007; Servais & 
Passerat 2009; Stoppe et al., 2014). The occurrence of antibiotic resistant bacteria in the natural 
environment can be due to a variety of reasons, including natural production of antibiotics by soil 
microbes, run-off from animal feed or crops contaminated with growth promoting antibiotics and 
from waste products originating from farm bred animals or humans (Boon & Cattanach, 1999; 
Davies, 1994; Levy, 1997; Tenover & McGowan, 1996; Witte, 1997, 1998). Recently a group of 
researchers have isolated fluoroquinolone and macrolide resistant Campylobacter spp. from the 
intestinal content and excreta of broiler chickens and swine from slaughter houses and 
conventional farms in China (Wang et al., 2015). The situation is important and indicative of the 
bacterial trend towards widespread resistance, that researchers have concluded that these 
antibiotics are no longer suitable for the treatment of human campylobacteriosis in China (Wang 
et a l, 2015).
In our study membrane filtration techniques were used to isolate and analyze the 
microbiota of the water samples. The membrane bound microbes were then grown on a variety of 
nutrient agar media, under both aerobic and anaerobic conditions in order to isolate the maximum
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number of bacteria belonging to both categories. A total of 146 bacterial isolates were isolated to 
pure culture and putatively identified using API strips. These isolates were subsequently tested 
for their antibiotic sensitivity (Table 3.6). The isolated strains were tested against a total of 16 
antibiotics; chloramphenicol, erythromycin, fusidic acid, oxacillin G, novobiocin, penicillin G, 
streptomycin, tetracycline, ampicillin, cephalothin, colistin sulphate, gentamicin, streptomycin, 
sulphatriad, tetracycline and co-trimoxazole. A significant number of bacterial isolates exhibited 
antibiotic resistance against one or more o f the selected antibiotics. Therefore, the hypothesis that 
the environment serves as a reservoir of antibiotic resistant bacteria was proven in this 
preliminary study.
Similar results were obtained in a study conducted in Victoria, South-Eastern Australia in 
Escherichia coli isolated from the Yarra River (Boon & Cattanach, 1999). The incidence of 
resistance towards ampicillin, chloramphenicol, kanamycin, nalidixic acid, neomycin and 
streptomycin and penicillin was found to be significant (Boon & Cattanach, 1999). In a separate 
study conducted by a group of researchers from the US, they reported similar observations (Ash 
et al., 2002). They isolated antibiotic-resistant bacteria from 16 different rivers that were resistant 
to P-lactam and non-p-lactam antibiotics. The antibiotics tested in their study include cefotaxime, 
ceftazidime, amoxicillin (plus clavulanic acid), cephalothin, imipenem, kanamycin, streptomycin, 
chloramphenicol, tetracycline and ciprofloxacin. An estimate of 40% of the total bacteria isolated 
were found to be resistant to more than one antibiotic and had at least one plasmid (Ash et al., 
2002) .
In this study, a total of 20 bacterial strains, which showed significant multidrug resistance 
were selected for further study. In addition to that, 13 isolates which possessed resistance towards 
penicillin G and tetracycline were also chosen for a drug inhibition assay in the 96-well plate 
system (Table 3.6). Four antibiotics chosen for the study included ampicillin, co-trimoxazole,
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novobiocin and tetracycline. Ampicillin is a broad spectrum semi-synthetic derivative of 
penicillin that can be taken orally to combat Gram-positive and Gram-negative bacteria 
(Rafailidis et al., 2007). Co-trimoxazole is a combination of drug used against both Gram­
positive and Gram-negative organisms. It is found to be effective in the treatment of many 
infections, especially Pneumocystis pneumonia in AIDS patients (Suthar et al., 2012). 
Novobiocin is a drug of choice for treating Gram-positive bacterial infections (Robson & 
Baddiley, 1977). Tetracycline is an aphthacene antibiotic that inhibits amino-acyl-tRNA binding 
during protein synthesis in bacteria. It is used against bacterial infections, especially pneumonia 
and other respiratory tract infections (PUB Chem, n.d.) Of the 33 bacterial isolates studied, five 
bacterial isolates exhibited resistance to all four antibiotics as evidenced by positive absorbance 
readings (450nm) in microtitre wells containing antibiotics at a concentration greater than 
128pg/mL in the drug inhibition assay (Table 3.7). These five strains were then identified using 
16S rRNA gene sequencing as Enterobacter spp., Burkholderia cepacia, Aeromonas hydrophila, 
Enterobacter agglomerans and Pseudomonas stutzeri (Table 3.8). These bacterial isolates were 
then subjected to further studies, which included screening for the presence of (i) plasmids, (ii) 
efflux pump, (iii) p-lactamase-mediated drug resistance, (iv) proteomic characterization, (v) 
comparison of outer membrane proteins of environmental isolates with laboratory strains and (vi) 
genomic characterization and comparison of virulence genes of environmental isolates with 
laboratory strains.
Enterobacter spp. are responsible for a substantial number of hospital infections attacking 
the lungs, urinary tract, intra-abdominal cavity and intravascular devices (Nazarowec-White & 
Farber, 1997). In one study, over 33,869 Gram-negative bacteria were isolated from intensive 
care units in the United States of which 16.1% comprised o f Enterobacter spp. (Itokazu et
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al, 1996). The isolated Enterobacter spp. exhibited marked resistance towards extended-spectrum 
cephalosporins (Itokazu et al, 1996).
Burkholderia cepacia is a Gram-negative bacterium, which is responsible for 
opportunistic infections in immuno-compromised patients or those who are hospitalized (Baylan, 
2012). Patients with underlying respiratory diseases, like cystic fibrosis and chronic 
granulomatous disease are more prone to infection by Burkholderia cepacia (Matthaiou et a l,
2011). B. cepacia complex (Bcc) bacteria are known to exhibit multidrug resistance via innate 
and acquired mechanisms of resistance (Aaron et al, 2000; Bums & Saiman 1999; Burns et al, 
1996; Nair et a l, 2004). In a study among cystic fibrosis patients with Burkholderia 
cepacia infection, 62 to 97% were found to harbour bacteria that were resistant towards 
antibiotics meropenem, ciprofloxacin, minocycline, trimethoprim-sulfamethoxazole and 
chloramphenicol (Zhou et al, 2007).
The genus Aeromonas includes Gram-negative, rod shaped bacteria comprising several 
species, and are associated with the aquatic environment. Aeromonas spp. have been reported in 
cases of septicaemia, gastroenteritis and skin diseases among human (Joseph et a l, 2013). In a 
study conducted on Aeromonas species isolated from aquatic environments a significant number 
of them were found out to be resistant towards antibiotics vancomycin, ampicillin, co- 
trimoxazole, nalidixic acid, tetracycline and rifampicin and 20% of them scored a MAR index 
that was higher than 0.2, which is indicative of the high risk environment (Joseph et a l, 2013).
Pseudomonas stutzeri is an aerobic, Gram-negative bacterium. It is generally found as a 
saprophyte in soil and water. However, it occasionally results in serious community or hospital 
acquired infections (Lalucat et a l, 2006), mainly in immuno-compromised patients with 
underlying conditions or in those who have undergone surgery (Noble & Overman, 1994). 
Pseudomonas stutzeri are mainly isolated from such patients’ surgical wounds, blood,
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respiratory tract and urine samples (Holmes 1986; Taneja et al., 2004). Pseudomonas 
stutzeri are generally susceptible to most of the antibiotics (Noble & Overman 1994; Tattawasart 
et al, 1999) owing to their lower incidence of infection in humans and hence, their lower 
exposure to antibiotics (Lalucat et al., 2006). However, it should be noted that drug- 
resistant forms may develop amongst clinical isolates and have been recovered for almost all 
antibiotic families (Lalucat et al., 2006).
Therefore, the first objective of the study “...to isolate and identify Gram-negative 
bacteria from a natural water environment that display multi-drug resistance” has been 
successfully achieved. A total of 146 bacterial organisms were initially isolated from the river 
water sample and from them 33 of them were selected based on the antibiotic sensitivity assay. 
Among the 33 isolates, five bacterial isolates which exhibited multidrug resistance (MDR) in 
drug inhibition assay were identified and used for further study. Thus, it can be concluded from 
the first part of experimental proves the hypothesis of the thesis that environment as a reservoir 
of antibiotic resistant bacteria.
The presence of bacterial isolates exhibiting high levels of antibacterial drug resistance 
can be directly related to high anthropogenic activity (Ayandiran et al., 2014). The incidence of 
bacterial resistance in river ecosystems is a highly dangerous situation, as the probability of 
people becoming infected by these organisms directly or indirectly through consumption of river 
fauna is significant (Schmidt et al., 2001). The prevalence of intrinsic multi-resistance to 
common antibiotics has been previously reported (Wright 2007; Baltz 2008; Brown & Balkwill 
2009; Thaller et al., 2010).
The mechanism by which different bacterial species attain antibiotic resistance varies 
widely depending on the bacteria and the environment in which they are present. The three 
fundamental mechanisms by which bacteria achieve this are; (i) enzymatic degradation of
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antibacterial drugs (e.g. the most prominent example being p-lactamase), (ii) alteration of 
bacterial proteins that are antimicrobial targets and (iii) through changes in membrane 
permeability to antibiotics (e.g. efflux pumps). Antibiotic resistance can be either plasmid- 
mediated or maintained on the bacterial chromosome (Dever, 1991). Therefore, in this study, the 
five selected bacterial species exhibiting multiple antibiotic resistance (MAR) were subjected to a 
series of experiments designed to exhibit whether the resistance they have acquired is plasmid- 
mediated, efflux pump mediated drug resistance or via the production of p-lactamase enzyme 
production.
Among various mechanisms, plasmid mediated drug resistance is of paramount 
importance as they aid in transference of non-conjugative and conjugative transposons housing 
resistance genes between different species and genera. Plasmids also play an important role in the 
dissemination of antimicrobial resistance genes within the gene pool in an environment (Wu et 
al., 2014). The presence of plasmid mediated drug resistance was studied employing 
transformation experiments using DH5a Escherichia coli. Plasmids isolated from all the bacterial 
strains under study were transformed into the DH5a E. coli cells. The transformants were 
subsequently grown on ampicillin-containing LB agar plates. DH5a E. coli cells containing 
plasmids from Burkholderia cepacia and Aeromonas hydrophila grew in LB agar plates 
containing ampicillin at a concentration of 128pg/mL and 64pg/mL respectively indicating the 
role of plasmids in transfer of drug resistance (Table 4.1). The presence of plasmid-mediated 
drug resistance has been previously reported in Burkholderia cepacia isolated from brackish 
water aquaculture farms in India (Kumar & Surendran, 2006). Six strains exhibiting multidrug 
resistance when tested for the presence of plasmid showed that all the strains harboured three, 
high copy number small plasmids of size 4kb, 2kb and <2.0 kb. Plasmid based antibiotic 
resistance was proven via curing and transformation experiments (Kumar & Surendran, 2006).
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Similarly the presence of plasmid mediated drug resistance in Aeromonas hydrophila was proven 
in a study on Aeromonas hydrophila isolates from skin lesions of the common freshwater fish, 
Telapia mossambica (Son et al., 1997). Of the 21 fish isolates studied, seven of them harboured 
plasmids, with sizes ranging from 3 to 63.4 kb. Plasmid based antibiotic resistance was proven 
using an Escherichia coli recipient by single-step conjugation (Son et al., 1997).
The presence of efflux pump mediated drug resistance was studied using the efflux 
inhibitor carbonyl cyanide m-chlorophenyl-hydrazone (CCCP). The results obtained suggest the 
presence of efflux pump mediated drug resistance in Enterobacter agglomerans and Enterobacter 
spp. There was a significant reduction in MIC for Enterobacter agglomerans and Enterobacter 
spp. where exposed to antibiotics in the presence of the efflux inhibitor. The presence of CCCP in 
the medium resulted in a reduction of minimum inhibitory concentration from 64 and 128pg/mL 
to 4pg/mL and lpg/mL in case of E. agglomerans and Enterobacter spp. respectively (Table 
4.2). Efflux via a membrane pump is a common antibiotic resistance (or tolerance) mechanism 
observed in Gram-negative and Gram-positive bacteria (Mahamoud et al., 2007). It has been 
previously reported that multidrug resistant forms of Enterobacter aerogenes, possess altered O- 
polysaccharide and active efflux of chloramphenicol (Gayet et al., 2003).
The presences of p-lactamase activity in the test organisms were determined using a P- 
lactamase inhibitor, clavulanic acid. No positive correlation was observed between the bacterial 
strains and their ability to survive in presence of P-lactamase inhibitor (Table 4.3). The result is 
suggestive o f absence of P-lactamase production in all the bacteria under study.
Through these experiments the role of plasmid-mediated and efflux pump-mediated drug 
resistance has been proven in Burkholderia cepacia, Aeromonas hydrophila (plasmid-mediated) 
and Enterobacter agglomerans and Enterobacter spp. (efflux pump-mediated) (Table 6.1). The 
mechanism by which Pseudomonas stutzeri achieves drug resistance remains unclear at this stage
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and further proteomic and genomic characterization experiments were conducted in these test 
organisms to learn more about the drug resistance at a much deeper level.
Table 6.1: The mechanisms of drug resistance in Burkholderia cepacia, 















Burkholderia cepacia ✓ X X
Enterobacter agglomerans X ✓ X
Aeromonas hydrophila ✓ X X
Enterobacter spp. X s X
Pseudomonas stutzeri X X X
The results of this table (6.1) are also in general agreement with the hypothesis of the 
thesis. The presence of bacteria harbouring plasmid-mediated and efflux pump-mediated 
resistance from the environmental isolates proves the hypothesis that the environment serves as a 
reservoir of antibiotic resistant bacteria, which have the ability to transfer their resistance 
mechanisms via horizontal and vertical transmission.
The proteomic characterization of the test strains comprised of sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) analysis of the outer membrane proteins of the 
test bacterial strains. The role of outer membrane proteins in multiple drug resistance has been 
previously described in Pseudomonas aeruginosa, where three different outer membrane 
proteins, OprM, OprJ and OprN are associated with multiple drug resistance (Masuda et al.,
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1995). Similarly in the pathogenic bacteria Klebsiella pneumonia, imipenem resistance was found 
to be linked to the loss of an outer membrane protein (Bradford et al., 1997). In the present study 
the outer membrane proteins of test strains were compared with those of their standard laboratory 
strains in order to determine the influence of the environment in moulding the closely related 
species for enhancing the drug resistance. Marked variations were observed in the case of the 
organisms tested, strongly suggesting the role of outer membrane proteins in conferring 
resistance in environmental isolates (Figure 5.5; Table 5.5). These results are also in favour of 
the tested hypothesis. It has been proven that the environment harbours antibiotic resistant 
bacteria exhibiting marked variations in membrane proteins as part of their attainment of 
antibiotic resistance.
Apart from the marked heterogeneity in the total number of bands, another major 
observation from the SDS-PAGE analysis was the marked variation in expression of outer 
membrane proteins isolated. Some of the proteins were found to be present in higher 
concentrations or lower concentrations when compared to their laboratory counterparts, as 
evidenced by variation in band density in SDS-PAGE gels. This was especially true in the case 
of Enterobacter spp. and P. stutzeri. Therefore, the next sets of experiments were designed to 
analyze the differences in expression of various genes that are closely associated with bacterial 
virulence. Reverse transcriptase PCR (RT-PCR) was used to study the differences in 
concentration of mRNA, which in turn helps to characterize and correlate differences in virulence 
gene expression. The total mRNA was isolated from all the environmental isolates and their 
corresponding laboratory strains and was then subjected to cDNA synthesis. Sets of five different 
primers corresponding to different virulence genes were designed to screen the test organisms. 
The virulence genes selected for the study included OprC (P. stutzeri), Tetc (E. agglomerans and 
Enterobacter spp.) cation multidrug gene (B. cepacia) and AheB (A. hydrophila). The results of
164
this experiment are also in agreement with the test hypothesis. Expression of virulence genes in 
the environmental isolates clearly indicates the role of the environment acting as a reservoir for 
multidrug resistant bacterial species (Figure 5.8, Figure 5.9 and Table 5.6). The expression rate 
of environmental strain of P. stutzeri was 11596.45 and in the case of its laboratory counterpart it 
was only 1767.21. An increased level of expression of OprC gene, which codes for the outer 
membrane protein in environmental strain of P. stutzeri, is indicative of increased virulence. 
Variations in expression of outer membrane protein enable pathogens to enhance their virulence 
in stressful environmental conditions. The role of outer membrane proteins in providing 
multidrug resistance has been shown previously (Masuda et ah, 1995). Similarly, the presence 
and increased expression of TetC gene in the E. agglomerans environmental strain indicates the 
role of antibiotic polluted environment in increasing the expression of the tetracycline resistance 
gene. The environmental isolate recorded an expression rate of 23738.48, where as in case of its 
laboratory counterpart it was substantially lower (10259.62). The presence of the tetracycline 
resistance genes in Enterobacter spp. has been previously proved in bacterial populations isolated 
two apple orchards (Schnabel & Jones, 1999).
The findings of the present study are of great importance, especially in the wake of latest 
reports from China, where a group of scientists recently reported the emergence of the plasmid- 
mediated polymyxin resistance mechanism, MCR-1, in Enterobacteriaceae isolated from pigs. 
Polymixins are the last group of effective antibiotics against which there were no previous reports 
of plasmid-mediated drug resistance (Liu et al., 2015). Scientists warn the possibility of spread of 
this antibiotic resistant gene and the present study further confirms this threat. The environment 
can act as breeding and fostering ground for this novel drug resistant genes eventually leading to 
their pan continental spread. Modem medicine will be forced to face and fight the advent of post 
antibiotic era if no coordinated steps are taken at a global level.
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6.1 Conclusions
In the present study, the incidence of plasmid-mediated drug resistance and efflux pump- 
mediated drug resistance has been proven. In addition to that, role of various membrane proteins 
in drug resistance and the environment mediated modulation of protein expression to enhance the 
virulence and overall survivability has been indicated. The hypothesis tested in this study was 
whether the environment serves as a reservoir for antibiotic resistant bacteria or not. 
Interpretation of the results strongly supports the role of the environment, which in this case is an 
anthropogenically polluted river, in harbouring, nurturing and acting as a reservoir for various 
bacterial pathogens of medical importance.
Similar results were reported by group of researchers from Nigeria, where they have 
isolated multi drug resistant Micrococcus spp., Streptococcus spp., Staphylococcus spp., 
Bacillus spp. and Pseudomonas spp. from the anthropogenically polluted Oluwa River 
(Ayandiran et al., 2014). Similarly, sediment and water samples from Liuxi River, China were 
found out to harbour antibiotic resistance genes (ARGs).The study concluded that the river 
environment was contaminated by antibiotics and proposed the role of river as a reservoir of 
ARGs (Xiong et al., 2014). The Dighty Bum is a lotic ecosystem with a high degree of spatial 
and temporal heterogeneity. Thus, it can be further hypothesized that within the river ecosystem, 
the benthic region that is comparatively stable serves as the reservoir for antibiotic resistant 
bacteria. Non-pathogenic indigenous bacteria acquire antibiotic resistance genes through their 
encounter with pathogenic bacteria that are anthropogenically introduced. A good proportion of 
the pathogenic bacteria are attached to the particulate matter reach the benthic region of river 
ecosystem via sedimentation. The water column above the benthic region is periodically 
inoculated with antibiotic harbouring bacteria via resuspension of water column. The following 
figure (6.1) is the schematic representation of this hypothesis.
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The environment is considered to be a “m elting po t o f  antim icrobial resistance ” (Da Costa et al., 
2013). This is mainly due to two reasons, (i) antimicrobial resistance genes are transferred from 
the environmental microbiota to various bacterial pathogens via various horizontal gene transfer 
mechanisms and (ii) the actual load of and identity of antibiotic resistance genes present in the 
natural environment is still not identified correctly.
Figure 6.1: Schematic representation showing the role of benthic environment of river 
ecosystem in serving as reservoir for antibiotic resistant bacteria. Where; (1 & 2) 
Introduction of antibiotic resistant bacteria (red) by anthropogenic activity; (3) Indigenous 
non-pathogenic bacteria (green); (4) Sedimentation of antibiotic resistant bacteria; (5) 
Interaction between non-pathogenic bacteria and antibiotic resistant bacteria; (6) 
Acquisition of antibiotic resistant gene via horizontal gene transfer; (7) Dispersal of 
antibiotic resistant bacteria (blue) to the water column above the benthic level and (8) Novel 
antibiotic resistant bacteria.
This study adds to the large body of evidence that the environment, especially aquatic 
ecosystems, harbours multidrug resistant pathogens. In addition to this, confirmation of the 
existence of plasmid- and efflux pump-mediated resistance among Gram-negative pathogens 
isolated from the river is suggestive of the possibility of a rapid spread of drug resistance among
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non-pathogenic indigenous bacteria, which in due course may reach humans. The present study 
also points out the role of environment in moulding pathogens to exhibit and express higher 
virulence when compared to their laboratory-raised counterparts. Therefore, more studies in this 
field are warranted in order to understand the complex succession of attainment of resistant genes 
by human pathogens (Martinez, 2012). Well planned, coordinated and proactive steps should also 
be taken at a global scale to counter the emergence and spread for multi-drug resistant pathogens 
with special emphasis on our natural ecosystems; e.g. water bodies. It is essential to enhance the 
surveillance / implement control measures and failure or further delay to do so may lead mankind 
to the inevitable beginning to “antibiotic apocalypse” (MacKenzie, 2015).
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6.2 Suggestions for future work
The results of the present study prove that anthropogenically polluted river can act as a reservoir 
of antibiotic resistant bacteria. The role of seasonal variations in bacterial load and benthic 
environment of river ecosystem in housing antibiotic resistance bacteria remains to be clarified. 
Therefore recommendations for future work include:
1. Isolation and identification of bacterial isolates with multi-drug resistance from sediment 
samples of river environment.
2. Study of seasonal variations in bacterial load and diversity of antibiotic resistant bacteria 
in the sediment and water samples. This can be achieved by periodic sampling of water 
from the same site during different seasons. The results obtained will help us to study the 
role of season-dependant physical and chemical variations in survival of antibiotic 
resistant bacteria.
3. SDS-PAGE comparison of environmental and laboratory isolates exhibited marked 
variations in outer membrane proteins concentrations. This was more pronounced in case 
of outer membrane protein of Enterobacter spp. and P. stutzeri. Purification, 
characterization and comparison of such proteins may help us to better understand and 
molecular mechanism by which environmental strains attain antibiotic resistance. 
Purification of protein can be carried out using gel filtration chromatography or electro­
elution. The intact mass and amino-acid sequencing of purified proteins can be done using 
MALDI-TOF mass spectroscopy and N terminal amino acid sequencing.
in silico analysis and protein modelling of virulence genes of OprC gene of P. stutzeri and tetC 
gene of E. agglomerans from environmental strains and laboratory strains. The comparison of
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